id	sid	tid	token	lemma	pos
iajs-2675	1	1	26	26	NUM
iajs-2675	1	2	metabolic	metabolic	NOUN
iajs-2675	1	3	syndrome	syndrome	NOUN
iajs-2675	1	4	noorhan	noorhan	PROPN
iajs-2675	1	5	khalid	khalid	PROPN
iajs-2675	1	6	shafeeq	shafeeq	PROPN
iajs-2675	1	7	tamara	tamara	PROPN
iajs-2675	1	8	ala`a	ala`a	PROPN
iajs-2675	1	9	hussein	hussein	PROPN
iajs-2675	1	10	eiman	eiman	PROPN
iajs-2675	1	11	aa.abass	aa.abass	PROPN
iajs-2675	1	12	abstract	abstract	ADJ
iajs-2675	1	13	metabolic	metabolic	NOUN
iajs-2675	1	14	syndrome	syndrome	NOUN
iajs-2675	1	15	(	(	PUNCT
iajs-2675	1	16	mets	met	NOUN
iajs-2675	1	17	)	)	PUNCT
iajs-2675	1	18	is	be	AUX
iajs-2675	1	19	a	a	DET
iajs-2675	1	20	combination	combination	NOUN
iajs-2675	1	21	of	of	ADP
iajs-2675	1	22	health	health	NOUN
iajs-2675	1	23	disorders	disorder	NOUN
iajs-2675	1	24	that	that	PRON
iajs-2675	1	25	mainly	mainly	ADV
iajs-2675	1	26	result	result	VERB
iajs-2675	1	27	from	from	ADP
iajs-2675	1	28	overweight	overweight	NOUN
iajs-2675	1	29	and	and	CCONJ
iajs-2675	1	30	obesity	obesity	NOUN
iajs-2675	1	31	.	.	PUNCT
iajs-2675	2	1	it	it	PRON
iajs-2675	2	2	increases	increase	VERB
iajs-2675	2	3	the	the	DET
iajs-2675	2	4	risk	risk	NOUN
iajs-2675	2	5	of	of	ADP
iajs-2675	2	6	developing	develop	VERB
iajs-2675	2	7	cardiovascular	cardiovascular	ADJ
iajs-2675	2	8	disease	disease	NOUN
iajs-2675	2	9	and	and	CCONJ
iajs-2675	2	10	diabetes	diabetes	NOUN
iajs-2675	2	11	.	.	PUNCT
iajs-2675	3	1	(	(	PUNCT
iajs-2675	3	2	mets	met	NOUN
iajs-2675	3	3	)	)	PUNCT
iajs-2675	3	4	closely	closely	ADV
iajs-2675	3	5	related	relate	VERB
iajs-2675	3	6	to	to	ADP
iajs-2675	3	7	the	the	DET
iajs-2675	3	8	existence	existence	NOUN
iajs-2675	3	9	weight	weight	NOUN
iajs-2675	3	10	gain	gain	NOUN
iajs-2675	3	11	or	or	CCONJ
iajs-2675	3	12	obesity	obesity	NOUN
iajs-2675	3	13	and	and	CCONJ
iajs-2675	3	14	laziness	laziness	NOUN
iajs-2675	3	15	.	.	PUNCT
iajs-2675	4	1	it	it	PRON
iajs-2675	4	2	increases	increase	VERB
iajs-2675	4	3	the	the	DET
iajs-2675	4	4	serum	serum	NOUN
iajs-2675	4	5	levels	level	NOUN
iajs-2675	4	6	of	of	ADP
iajs-2675	4	7	tnf	tnf	PROPN
iajs-2675	4	8	-	-	PUNCT
iajs-2675	4	9	α	α	PROPN
iajs-2675	4	10	and	and	CCONJ
iajs-2675	4	11	change	change	VERB
iajs-2675	4	12	the	the	DET
iajs-2675	4	13	levels	level	NOUN
iajs-2675	4	14	of	of	ADP
iajs-2675	4	15	a	a	DET
iajs-2675	4	16	number	number	NOUN
iajs-2675	4	17	of	of	ADP
iajs-2675	4	18	other	other	ADJ
iajs-2675	4	19	parameters	parameter	NOUN
iajs-2675	4	20	(	(	PUNCT
iajs-2675	4	21	e.g.	e.g.	ADV
iajs-2675	4	22	,	,	PUNCT
iajs-2675	4	23	adiponectin	adiponectin	NOUN
iajs-2675	4	24	,	,	PUNCT
iajs-2675	4	25	resistin	resistin	NOUN
iajs-2675	4	26	,	,	PUNCT
iajs-2675	4	27	and	and	CCONJ
iajs-2675	4	28	pai-1	pai-1	NUM
iajs-2675	4	29	)	)	PUNCT
iajs-2675	4	30	.	.	PUNCT
iajs-2675	5	1	tnf	tnf	PROPN
iajs-2675	5	2	-	-	PUNCT
iajs-2675	5	3	α	α	PROPN
iajs-2675	5	4	dose	dose	VERB
iajs-2675	5	5	not	not	PART
iajs-2675	5	6	only	only	ADV
iajs-2675	5	7	appear	appear	VERB
iajs-2675	5	8	to	to	PART
iajs-2675	5	9	cause	cause	VERB
iajs-2675	5	10	the	the	DET
iajs-2675	5	11	production	production	NOUN
iajs-2675	5	12	of	of	ADP
iajs-2675	5	13	inflammatory	inflammatory	ADJ
iajs-2675	5	14	cytokines	cytokine	NOUN
iajs-2675	5	15	.	.	PUNCT
iajs-2675	6	1	it	it	PRON
iajs-2675	6	2	can	can	AUX
iajs-2675	6	3	trigger	trigger	VERB
iajs-2675	6	4	cell	cell	NOUN
iajs-2675	6	5	signaling	signal	VERB
iajs-2675	6	6	by	by	ADP
iajs-2675	6	7	interacting	interact	VERB
iajs-2675	6	8	with	with	ADP
iajs-2675	6	9	tnf	tnf	PROPN
iajs-2675	6	10	-	-	PUNCT
iajs-2675	6	11	α	α	NOUN
iajs-2675	6	12	receptors	receptor	NOUN
iajs-2675	6	13	that	that	PRON
iajs-2675	6	14	can	can	AUX
iajs-2675	6	15	lead	lead	VERB
iajs-2675	6	16	to	to	ADP
iajs-2675	6	17	insulin	insulin	NOUN
iajs-2675	6	18	resistance	resistance	NOUN
iajs-2675	6	19	.	.	PUNCT
iajs-2675	7	1	usually	usually	ADV
iajs-2675	7	2	,	,	PUNCT
iajs-2675	7	3	the	the	DET
iajs-2675	7	4	digestive	digestive	ADJ
iajs-2675	7	5	system	system	NOUN
iajs-2675	7	6	molders	molder	NOUN
iajs-2675	7	7	the	the	DET
iajs-2675	7	8	foods	food	NOUN
iajs-2675	7	9	you	you	PRON
iajs-2675	7	10	eat	eat	VERB
iajs-2675	7	11	and	and	CCONJ
iajs-2675	7	12	converts	convert	VERB
iajs-2675	7	13	them	they	PRON
iajs-2675	7	14	to	to	PART
iajs-2675	7	15	glucose	glucose	VERB
iajs-2675	7	16	.	.	PUNCT
iajs-2675	8	1	insulin	insulin	NOUN
iajs-2675	8	2	is	be	AUX
iajs-2675	8	3	an	an	DET
iajs-2675	8	4	anabolic	anabolic	ADJ
iajs-2675	8	5	hormone	hormone	NOUN
iajs-2675	8	6	produced	produce	VERB
iajs-2675	8	7	by	by	ADP
iajs-2675	8	8	the	the	DET
iajs-2675	8	9	pancreas	pancrea	NOUN
iajs-2675	8	10	that	that	PRON
iajs-2675	8	11	aids	aid	VERB
iajs-2675	8	12	glucose	glucose	NOUN
iajs-2675	8	13	get	get	VERB
iajs-2675	8	14	in	in	ADP
iajs-2675	8	15	your	your	PRON
iajs-2675	8	16	cells	cell	NOUN
iajs-2675	8	17	.	.	PUNCT
iajs-2675	9	1	to	to	PART
iajs-2675	9	2	be	be	AUX
iajs-2675	9	3	utilize	utilize	NOUN
iajs-2675	9	4	,	,	PUNCT
iajs-2675	9	5	as	as	ADP
iajs-2675	9	6	an	an	DET
iajs-2675	9	7	energy	energy	NOUN
iajs-2675	9	8	source	source	NOUN
iajs-2675	9	9	.cells	.cells	PUNCT
iajs-2675	9	10	do	do	AUX
iajs-2675	9	11	not	not	PART
iajs-2675	9	12	respond	respond	VERB
iajs-2675	9	13	to	to	ADP
iajs-2675	9	14	insulin	insulin	NOUN
iajs-2675	9	15	normally	normally	ADV
iajs-2675	9	16	,	,	PUNCT
iajs-2675	9	17	and	and	CCONJ
iajs-2675	9	18	sugar	sugar	NOUN
iajs-2675	9	19	can	can	AUX
iajs-2675	9	20	not	not	PART
iajs-2675	9	21	easily	easily	ADV
iajs-2675	9	22	enter	enter	VERB
iajs-2675	9	23	cells	cell	NOUN
iajs-2675	9	24	in	in	ADP
iajs-2675	9	25	people	people	NOUN
iajs-2675	9	26	with	with	ADP
iajs-2675	9	27	insulin	insulin	NOUN
iajs-2675	9	28	resistance	resistance	NOUN
iajs-2675	9	29	.	.	PUNCT
iajs-2675	10	1	as	as	ADP
iajs-2675	10	2	outcome	outcome	NOUN
iajs-2675	10	3	,	,	PUNCT
iajs-2675	10	4	blood	blood	NOUN
iajs-2675	10	5	glucose	glucose	NOUN
iajs-2675	10	6	rises	rise	NOUN
iajs-2675	10	7	,	,	PUNCT
iajs-2675	10	8	until	until	SCONJ
iajs-2675	10	9	the	the	DET
iajs-2675	10	10	body	body	NOUN
iajs-2675	10	11	produces	produce	VERB
iajs-2675	10	12	more	more	ADJ
iajs-2675	10	13	insulin	insulin	NOUN
iajs-2675	10	14	in	in	ADP
iajs-2675	10	15	an	an	DET
iajs-2675	10	16	attempt	attempt	NOUN
iajs-2675	10	17	to	to	PART
iajs-2675	10	18	lower	lower	VERB
iajs-2675	10	19	blood	blood	NOUN
iajs-2675	10	20	sugar	sugar	NOUN
iajs-2675	10	21	.	.	PUNCT
iajs-2675	11	1	the	the	DET
iajs-2675	11	2	following	follow	VERB
iajs-2675	11	3	factors	factor	NOUN
iajs-2675	11	4	increase	increase	VERB
iajs-2675	11	5	the	the	DET
iajs-2675	11	6	chance	chance	NOUN
iajs-2675	11	7	of	of	ADP
iajs-2675	11	8	developing	develop	VERB
iajs-2675	11	9	mets	met	NOUN
iajs-2675	11	10	as	as	SCONJ
iajs-2675	11	11	age	age	NOUN
iajs-2675	11	12	increases	increase	VERB
iajs-2675	11	13	the	the	DET
iajs-2675	11	14	risk	risk	NOUN
iajs-2675	11	15	of	of	ADP
iajs-2675	11	16	developing	develop	VERB
iajs-2675	11	17	mets	met	NOUN
iajs-2675	11	18	with	with	ADP
iajs-2675	11	19	age	age	NOUN
iajs-2675	11	20	and	and	CCONJ
iajs-2675	11	21	ethnicity	ethnicity	NOUN
iajs-2675	11	22	.	.	PUNCT
iajs-2675	12	1	in	in	ADP
iajs-2675	12	2	the	the	DET
iajs-2675	12	3	united	united	PROPN
iajs-2675	12	4	states	states	PROPN
iajs-2675	12	5	,	,	PUNCT
iajs-2675	12	6	it	it	PRON
iajs-2675	12	7	appears	appear	VERB
iajs-2675	12	8	that	that	SCONJ
iajs-2675	12	9	women	woman	NOUN
iajs-2675	12	10	of	of	ADP
iajs-2675	12	11	mexican	mexican	ADJ
iajs-2675	12	12	descent	descent	NOUN
iajs-2675	12	13	are	be	AUX
iajs-2675	12	14	more	more	ADV
iajs-2675	12	15	likely	likely	ADJ
iajs-2675	12	16	to	to	PART
iajs-2675	12	17	develop	develop	VERB
iajs-2675	12	18	mets	met	NOUN
iajs-2675	12	19	.	.	PUNCT
iajs-2675	13	1	obesity	obesity	NOUN
iajs-2675	13	2	carrying	carry	VERB
iajs-2675	13	3	an	an	DET
iajs-2675	13	4	extra	extra	ADJ
iajs-2675	13	5	amount	amount	NOUN
iajs-2675	13	6	of	of	ADP
iajs-2675	13	7	weight	weight	NOUN
iajs-2675	13	8	,	,	PUNCT
iajs-2675	13	9	especially	especially	ADV
iajs-2675	13	10	in	in	ADP
iajs-2675	13	11	the	the	DET
iajs-2675	13	12	abdomen	abdomen	NOUN
iajs-2675	13	13	,	,	PUNCT
iajs-2675	13	14	increases	increase	VERB
iajs-2675	13	15	the	the	DET
iajs-2675	13	16	risk	risk	NOUN
iajs-2675	13	17	of	of	ADP
iajs-2675	13	18	mets	met	NOUN
iajs-2675	13	19	.	.	PUNCT
iajs-2675	14	1	from	from	ADP
iajs-2675	14	2	this	this	DET
iajs-2675	14	3	review	review	NOUN
iajs-2675	14	4	,	,	PUNCT
iajs-2675	14	5	it	it	PRON
iajs-2675	14	6	stated	state	VERB
iajs-2675	14	7	that	that	SCONJ
iajs-2675	14	8	metabolic	metabolic	NOUN
iajs-2675	14	9	syndrome	syndrome	NOUN
iajs-2675	14	10	stands	stand	VERB
iajs-2675	14	11	for	for	ADP
iajs-2675	14	12	the	the	DET
iajs-2675	14	13	constellation	constellation	NOUN
iajs-2675	14	14	of	of	ADP
iajs-2675	14	15	cardiovascular	cardiovascular	ADJ
iajs-2675	14	16	risk	risk	NOUN
iajs-2675	14	17	factors	factor	NOUN
iajs-2675	14	18	that	that	PRON
iajs-2675	14	19	raise	raise	VERB
iajs-2675	14	20	the	the	DET
iajs-2675	14	21	risk	risk	NOUN
iajs-2675	14	22	of	of	ADP
iajs-2675	14	23	cardiovascular	cardiovascular	ADJ
iajs-2675	14	24	arteriosclerosis	arteriosclerosis	NOUN
iajs-2675	14	25	and	and	CCONJ
iajs-2675	14	26	type	type	NOUN
iajs-2675	14	27	2	2	NUM
iajs-2675	14	28	diabetes	diabetes	NOUN
iajs-2675	14	29	.	.	PUNCT
iajs-2675	15	1	type	type	NOUN
iajs-2675	15	2	2	2	NUM
iajs-2675	15	3	diabetes	diabetes	NOUN
iajs-2675	15	4	is	be	AUX
iajs-2675	15	5	a	a	DET
iajs-2675	15	6	major	major	ADJ
iajs-2675	15	7	global	global	ADJ
iajs-2675	15	8	public	public	ADJ
iajs-2675	15	9	health	health	NOUN
iajs-2675	15	10	issue	issue	NOUN
iajs-2675	15	11	with	with	ADP
iajs-2675	15	12	more	more	ADJ
iajs-2675	15	13	than	than	ADP
iajs-2675	15	14	300	300	NUM
iajs-2675	15	15	million	million	NUM
iajs-2675	15	16	people	people	NOUN
iajs-2675	15	17	projected	project	VERB
iajs-2675	15	18	in	in	ADP
iajs-2675	15	19	2025	2025	NUM
iajs-2675	15	20	.	.	PUNCT
iajs-2675	16	1	ibn	ibn	PROPN
iajs-2675	16	2	al	al	PROPN
iajs-2675	16	3	haitham	haitham	PROPN
iajs-2675	16	4	journal	journal	PROPN
iajs-2675	16	5	for	for	ADP
iajs-2675	16	6	pure	pure	ADJ
iajs-2675	16	7	and	and	CCONJ
iajs-2675	16	8	applied	apply	VERB
iajs-2675	16	9	science	science	NOUN
iajs-2675	16	10	journal	journal	PROPN
iajs-2675	16	11	homepage	homepage	NOUN
iajs-2675	16	12	:	:	PUNCT
iajs-2675	16	13	http://jih.uobaghdad.edu.iq/index.php/j/index	http://jih.uobaghdad.edu.iq/index.php/j/index	NOUN
iajs-2675	16	14	doi	doi	NOUN
iajs-2675	16	15	:	:	PUNCT
iajs-2675	16	16	10.30526/34.3.2675	10.30526/34.3.2675	PROPN
iajs-2675	16	17	article	article	NOUN
iajs-2675	16	18	history	history	NOUN
iajs-2675	16	19	:	:	PUNCT
iajs-2675	16	20	received	receive	VERB
iajs-2675	16	21	23	23	NUM
iajs-2675	16	22	march	march	NOUN
iajs-2675	16	23	2021	2021	NUM
iajs-2675	16	24	,	,	PUNCT
iajs-2675	16	25	accepted	accept	VERB
iajs-2675	16	26	1	1	NUM
iajs-2675	16	27	june	june	PROPN
iajs-2675	16	28	2021	2021	NUM
iajs-2675	16	29	,	,	PUNCT
iajs-2675	16	30	published	publish	VERB
iajs-2675	16	31	in	in	ADP
iajs-2675	16	32	2021	2021	NUM
iajs-2675	16	33	.	.	PUNCT
iajs-2675	17	1	department	department	NOUN
iajs-2675	17	2	of	of	ADP
iajs-2675	17	3	chemistry/	chemistry/	NUM
iajs-2675	17	4	college	college	NOUN
iajs-2675	17	5	of	of	ADP
iajs-2675	17	6	education	education	NOUN
iajs-2675	17	7	,	,	PUNCT
iajs-2675	17	8	for	for	ADP
iajs-2675	17	9	pure	pure	ADJ
iajs-2675	17	10	science(ibn	science(ibn	PROPN
iajs-2675	17	11	-	-	PUNCT
iajs-2675	17	12	al	al	PROPN
iajs-2675	17	13	-	-	PUNCT
iajs-2675	17	14	haitham	haitham	PROPN
iajs-2675	17	15	)	)	PUNCT
iajs-2675	17	16	university	university	PROPN
iajs-2675	17	17	of	of	ADP
iajs-2675	17	18	baghdad	baghdad	PROPN
iajs-2675	17	19	.	.	PUNCT
iajs-2675	18	1	iraq	iraq	PROPN
iajs-2675	18	2	noorhan.albayaty@gmail.com	noorhan.albayaty@gmail.com	PROPN
iajs-2675	18	3	department	department	PROPN
iajs-2675	18	4	of	of	ADP
iajs-2675	18	5	chemistry/	chemistry/	NUM
iajs-2675	18	6	college	college	NOUN
iajs-2675	18	7	of	of	ADP
iajs-2675	18	8	education	education	NOUN
iajs-2675	18	9	,	,	PUNCT
iajs-2675	18	10	for	for	ADP
iajs-2675	18	11	pure	pure	ADJ
iajs-2675	18	12	science(ibn	science(ibn	PROPN
iajs-2675	18	13	-	-	PUNCT
iajs-2675	18	14	al	al	PROPN
iajs-2675	18	15	-	-	PUNCT
iajs-2675	18	16	haitham	haitham	PROPN
iajs-2675	18	17	)	)	PUNCT
iajs-2675	18	18	university	university	PROPN
iajs-2675	18	19	of	of	ADP
iajs-2675	18	20	baghdad	baghdad	PROPN
iajs-2675	18	21	.	.	PUNCT
iajs-2675	19	1	iraq	iraq	PROPN
iajs-2675	19	2	drbiochem2007@gmail.com	drbiochem2007@gmail.com	PROPN
iajs-2675	19	3	department	department	PROPN
iajs-2675	19	4	of	of	ADP
iajs-2675	19	5	chemistry/	chemistry/	NUM
iajs-2675	19	6	college/	college/	NUM
iajs-2675	19	7	faculty	faculty	NOUN
iajs-2675	19	8	of	of	ADP
iajs-2675	19	9	dentistry	dentistry	NOUN
iajs-2675	19	10	/	/	SYM
iajs-2675	19	11	university	university	PROPN
iajs-2675	19	12	of	of	ADP
iajs-2675	19	13	kufa	kufa	PROPN
iajs-2675	19	14	.	.	PUNCT
iajs-2675	20	1	tamara.hussein@uokufa.edu.iq	tamara.hussein@uokufa.edu.iq	PROPN
iajs-2675	20	2	mailto:noorha.albayaty@gmail.com	mailto:noorha.albayaty@gmail.com	PROPN
iajs-2675	20	3	mailto:noorha.albayaty@gmail.com	mailto:noorha.albayaty@gmail.com	PROPN
iajs-2675	20	4	mailto:drbiochem2007@gmail.com	mailto:drbiochem2007@gmail.com	PROPN
iajs-2675	20	5	mailto:tamara.hussein@uokufa.edu.iq	mailto:tamara.hussein@uokufa.edu.iq	PROPN
iajs-2675	20	6	ibn	ibn	PROPN
iajs-2675	20	7	al	al	PROPN
iajs-2675	20	8	-	-	PUNCT
iajs-2675	20	9	haitham	haitham	PROPN
iajs-2675	20	10	jour	jour	X
iajs-2675	20	11	.	.	PROPN
iajs-2675	21	1	for	for	ADP
iajs-2675	21	2	pure	pure	ADJ
iajs-2675	21	3	&	&	CCONJ
iajs-2675	21	4	appl	appl	PROPN
iajs-2675	21	5	.	.	PUNCT
iajs-2675	22	1	sci	sci	PROPN
iajs-2675	22	2	.	.	PROPN
iajs-2675	23	1	34(3)2021	34(3)2021	NUM
iajs-2675	23	2	27	27	NUM
iajs-2675	23	3	keywords	keyword	NOUN
iajs-2675	23	4	:	:	PUNCT
iajs-2675	23	5	metabolic	metabolic	NOUN
iajs-2675	23	6	syndrome	syndrome	NOUN
iajs-2675	23	7	,	,	PUNCT
iajs-2675	23	8	obesity	obesity	NOUN
iajs-2675	23	9	,	,	PUNCT
iajs-2675	23	10	diabetes	diabetes	NOUN
iajs-2675	23	11	.	.	PUNCT
iajs-2675	24	1	1.introduction	1.introduction	NUM
iajs-2675	24	2	metabolic	metabolic	NOUN
iajs-2675	24	3	syndrome	syndrome	NOUN
iajs-2675	24	4	(	(	PUNCT
iajs-2675	24	5	mets	met	NOUN
iajs-2675	24	6	)	)	PUNCT
iajs-2675	24	7	in	in	ADP
iajs-2675	24	8	individuals	individual	NOUN
iajs-2675	24	9	sensitive	sensitive	ADJ
iajs-2675	24	10	to	to	ADP
iajs-2675	24	11	cardiovascular	cardiovascular	ADJ
iajs-2675	24	12	disease	disease	NOUN
iajs-2675	24	13	(	(	PUNCT
iajs-2675	24	14	cvd	cvd	PROPN
iajs-2675	24	15	)	)	PUNCT
iajs-2675	24	16	and	and	CCONJ
iajs-2675	24	17	type	type	NOUN
iajs-2675	24	18	2	2	NUM
iajs-2675	24	19	diabetes	diabetes	NOUN
iajs-2675	24	20	(	(	PUNCT
iajs-2675	24	21	t2	t2	NOUN
iajs-2675	24	22	dm	dm	NOUN
iajs-2675	24	23	)	)	PUNCT
iajs-2675	24	24	had	have	AUX
iajs-2675	24	25	been	be	AUX
iajs-2675	24	26	theorized	theorize	VERB
iajs-2675	24	27	in	in	ADP
iajs-2675	24	28	accordance	accordance	NOUN
iajs-2675	24	29	with	with	ADP
iajs-2675	24	30	a	a	DET
iajs-2675	24	31	constellation	constellation	NOUN
iajs-2675	24	32	of	of	ADP
iajs-2675	24	33	risk	risk	NOUN
iajs-2675	24	34	factors	factor	NOUN
iajs-2675	24	35	like	like	ADP
iajs-2675	24	36	high	high	ADJ
iajs-2675	24	37	rapid	rapid	ADJ
iajs-2675	24	38	blood	blood	NOUN
iajs-2675	24	39	glucose	glucose	NOUN
iajs-2675	24	40	,	,	PUNCT
iajs-2675	24	41	atheragenic	atheragenic	ADJ
iajs-2675	24	42	dyslipidemia	dyslipidemia	NOUN
iajs-2675	24	43	,	,	PUNCT
iajs-2675	24	44	high	high	ADJ
iajs-2675	24	45	blood	blood	NOUN
iajs-2675	24	46	pressure	pressure	NOUN
iajs-2675	24	47	,	,	PUNCT
iajs-2675	24	48	and	and	CCONJ
iajs-2675	24	49	abdominal	abdominal	ADJ
iajs-2675	24	50	obesity	obesity	NOUN
iajs-2675	24	51	[	[	X
iajs-2675	24	52	1	1	NUM
iajs-2675	24	53	]	]	PUNCT
iajs-2675	24	54	.	.	PUNCT
iajs-2675	25	1	guidelines	guideline	NOUN
iajs-2675	25	2	were	be	AUX
iajs-2675	25	3	developed	develop	VERB
iajs-2675	25	4	by	by	ADP
iajs-2675	25	5	means	mean	NOUN
iajs-2675	25	6	of	of	ADP
iajs-2675	25	7	readily	readily	ADV
iajs-2675	25	8	existing	exist	VERB
iajs-2675	25	9	clinical	clinical	ADJ
iajs-2675	25	10	variables	variable	NOUN
iajs-2675	25	11	for	for	ADP
iajs-2675	25	12	a	a	DET
iajs-2675	25	13	clinical	clinical	ADJ
iajs-2675	25	14	and	and	CCONJ
iajs-2675	25	15	epidemiological	epidemiological	ADJ
iajs-2675	25	16	managing	managing	NOUN
iajs-2675	25	17	of	of	ADP
iajs-2675	25	18	mets	met	NOUN
iajs-2675	25	19	.	.	PUNCT
iajs-2675	26	1	[	[	X
iajs-2675	26	2	2	2	NUM
iajs-2675	26	3	]	]	PUNCT
iajs-2675	26	4	.	.	PUNCT
iajs-2675	27	1	several	several	ADJ
iajs-2675	27	2	researches	research	NOUN
iajs-2675	27	3	have	have	AUX
iajs-2675	27	4	shown	show	VERB
iajs-2675	27	5	that	that	SCONJ
iajs-2675	27	6	mets	met	NOUN
iajs-2675	27	7	and	and	CCONJ
iajs-2675	27	8	its	its	PRON
iajs-2675	27	9	constituents	constituent	NOUN
iajs-2675	27	10	were	be	AUX
iajs-2675	27	11	strongly	strongly	ADV
iajs-2675	27	12	related	relate	VERB
iajs-2675	27	13	to	to	ADP
iajs-2675	27	14	a	a	DET
iajs-2675	27	15	risk	risk	NOUN
iajs-2675	27	16	of	of	ADP
iajs-2675	27	17	type	type	NOUN
iajs-2675	27	18	2	2	NUM
iajs-2675	27	19	diabetes	diabetes	NOUN
iajs-2675	27	20	incident	incident	NOUN
iajs-2675	27	21	[	[	X
iajs-2675	27	22	3	3	NUM
iajs-2675	27	23	]	]	PUNCT
iajs-2675	27	24	.	.	PUNCT
iajs-2675	28	1	a	a	DET
iajs-2675	28	2	resistance	resistance	NOUN
iajs-2675	28	3	to	to	ADP
iajs-2675	28	4	insulin	insulin	NOUN
iajs-2675	28	5	,	,	PUNCT
iajs-2675	28	6	metabolic	metabolic	NOUN
iajs-2675	28	7	syndrome	syndrome	NOUN
iajs-2675	28	8	,	,	PUNCT
iajs-2675	28	9	and	and	CCONJ
iajs-2675	28	10	prediabetes	prediabete	NOUN
iajs-2675	28	11	were	be	AUX
iajs-2675	28	12	closely	closely	ADV
iajs-2675	28	13	related	relate	VERB
iajs-2675	28	14	and	and	CCONJ
iajs-2675	28	15	overlap	overlap	NOUN
iajs-2675	28	16	.	.	PUNCT
iajs-2675	29	1	underlying	underlie	VERB
iajs-2675	29	2	disorder	disorder	NOUN
iajs-2675	29	3	in	in	ADP
iajs-2675	29	4	energy	energy	NOUN
iajs-2675	29	5	usage	usage	NOUN
iajs-2675	29	6	and	and	CCONJ
iajs-2675	29	7	storage	storage	NOUN
iajs-2675	29	8	was	be	AUX
iajs-2675	29	9	thought	think	VERB
iajs-2675	29	10	to	to	PART
iajs-2675	29	11	be	be	AUX
iajs-2675	29	12	the	the	DET
iajs-2675	29	13	cause	cause	NOUN
iajs-2675	29	14	of	of	ADP
iajs-2675	29	15	the	the	DET
iajs-2675	29	16	syndrome	syndrome	NOUN
iajs-2675	29	17	.	.	PUNCT
iajs-2675	30	1	the	the	DET
iajs-2675	30	2	cause	cause	VERB
iajs-2675	30	3	a	a	DET
iajs-2675	30	4	continuous	continuous	ADJ
iajs-2675	30	5	medical	medical	ADJ
iajs-2675	30	6	research	research	NOUN
iajs-2675	30	7	[	[	X
iajs-2675	30	8	4	4	NUM
iajs-2675	30	9	,	,	PUNCT
iajs-2675	30	10	5	5	NUM
iajs-2675	30	11	]	]	PUNCT
iajs-2675	30	12	.	.	PUNCT
iajs-2675	31	1	metabolic	metabolic	PROPN
iajs-2675	31	2	syndrome	syndrome	PROPN
iajs-2675	31	3	began	begin	VERB
iajs-2675	31	4	as	as	ADP
iajs-2675	31	5	a	a	DET
iajs-2675	31	6	conception	conception	NOUN
iajs-2675	31	7	instead	instead	ADV
iajs-2675	31	8	of	of	ADP
iajs-2675	31	9	a	a	DET
iajs-2675	31	10	diagnosis	diagnosis	NOUN
iajs-2675	31	11	[	[	X
iajs-2675	31	12	6	6	NUM
iajs-2675	31	13	]	]	PUNCT
iajs-2675	31	14	.	.	PUNCT
iajs-2675	32	1	the	the	DET
iajs-2675	32	2	metabolic	metabolic	NOUN
iajs-2675	32	3	syndrome	syndrome	NOUN
iajs-2675	32	4	began	begin	VERB
iajs-2675	32	5	in	in	ADP
iajs-2675	32	6	1920	1920	NUM
iajs-2675	32	7	with	with	ADP
iajs-2675	32	8	the	the	DET
iajs-2675	32	9	high	high	ADJ
iajs-2675	32	10	blood	blood	NOUN
iajs-2675	32	11	pressure	pressure	NOUN
iajs-2675	32	12	(	(	PUNCT
iajs-2675	32	13	hypertension	hypertension	NOUN
iajs-2675	32	14	)	)	PUNCT
iajs-2675	32	15	,	,	PUNCT
iajs-2675	32	16	huge	huge	ADJ
iajs-2675	32	17	blood	blood	NOUN
iajs-2675	32	18	glucose	glucose	NOUN
iajs-2675	32	19	(	(	PUNCT
iajs-2675	32	20	hyperglycemia	hyperglycemia	NOUN
iajs-2675	32	21	)	)	PUNCT
iajs-2675	32	22	and	and	CCONJ
iajs-2675	32	23	gout	gout	NOUN
iajs-2675	32	24	associated	associate	VERB
iajs-2675	32	25	to	to	ADP
iajs-2675	32	26	kylin	kylin	PROPN
iajs-2675	32	27	,	,	PUNCT
iajs-2675	32	28	a	a	DET
iajs-2675	32	29	swedish	swedish	ADJ
iajs-2675	32	30	physician	physician	NOUN
iajs-2675	33	1	[	[	X
iajs-2675	33	2	7	7	NUM
iajs-2675	33	3	]	]	PUNCT
iajs-2675	33	4	.	.	PUNCT
iajs-2675	34	1	after	after	ADP
iajs-2675	34	2	that	that	PRON
iajs-2675	34	3	in	in	ADP
iajs-2675	34	4	1947	1947	NUM
iajs-2675	34	5	,	,	PUNCT
iajs-2675	34	6	vague	vague	NOUN
iajs-2675	34	7	defined	define	VERB
iajs-2675	34	8	a	a	DET
iajs-2675	34	9	common	common	ADJ
iajs-2675	34	10	link	link	NOUN
iajs-2675	34	11	between	between	ADP
iajs-2675	34	12	visceral	visceral	ADJ
iajs-2675	34	13	obesity	obesity	NOUN
iajs-2675	34	14	and	and	CCONJ
iajs-2675	34	15	the	the	DET
iajs-2675	34	16	metabolism	metabolism	NOUN
iajs-2675	34	17	found	find	VERB
iajs-2675	34	18	in	in	ADP
iajs-2675	34	19	cvd	cvd	PROPN
iajs-2675	34	20	and	and	CCONJ
iajs-2675	34	21	t2	t2	PROPN
iajs-2675	34	22	dm	dm	PROPN
iajs-2675	35	1	[	[	X
iajs-2675	35	2	3	3	NUM
iajs-2675	35	3	,	,	PUNCT
iajs-2675	35	4	8	8	NUM
iajs-2675	35	5	]	]	PUNCT
iajs-2675	35	6	.	.	PUNCT
iajs-2675	36	1	after	after	ADP
iajs-2675	36	2	this	this	PRON
iajs-2675	36	3	,	,	PUNCT
iajs-2675	36	4	in	in	ADP
iajs-2675	36	5	1965	1965	NUM
iajs-2675	36	6	,	,	PUNCT
iajs-2675	36	7	avogaro	avogaro	ADJ
iajs-2675	36	8	and	and	CCONJ
iajs-2675	36	9	crepaldi	crepaldi	NOUN
iajs-2675	36	10	[	[	X
iajs-2675	36	11	9	9	NUM
iajs-2675	36	12	]	]	PUNCT
iajs-2675	36	13	depicted	depicted	ADJ
iajs-2675	36	14	syndrome	syndrome	NOUN
iajs-2675	36	15	in	in	ADP
iajs-2675	36	16	their	their	PRON
iajs-2675	36	17	study	study	NOUN
iajs-2675	36	18	based	base	VERB
iajs-2675	36	19	on	on	ADP
iajs-2675	36	20	hypertension	hypertension	NOUN
iajs-2675	36	21	,	,	PUNCT
iajs-2675	36	22	hyperglycemia	hyperglycemia	NOUN
iajs-2675	36	23	and	and	CCONJ
iajs-2675	36	24	obesity	obesity	NOUN
iajs-2675	36	25	,	,	PUNCT
iajs-2675	36	26	which	which	PRON
iajs-2675	36	27	was	be	AUX
iajs-2675	36	28	presented	present	VERB
iajs-2675	36	29	at	at	ADP
iajs-2675	36	30	an	an	DET
iajs-2675	36	31	annual	annual	ADJ
iajs-2675	36	32	european	european	ADJ
iajs-2675	36	33	association	association	NOUN
iajs-2675	36	34	for	for	ADP
iajs-2675	36	35	diabetes	diabetes	NOUN
iajs-2675	36	36	studies	study	NOUN
iajs-2675	36	37	(	(	PUNCT
iajs-2675	36	38	esds	esds	NOUN
iajs-2675	36	39	)	)	PUNCT
iajs-2675	36	40	.	.	PUNCT
iajs-2675	37	1	after	after	ADP
iajs-2675	37	2	a	a	DET
iajs-2675	37	3	1988	1988	NUM
iajs-2675	37	4	lecture	lecture	NOUN
iajs-2675	37	5	on	on	ADP
iajs-2675	37	6	the	the	DET
iajs-2675	37	7	role	role	NOUN
iajs-2675	37	8	of	of	ADP
iajs-2675	37	9	insulin	insulin	NOUN
iajs-2675	37	10	resistance	resistance	NOUN
iajs-2675	37	11	in	in	ADP
iajs-2675	37	12	human	human	ADJ
iajs-2675	37	13	diseases	disease	NOUN
iajs-2675	37	14	identified	identify	VERB
iajs-2675	37	15	by	by	ADP
iajs-2675	37	16	reaven	reaven	NOUN
iajs-2675	37	17	,	,	PUNCT
iajs-2675	37	18	the	the	DET
iajs-2675	37	19	field	field	NOUN
iajs-2675	37	20	has	have	AUX
iajs-2675	37	21	progressed	progress	VERB
iajs-2675	37	22	significantly	significantly	ADV
iajs-2675	37	23	[	[	X
iajs-2675	37	24	10	10	NUM
iajs-2675	37	25	]	]	PUNCT
iajs-2675	37	26	.	.	PUNCT
iajs-2675	38	1	he	he	PRON
iajs-2675	38	2	called	call	VERB
iajs-2675	38	3	it	it	PRON
iajs-2675	38	4	"	"	PUNCT
iajs-2675	38	5	syndrome	syndrome	NOUN
iajs-2675	38	6	x	x	NOUN
iajs-2675	38	7	"	"	PUNCT
iajs-2675	38	8	and	and	CCONJ
iajs-2675	38	9	described	describe	VERB
iajs-2675	38	10	it	it	PRON
iajs-2675	38	11	as	as	ADP
iajs-2675	38	12	"	"	PUNCT
iajs-2675	38	13	a	a	DET
iajs-2675	38	14	cluster	cluster	NOUN
iajs-2675	38	15	of	of	ADP
iajs-2675	38	16	risk	risk	NOUN
iajs-2675	38	17	facilities	facility	NOUN
iajs-2675	38	18	for	for	ADP
iajs-2675	38	19	cardiovascular	cardiovascular	ADJ
iajs-2675	38	20	and	and	CCONJ
iajs-2675	38	21	diabetes	diabetes	NOUN
iajs-2675	38	22	disease	disease	NOUN
iajs-2675	38	23	.	.	PUNCT
iajs-2675	38	24	"	"	PUNCT
iajs-2675	39	1	introducing	introduce	VERB
iajs-2675	39	2	a	a	DET
iajs-2675	39	3	concept	concept	NOUN
iajs-2675	39	4	of	of	ADP
iajs-2675	39	5	insulin	insulin	NOUN
iajs-2675	39	6	resistance	resistance	NOUN
iajs-2675	39	7	was	be	AUX
iajs-2675	39	8	his	his	PRON
iajs-2675	39	9	main	main	ADJ
iajs-2675	39	10	contribution	contribution	NOUN
iajs-2675	39	11	.	.	PUNCT
iajs-2675	40	1	nevertheless	nevertheless	ADV
iajs-2675	40	2	,	,	PUNCT
iajs-2675	40	3	a	a	DET
iajs-2675	40	4	definition	definition	NOUN
iajs-2675	40	5	had	have	AUX
iajs-2675	40	6	been	be	AUX
iajs-2675	40	7	later	later	ADV
iajs-2675	40	8	added	add	VERB
iajs-2675	40	9	as	as	ADP
iajs-2675	40	10	a	a	DET
iajs-2675	40	11	crucial	crucial	ADJ
iajs-2675	40	12	abnormality	abnormality	NOUN
iajs-2675	40	13	abnormally	abnormally	ADV
iajs-2675	40	14	lacked	lack	VERB
iajs-2675	40	15	obesity	obesity	NOUN
iajs-2675	40	16	or	or	CCONJ
iajs-2675	40	17	visceral	visceral	ADJ
iajs-2675	40	18	obesity	obesity	NOUN
iajs-2675	40	19	.	.	PUNCT
iajs-2675	41	1	for	for	ADP
iajs-2675	41	2	the	the	DET
iajs-2675	41	3	combination	combination	NOUN
iajs-2675	41	4	of	of	ADP
iajs-2675	41	5	high	high	ADJ
iajs-2675	41	6	body	body	NOUN
iajs-2675	41	7	obesity	obesity	NOUN
iajs-2675	41	8	,	,	PUNCT
iajs-2675	41	9	intolerance	intolerance	NOUN
iajs-2675	41	10	of	of	ADP
iajs-2675	41	11	glucose	glucose	NOUN
iajs-2675	41	12	,	,	PUNCT
iajs-2675	41	13	hypertriglyceridemia	hypertriglyceridemia	NOUN
iajs-2675	41	14	and	and	CCONJ
iajs-2675	41	15	hypertension	hypertension	NOUN
iajs-2675	41	16	.	.	PUNCT
iajs-2675	42	1	kaplan	kaplan	PROPN
iajs-2675	42	2	[	[	X
iajs-2675	42	3	11	11	NUM
iajs-2675	42	4	]	]	PUNCT
iajs-2675	42	5	renamed	rename	VERB
iajs-2675	42	6	the	the	DET
iajs-2675	42	7	"	"	PUNCT
iajs-2675	42	8	deadly	deadly	ADJ
iajs-2675	42	9	quartet	quartet	NOUN
iajs-2675	42	10	"	"	PUNCT
iajs-2675	42	11	syndrome	syndrome	NOUN
iajs-2675	42	12	,	,	PUNCT
iajs-2675	42	13	but	but	CCONJ
iajs-2675	42	14	again	again	ADV
iajs-2675	42	15	in	in	ADP
iajs-2675	42	16	1992	1992	NUM
iajs-2675	42	17	,	,	PUNCT
iajs-2675	42	18	it	it	PRON
iajs-2675	42	19	had	have	AUX
iajs-2675	42	20	been	be	AUX
iajs-2675	42	21	renamed	rename	VERB
iajs-2675	42	22	as	as	ADP
iajs-2675	42	23	"	"	PUNCT
iajs-2675	42	24	the	the	DET
iajs-2675	42	25	insulin	insulin	NOUN
iajs-2675	42	26	resistance	resistance	NOUN
iajs-2675	42	27	syndrome	syndrome	NOUN
iajs-2675	42	28	"	"	PUNCT
iajs-2675	43	1	[	[	X
iajs-2675	43	2	12	12	NUM
iajs-2675	43	3	]	]	PUNCT
iajs-2675	43	4	.	.	PUNCT
iajs-2675	44	1	many	many	ADJ
iajs-2675	44	2	groups	group	NOUN
iajs-2675	44	3	tried	try	VERB
iajs-2675	44	4	to	to	PART
iajs-2675	44	5	advance	advance	VERB
iajs-2675	44	6	diagnostic	diagnostic	ADJ
iajs-2675	44	7	standards	standard	NOUN
iajs-2675	44	8	for	for	ADP
iajs-2675	44	9	mets	met	NOUN
iajs-2675	44	10	diagnosis	diagnosis	NOUN
iajs-2675	44	11	[	[	X
iajs-2675	44	12	13	13	NUM
iajs-2675	44	13	]	]	PUNCT
iajs-2675	44	14	.	.	PUNCT
iajs-2675	45	1	the	the	DET
iajs-2675	45	2	initial	initial	ADJ
iajs-2675	45	3	attempt	attempt	NOUN
iajs-2675	45	4	had	have	AUX
iajs-2675	45	5	done	do	VERB
iajs-2675	45	6	in	in	ADP
iajs-2675	45	7	1998	1998	NUM
iajs-2675	45	8	by	by	ADP
iajs-2675	45	9	a	a	DET
iajs-2675	45	10	diabetes	diabetes	NOUN
iajs-2675	45	11	group	group	NOUN
iajs-2675	45	12	of	of	ADP
iajs-2675	45	13	the	the	DET
iajs-2675	45	14	world	world	PROPN
iajs-2675	45	15	health	health	NOUN
iajs-2675	45	16	organization	organization	NOUN
iajs-2675	45	17	(	(	PUNCT
iajs-2675	45	18	who	who	PRON
iajs-2675	45	19	)	)	PUNCT
iajs-2675	45	20	to	to	PART
iajs-2675	45	21	define	define	VERB
iajs-2675	45	22	mets	met	NOUN
iajs-2675	45	23	[	[	X
iajs-2675	45	24	14	14	NUM
iajs-2675	45	25	]	]	PUNCT
iajs-2675	45	26	.	.	PUNCT
iajs-2675	46	1	in	in	ADP
iajs-2675	46	2	reply	reply	NOUN
iajs-2675	46	3	,	,	PUNCT
iajs-2675	46	4	the	the	DET
iajs-2675	46	5	european	european	ADJ
iajs-2675	46	6	insulin	insulin	NOUN
iajs-2675	46	7	resistance	resistance	NOUN
iajs-2675	46	8	study	study	NOUN
iajs-2675	46	9	group	group	NOUN
iajs-2675	46	10	(	(	PUNCT
iajs-2675	46	11	egir	egir	PROPN
iajs-2675	46	12	)	)	PUNCT
iajs-2675	46	13	in	in	ADP
iajs-2675	46	14	1999	1999	NUM
iajs-2675	46	15	rejected	reject	VERB
iajs-2675	46	16	an	an	DET
iajs-2675	46	17	amendment	amendment	NOUN
iajs-2675	46	18	to	to	ADP
iajs-2675	46	19	the	the	DET
iajs-2675	46	20	definition	definition	NOUN
iajs-2675	46	21	of	of	ADP
iajs-2675	46	22	who	who	PRON
iajs-2675	46	23	[	[	X
iajs-2675	46	24	15	15	NUM
iajs-2675	46	25	]	]	PUNCT
iajs-2675	46	26	.	.	PUNCT
iajs-2675	47	1	the	the	DET
iajs-2675	47	2	national	national	PROPN
iajs-2675	47	3	adult	adult	PROPN
iajs-2675	47	4	treatment	treatment	NOUN
iajs-2675	47	5	panel	panel	NOUN
iajs-2675	47	6	cholesterol	cholesterol	NOUN
iajs-2675	47	7	education	education	NOUN
iajs-2675	47	8	program	program	NOUN
iajs-2675	47	9	(	(	PUNCT
iajs-2675	47	10	ncep	ncep	PROPN
iajs-2675	47	11	/	/	SYM
iajs-2675	47	12	atp	atp	PROPN
iajs-2675	47	13	)	)	PUNCT
iajs-2675	47	14	launched	launch	VERB
iajs-2675	47	15	its	its	PRON
iajs-2675	47	16	definition	definition	NOUN
iajs-2675	47	17	in	in	ADP
iajs-2675	47	18	2001	2001	NUM
iajs-2675	47	19	[	[	X
iajs-2675	47	20	16	16	NUM
iajs-2675	47	21	]	]	PUNCT
iajs-2675	47	22	.	.	PUNCT
iajs-2675	48	1	the	the	DET
iajs-2675	48	2	american	american	PROPN
iajs-2675	48	3	association	association	PROPN
iajs-2675	48	4	of	of	ADP
iajs-2675	48	5	clinical	clinical	ADJ
iajs-2675	48	6	endocrinologists	endocrinologist	NOUN
iajs-2675	48	7	(	(	PUNCT
iajs-2675	48	8	aace	aace	NOUN
iajs-2675	48	9	)	)	PUNCT
iajs-2675	48	10	subsequently	subsequently	ADV
iajs-2675	48	11	presented	present	VERB
iajs-2675	48	12	its	its	PRON
iajs-2675	48	13	points	point	NOUN
iajs-2675	48	14	of	of	ADP
iajs-2675	48	15	view	view	NOUN
iajs-2675	48	16	in	in	ADP
iajs-2675	48	17	2003	2003	NUM
iajs-2675	48	18	on	on	ADP
iajs-2675	48	19	the	the	DET
iajs-2675	48	20	syndrome	syndrome	NOUN
iajs-2675	48	21	definition	definition	NOUN
iajs-2675	48	22	[	[	X
iajs-2675	48	23	17	17	NUM
iajs-2675	48	24	]	]	PUNCT
iajs-2675	48	25	.	.	PUNCT
iajs-2675	49	1	2.pathogenesis	2.pathogenesis	NUM
iajs-2675	49	2	of	of	ADP
iajs-2675	49	3	metabolic	metabolic	NOUN
iajs-2675	49	4	syndrome	syndrome	NOUN
iajs-2675	49	5	intensive	intensive	ADJ
iajs-2675	49	6	research	research	NOUN
iajs-2675	49	7	is	be	AUX
iajs-2675	49	8	intended	intend	VERB
iajs-2675	49	9	to	to	PART
iajs-2675	49	10	underlay	underlay	VERB
iajs-2675	49	11	mechanism	mechanism	NOUN
iajs-2675	49	12	through	through	ADP
iajs-2675	49	13	which	which	PRON
iajs-2675	49	14	the	the	DET
iajs-2675	49	15	mets	met	NOUN
iajs-2675	49	16	elements	element	NOUN
iajs-2675	49	17	share	share	VERB
iajs-2675	49	18	aspects	aspect	NOUN
iajs-2675	49	19	of	of	ADP
iajs-2675	49	20	their	their	PRON
iajs-2675	49	21	pathophysiology	pathophysiology	NOUN
iajs-2675	49	22	.	.	PUNCT
iajs-2675	50	1	the	the	DET
iajs-2675	50	2	ability	ability	NOUN
iajs-2675	50	3	of	of	ADP
iajs-2675	50	4	the	the	DET
iajs-2675	50	5	adipose	adipose	ADJ
iajs-2675	50	6	tissue	tissue	NOUN
iajs-2675	50	7	in	in	ADP
iajs-2675	50	8	its	its	PRON
iajs-2675	50	9	pathophysiology	pathophysiology	NOUN
iajs-2675	50	10	is	be	AUX
iajs-2675	50	11	essential	essential	ADJ
iajs-2675	50	12	for	for	ADP
iajs-2675	50	13	the	the	DET
iajs-2675	50	14	development	development	NOUN
iajs-2675	50	15	and	and	CCONJ
iajs-2675	50	16	storage	storage	NOUN
iajs-2675	50	17	of	of	ADP
iajs-2675	50	18	energy	energy	NOUN
iajs-2675	50	19	substrates	substrate	NOUN
iajs-2675	50	20	.	.	PUNCT
iajs-2675	51	1	but	but	CCONJ
iajs-2675	51	2	other	other	ADJ
iajs-2675	51	3	metabolic	metabolic	NOUN
iajs-2675	51	4	pathways	pathway	NOUN
iajs-2675	51	5	should	should	AUX
iajs-2675	51	6	be	be	AUX
iajs-2675	51	7	used	use	VERB
iajs-2675	51	8	since	since	SCONJ
iajs-2675	51	9	the	the	DET
iajs-2675	51	10	same	same	ADJ
iajs-2675	51	11	metabolic	metabolic	NOUN
iajs-2675	51	12	malfunctions	malfunction	NOUN
iajs-2675	51	13	in	in	ADP
iajs-2675	51	14	lean	lean	ADJ
iajs-2675	51	15	ibn	ibn	PROPN
iajs-2675	51	16	al	al	PROPN
iajs-2675	51	17	-	-	PUNCT
iajs-2675	51	18	haitham	haitham	PROPN
iajs-2675	51	19	jour	jour	X
iajs-2675	51	20	.	.	PROPN
iajs-2675	51	21	for	for	ADP
iajs-2675	51	22	pure	pure	ADJ
iajs-2675	51	23	&	&	CCONJ
iajs-2675	51	24	appl	appl	PROPN
iajs-2675	51	25	.	.	PUNCT
iajs-2675	52	1	sci	sci	PROPN
iajs-2675	52	2	.	.	PROPN
iajs-2675	53	1	34(3)2021	34(3)2021	NUM
iajs-2675	53	2	28	28	NUM
iajs-2675	53	3	individuals	individual	NOUN
iajs-2675	53	4	could	could	AUX
iajs-2675	53	5	occur	occur	VERB
iajs-2675	53	6	in	in	ADP
iajs-2675	53	7	mets	met	NOUN
iajs-2675	53	8	[	[	X
iajs-2675	53	9	18	18	NUM
iajs-2675	53	10	]	]	PUNCT
iajs-2675	53	11	.	.	PUNCT
iajs-2675	54	1	systems	system	NOUN
iajs-2675	54	2	biology	biology	NOUN
iajs-2675	54	3	approaches	approach	NOUN
iajs-2675	54	4	and	and	CCONJ
iajs-2675	54	5	the	the	DET
iajs-2675	54	6	development	development	NOUN
iajs-2675	54	7	of	of	ADP
iajs-2675	54	8	new	new	ADJ
iajs-2675	54	9	global	global	ADJ
iajs-2675	54	10	models	model	NOUN
iajs-2675	54	11	are	be	AUX
iajs-2675	54	12	crucial	crucial	ADJ
iajs-2675	54	13	for	for	ADP
iajs-2675	54	14	omics	omic	NOUN
iajs-2675	54	15	-	-	PUNCT
iajs-2675	54	16	based	base	VERB
iajs-2675	54	17	research	research	NOUN
iajs-2675	54	18	[	[	X
iajs-2675	54	19	19	19	NUM
iajs-2675	54	20	]	]	PUNCT
iajs-2675	54	21	.	.	PUNCT
iajs-2675	55	1	this	this	PRON
iajs-2675	55	2	is	be	AUX
iajs-2675	55	3	the	the	DET
iajs-2675	55	4	case	case	NOUN
iajs-2675	55	5	for	for	ADP
iajs-2675	55	6	recent	recent	ADJ
iajs-2675	55	7	system	system	NOUN
iajs-2675	55	8	biology	biology	NOUN
iajs-2675	55	9	studies	study	NOUN
iajs-2675	55	10	in	in	ADP
iajs-2675	55	11	non	non	ADJ
iajs-2675	55	12	-	-	ADJ
iajs-2675	55	13	alcoholic	alcoholic	ADJ
iajs-2675	55	14	steatohepatitis	steatohepatitis	NOUN
iajs-2675	55	15	patients	patient	NOUN
iajs-2675	55	16	[	[	X
iajs-2675	55	17	20	20	NUM
iajs-2675	55	18	]	]	PUNCT
iajs-2675	55	19	.	.	PUNCT
iajs-2675	56	1	the	the	DET
iajs-2675	56	2	involvement	involvement	NOUN
iajs-2675	56	3	of	of	ADP
iajs-2675	56	4	various	various	ADJ
iajs-2675	56	5	methods	method	NOUN
iajs-2675	56	6	(	(	PUNCT
iajs-2675	56	7	de	de	X
iajs-2675	56	8	novo	novo	NOUN
iajs-2675	56	9	lipogenesis	lipogenesis	NOUN
iajs-2675	56	10	,	,	PUNCT
iajs-2675	56	11	beta	beta	ADJ
iajs-2675	56	12	oxidation	oxidation	NOUN
iajs-2675	56	13	,	,	PUNCT
iajs-2675	56	14	pyruvate	pyruvate	NOUN
iajs-2675	56	15	use	use	NOUN
iajs-2675	56	16	and	and	CCONJ
iajs-2675	56	17	serine	serine	NOUN
iajs-2675	56	18	and	and	CCONJ
iajs-2675	56	19	glutathione	glutathione	NOUN
iajs-2675	56	20	synthesis	synthesis	NOUN
iajs-2675	56	21	)	)	PUNCT
iajs-2675	56	22	was	be	AUX
iajs-2675	56	23	identified	identify	VERB
iajs-2675	56	24	based	base	VERB
iajs-2675	56	25	on	on	ADP
iajs-2675	56	26	this	this	DET
iajs-2675	56	27	approach	approach	NOUN
iajs-2675	56	28	.	.	PUNCT
iajs-2675	57	1	in	in	ADP
iajs-2675	57	2	some	some	DET
iajs-2675	57	3	cases	case	NOUN
iajs-2675	57	4	,	,	PUNCT
iajs-2675	57	5	the	the	DET
iajs-2675	57	6	excess	excess	ADJ
iajs-2675	57	7	energy	energy	NOUN
iajs-2675	57	8	flow	flow	NOUN
iajs-2675	57	9	measures	measure	NOUN
iajs-2675	57	10	presented	present	VERB
iajs-2675	57	11	in	in	ADP
iajs-2675	57	12	the	the	DET
iajs-2675	57	13	mets	met	NOUN
iajs-2675	57	14	are	be	AUX
iajs-2675	57	15	managed	manage	VERB
iajs-2675	57	16	and	and	CCONJ
iajs-2675	57	17	prevent	prevent	VERB
iajs-2675	57	18	oxygen	oxygen	NOUN
iajs-2675	57	19	roots	root	NOUN
iajs-2675	57	20	from	from	ADP
iajs-2675	57	21	accumulating	accumulate	VERB
iajs-2675	57	22	.	.	PUNCT
iajs-2675	58	1	in	in	ADP
iajs-2675	58	2	addition	addition	NOUN
iajs-2675	58	3	,	,	PUNCT
iajs-2675	58	4	it	it	PRON
iajs-2675	58	5	identifies	identify	VERB
iajs-2675	58	6	the	the	DET
iajs-2675	58	7	critical	critical	ADJ
iajs-2675	58	8	role	role	NOUN
iajs-2675	58	9	of	of	ADP
iajs-2675	58	10	the	the	DET
iajs-2675	58	11	liver	liver	NOUN
iajs-2675	58	12	red	red	ADJ
iajs-2675	58	13	cell	cell	NOUN
iajs-2675	58	14	(	(	PUNCT
iajs-2675	58	15	pklr	pklr	ADJ
iajs-2675	58	16	)	)	PUNCT
iajs-2675	58	17	in	in	ADP
iajs-2675	58	18	triglyceride	triglyceride	ADJ
iajs-2675	58	19	accumulation	accumulation	NOUN
iajs-2675	58	20	in	in	ADP
iajs-2675	58	21	the	the	DET
iajs-2675	58	22	liver	liver	NOUN
iajs-2675	58	23	[	[	X
iajs-2675	58	24	21	21	NUM
iajs-2675	58	25	]	]	PUNCT
iajs-2675	58	26	.	.	PUNCT
iajs-2675	59	1	in	in	ADP
iajs-2675	59	2	sum	sum	NOUN
iajs-2675	59	3	,	,	PUNCT
iajs-2675	59	4	the	the	DET
iajs-2675	59	5	complementary	complementary	ADJ
iajs-2675	59	6	mechanisms	mechanism	NOUN
iajs-2675	59	7	prevailing	prevail	VERB
iajs-2675	59	8	in	in	ADP
iajs-2675	59	9	most	most	ADJ
iajs-2675	59	10	groups	group	NOUN
iajs-2675	59	11	are	be	AUX
iajs-2675	59	12	lip	lip	NOUN
iajs-2675	59	13	toxicity	toxicity	NOUN
iajs-2675	59	14	,	,	PUNCT
iajs-2675	59	15	low	low	ADJ
iajs-2675	59	16	-	-	PUNCT
iajs-2675	59	17	grade	grade	NOUN
iajs-2675	59	18	chronic	chronic	ADJ
iajs-2675	59	19	inflammation	inflammation	NOUN
iajs-2675	59	20	,	,	PUNCT
iajs-2675	59	21	and	and	CCONJ
iajs-2675	59	22	insulin	insulin	NOUN
iajs-2675	59	23	resistance	resistance	NOUN
iajs-2675	59	24	.	.	PUNCT
iajs-2675	60	1	his	his	PRON
iajs-2675	60	2	description	description	NOUN
iajs-2675	60	3	extends	extend	VERB
iajs-2675	60	4	beyond	beyond	ADP
iajs-2675	60	5	this	this	DET
iajs-2675	60	6	review	review	NOUN
iajs-2675	60	7	's	's	PART
iajs-2675	60	8	scope	scope	NOUN
iajs-2675	60	9	.	.	PUNCT
iajs-2675	61	1	the	the	DET
iajs-2675	61	2	outstanding	outstanding	ADJ
iajs-2675	61	3	reviews	review	NOUN
iajs-2675	61	4	in	in	ADP
iajs-2675	61	5	the	the	DET
iajs-2675	61	6	references	reference	NOUN
iajs-2675	61	7	section	section	NOUN
iajs-2675	61	8	will	will	AUX
iajs-2675	61	9	provide	provide	VERB
iajs-2675	61	10	interested	interested	ADJ
iajs-2675	61	11	readers	reader	NOUN
iajs-2675	61	12	with	with	ADP
iajs-2675	61	13	a	a	DET
iajs-2675	61	14	description	description	NOUN
iajs-2675	61	15	of	of	ADP
iajs-2675	61	16	the	the	DET
iajs-2675	61	17	art	art	NOUN
iajs-2675	61	18	of	of	ADP
iajs-2675	61	19	this	this	DET
iajs-2675	61	20	field	field	NOUN
iajs-2675	62	1	[	[	X
iajs-2675	62	2	22	22	NUM
iajs-2675	62	3	-	-	SYM
iajs-2675	62	4	26	26	NUM
iajs-2675	62	5	]	]	PUNCT
iajs-2675	62	6	.	.	PUNCT
iajs-2675	63	1	figure	figure	NOUN
iajs-2675	63	2	1	1	NUM
iajs-2675	63	3	.	.	PUNCT
iajs-2675	64	1	mechanisms	mechanism	NOUN
iajs-2675	64	2	of	of	ADP
iajs-2675	64	3	metabolic	metabolic	NOUN
iajs-2675	64	4	pathophysiology	pathophysiology	NOUN
iajs-2675	64	5	.	.	PUNCT
iajs-2675	65	1	c	c	X
iajs-2675	65	2	-	-	PUNCT
iajs-2675	65	3	reactive	reactive	ADJ
iajs-2675	65	4	protein	protein	NOUN
iajs-2675	65	5	(	(	PUNCT
iajs-2675	65	6	crp	crp	PROPN
iajs-2675	65	7	)	)	PUNCT
iajs-2675	65	8	,	,	PUNCT
iajs-2675	65	9	interleukin	interleukin	NOUN
iajs-2675	65	10	6	6	NUM
iajs-2675	65	11	,	,	PUNCT
iajs-2675	65	12	il-6	il-6	PRON
iajs-2675	65	13	,	,	PUNCT
iajs-2675	65	14	ros	ros	PROPN
iajs-2675	65	15	,	,	PUNCT
iajs-2675	65	16	reactive	reactive	ADJ
iajs-2675	65	17	oxygen	oxygen	NOUN
iajs-2675	65	18	species	specie	NOUN
iajs-2675	65	19	;	;	PUNCT
iajs-2675	65	20	tnf	tnf	PROPN
iajs-2675	65	21	,	,	PUNCT
iajs-2675	65	22	tumor	tumor	NOUN
iajs-2675	65	23	necroses	necrose	NOUN
iajs-2675	65	24	factor	factor	NOUN
iajs-2675	65	25	(	(	PUNCT
iajs-2675	65	26	at2	at2	PROPN
iajs-2675	65	27	,	,	PUNCT
iajs-2675	65	28	angiotensin	angiotensin	NOUN
iajs-2675	65	29	ii	ii	PROPN
iajs-2675	65	30	type	type	NOUN
iajs-2675	65	31	2	2	NUM
iajs-2675	65	32	receptor	receptor	NOUN
iajs-2675	65	33	;	;	PUNCT
iajs-2675	65	34	raas	raas	NOUN
iajs-2675	65	35	,	,	PUNCT
iajs-2675	65	36	reninangiotensin	reninangiotensin	NOUN
iajs-2675	65	37	-	-	PUNCT
iajs-2675	65	38	aldosterone	aldosterone	NOUN
iajs-2675	65	39	systems	system	NOUN
iajs-2675	65	40	;	;	PUNCT
iajs-2675	65	41	reactive	reactive	ADJ
iajs-2675	65	42	oxygen	oxygen	NOUN
iajs-2675	65	43	species	specie	NOUN
iajs-2675	65	44	(	(	PUNCT
iajs-2675	65	45	ros	ros	PROPN
iajs-2675	65	46	)	)	PUNCT
iajs-2675	65	47	.	.	PUNCT
iajs-2675	66	1	[	[	X
iajs-2675	66	2	27	27	NUM
iajs-2675	66	3	]	]	PUNCT
iajs-2675	66	4	.	.	PUNCT
iajs-2675	67	1	3.metabolic	3.metabolic	NUM
iajs-2675	67	2	syndrome	syndrome	NOUN
iajs-2675	67	3	and	and	CCONJ
iajs-2675	67	4	angiotensinogen	angiotensinogen	NOUN
iajs-2675	67	5	the	the	DET
iajs-2675	67	6	renin	renin	ADJ
iajs-2675	67	7	-	-	PUNCT
iajs-2675	67	8	angiotensin	angiotensin	NOUN
iajs-2675	67	9	(	(	PUNCT
iajs-2675	67	10	ras	ras	NOUN
iajs-2675	67	11	)	)	PUNCT
iajs-2675	67	12	precursor	precursor	NOUN
iajs-2675	67	13	is	be	AUX
iajs-2675	67	14	transformed	transform	VERB
iajs-2675	67	15	to	to	PART
iajs-2675	67	16	angiotensin	angiotensin	VERB
iajs-2675	67	17	i	i	PRON
iajs-2675	67	18	and	and	CCONJ
iajs-2675	67	19	angiotensin	angiotensin	PROPN
iajs-2675	67	20	ii	ii	PROPN
iajs-2675	67	21	through	through	ADP
iajs-2675	67	22	the	the	DET
iajs-2675	67	23	enzyme	enzyme	NOUN
iajs-2675	67	24	cascade	cascade	NOUN
iajs-2675	67	25	(	(	PUNCT
iajs-2675	67	26	agt	agt	PROPN
iajs-2675	67	27	)	)	PUNCT
iajs-2675	67	28	by	by	ADP
iajs-2675	67	29	renin	renin	ADJ
iajs-2675	67	30	and	and	CCONJ
iajs-2675	67	31	angiosin	angiosin	NOUN
iajs-2675	67	32	-	-	PUNCT
iajs-2675	67	33	conversion	conversion	NOUN
iajs-2675	67	34	(	(	PUNCT
iajs-2675	67	35	ace	ace	NOUN
iajs-2675	67	36	)	)	PUNCT
iajs-2675	67	37	actions	action	NOUN
iajs-2675	67	38	,	,	PUNCT
iajs-2675	67	39	correspondingly	correspondingly	ADV
iajs-2675	67	40	.	.	PUNCT
iajs-2675	68	1	ang	ang	INTJ
iajs-2675	68	2	(	(	PUNCT
iajs-2675	68	3	1–7	1–7	NUM
iajs-2675	68	4	)	)	PUNCT
iajs-2675	68	5	consists	consist	VERB
iajs-2675	68	6	of	of	ADP
iajs-2675	68	7	ang	ang	INTJ
iajs-2675	69	1	i	i	PRON
iajs-2675	69	2	and	and	CCONJ
iajs-2675	69	3	ang	ang	PROPN
iajs-2675	69	4	ii	ii	PROPN
iajs-2675	69	5	of	of	ADP
iajs-2675	69	6	ace2	ace2	PROPN
iajs-2675	69	7	.	.	PUNCT
iajs-2675	70	1	ang	ang	PROPN
iajs-2675	70	2	ii	ii	PROPN
iajs-2675	70	3	is	be	AUX
iajs-2675	70	4	associated	associate	VERB
iajs-2675	70	5	with	with	ADP
iajs-2675	70	6	high	high	ADJ
iajs-2675	70	7	blood	blood	NOUN
iajs-2675	70	8	pressure	pressure	NOUN
iajs-2675	70	9	and	and	CCONJ
iajs-2675	70	10	several	several	ADJ
iajs-2675	70	11	inflammatory	inflammatory	ADJ
iajs-2675	70	12	illnesses	illness	NOUN
iajs-2675	70	13	,	,	PUNCT
iajs-2675	70	14	involving	involve	VERB
iajs-2675	70	15	cardiovascular	cardiovascular	ADJ
iajs-2675	70	16	and	and	CCONJ
iajs-2675	70	17	kidney	kidney	NOUN
iajs-2675	70	18	disease	disease	NOUN
iajs-2675	70	19	,	,	PUNCT
iajs-2675	70	20	dyslipidemia	dyslipidemia	NOUN
iajs-2675	70	21	and	and	CCONJ
iajs-2675	70	22	metabolic	metabolic	NOUN
iajs-2675	70	23	syndrome	syndrome	NOUN
iajs-2675	70	24	.	.	PUNCT
iajs-2675	71	1	agt	agt	PROPN
iajs-2675	71	2	is	be	AUX
iajs-2675	71	3	extremely	extremely	ADV
iajs-2675	71	4	stated	state	VERB
iajs-2675	71	5	in	in	ADP
iajs-2675	71	6	adipose	adipose	ADJ
iajs-2675	71	7	tissue	tissue	NOUN
iajs-2675	71	8	and	and	CCONJ
iajs-2675	71	9	separated	separate	VERB
iajs-2675	71	10	by	by	ADP
iajs-2675	71	11	mature	mature	ADJ
iajs-2675	71	12	adipocytes	adipocyte	NOUN
iajs-2675	71	13	in	in	ADP
iajs-2675	71	14	human	human	ADJ
iajs-2675	71	15	and	and	CCONJ
iajs-2675	71	16	animal	animal	NOUN
iajs-2675	71	17	models	model	NOUN
iajs-2675	71	18	from	from	ADP
iajs-2675	71	19	separate	separate	ADJ
iajs-2675	71	20	adipose	adipose	PRON
iajs-2675	71	21	deposits	deposit	NOUN
iajs-2675	71	22	[	[	X
iajs-2675	71	23	28	28	NUM
iajs-2675	71	24	]	]	PUNCT
iajs-2675	71	25	.	.	PUNCT
iajs-2675	72	1	rodents	rodent	NOUN
iajs-2675	72	2	are	be	AUX
iajs-2675	72	3	capable	capable	ADJ
iajs-2675	72	4	of	of	ADP
iajs-2675	72	5	producing	produce	VERB
iajs-2675	72	6	up	up	ADP
iajs-2675	72	7	to	to	PART
iajs-2675	72	8	30	30	NUM
iajs-2675	72	9	%	%	NOUN
iajs-2675	72	10	of	of	ADP
iajs-2675	72	11	the	the	DET
iajs-2675	72	12	circulating	circulate	VERB
iajs-2675	72	13	agt	agt	PROPN
iajs-2675	72	14	levels	level	NOUN
iajs-2675	72	15	in	in	ADP
iajs-2675	72	16	vivo	vivo	NOUN
iajs-2675	72	17	[	[	X
iajs-2675	72	18	29	29	NUM
iajs-2675	72	19	]	]	PUNCT
iajs-2675	72	20	,	,	PUNCT
iajs-2675	72	21	in	in	ADP
iajs-2675	72	22	disagreement	disagreement	NOUN
iajs-2675	72	23	for	for	ADP
iajs-2675	72	24	the	the	DET
iajs-2675	72	25	role	role	NOUN
iajs-2675	72	26	of	of	ADP
iajs-2675	72	27	paracrine	paracrine	NOUN
iajs-2675	72	28	agt	agt	PROPN
iajs-2675	72	29	adipose	adipose	NOUN
iajs-2675	72	30	and	and	CCONJ
iajs-2675	72	31	the	the	DET
iajs-2675	72	32	new	new	ADJ
iajs-2675	72	33	views	view	NOUN
iajs-2675	72	34	of	of	ADP
iajs-2675	72	35	the	the	DET
iajs-2675	72	36	endocrine	endocrine	ADJ
iajs-2675	72	37	tissue	tissue	NOUN
iajs-2675	72	38	.	.	PUNCT
iajs-2675	73	1	adipose	adipose	ADP
iajs-2675	73	2	agt	agt	PROPN
iajs-2675	73	3	may	may	AUX
iajs-2675	73	4	as	as	ADV
iajs-2675	73	5	well	well	ADV
iajs-2675	73	6	have	have	VERB
iajs-2675	73	7	autocrine	autocrine	NOUN
iajs-2675	73	8	influences	influence	NOUN
iajs-2675	73	9	,	,	PUNCT
iajs-2675	73	10	because	because	SCONJ
iajs-2675	73	11	all	all	DET
iajs-2675	73	12	components	component	NOUN
iajs-2675	73	13	including	include	VERB
iajs-2675	73	14	renin	renin	ADJ
iajs-2675	73	15	,	,	PUNCT
iajs-2675	73	16	ace	ace	NOUN
iajs-2675	73	17	and	and	CCONJ
iajs-2675	73	18	ace2	ace2	NOUN
iajs-2675	73	19	are	be	AUX
iajs-2675	73	20	expressed	express	VERB
iajs-2675	73	21	in	in	ADP
iajs-2675	73	22	adipose	adipose	ADJ
iajs-2675	73	23	tissue	tissue	NOUN
iajs-2675	73	24	.	.	PUNCT
iajs-2675	74	1	this	this	PRON
iajs-2675	74	2	allows	allow	VERB
iajs-2675	74	3	for	for	ADP
iajs-2675	74	4	local	local	ADJ
iajs-2675	74	5	ang	ang	PROPN
iajs-2675	74	6	ii	ii	PROPN
iajs-2675	74	7	and	and	CCONJ
iajs-2675	74	8	other	other	ADJ
iajs-2675	74	9	adipose	adipose	PRON
iajs-2675	74	10	tissue	tissue	NOUN
iajs-2675	74	11	angiotensin	angiotensin	NOUN
iajs-2675	74	12	peptides	peptide	NOUN
iajs-2675	74	13	to	to	PART
iajs-2675	74	14	be	be	AUX
iajs-2675	74	15	produced	produce	VERB
iajs-2675	74	16	.	.	PUNCT
iajs-2675	75	1	[	[	X
iajs-2675	75	2	30,31	30,31	NUM
iajs-2675	75	3	]	]	PUNCT
iajs-2675	75	4	.	.	PUNCT
iajs-2675	76	1	the	the	DET
iajs-2675	76	2	receptors	receptor	NOUN
iajs-2675	76	3	of	of	ADP
iajs-2675	76	4	angiotensin	angiotensin	NOUN
iajs-2675	76	5	both	both	CCONJ
iajs-2675	76	6	adipocytes	adipocyte	NOUN
iajs-2675	76	7	and	and	CCONJ
iajs-2675	76	8	preadipocytes	preadipocyte	NOUN
iajs-2675	76	9	include	include	VERB
iajs-2675	76	10	the	the	DET
iajs-2675	76	11	type	type	NOUN
iajs-2675	76	12	1	1	NUM
iajs-2675	76	13	ang	ang	PROPN
iajs-2675	76	14	ii	ii	PROPN
iajs-2675	76	15	(	(	PUNCT
iajs-2675	76	16	at1	at1	PROPN
iajs-2675	76	17	)	)	PUNCT
iajs-2675	76	18	and	and	CCONJ
iajs-2675	76	19	2	2	NUM
iajs-2675	76	20	(	(	PUNCT
iajs-2675	76	21	at2	at2	NOUN
iajs-2675	76	22	)	)	PUNCT
iajs-2675	76	23	receptors	receptor	NOUN
iajs-2675	76	24	and	and	CCONJ
iajs-2675	76	25	ang	ang	NOUN
iajs-2675	76	26	iv	iv	X
iajs-2675	76	27	(	(	PUNCT
iajs-2675	76	28	1–7	1–7	NUM
iajs-2675	76	29	)	)	PUNCT
iajs-2675	76	30	(	(	PUNCT
iajs-2675	76	31	masr	masr	PROPN
iajs-2675	76	32	)	)	PUNCT
iajs-2675	77	1	[	[	X
iajs-2675	77	2	32	32	NUM
iajs-2675	77	3	]	]	PUNCT
iajs-2675	77	4	.	.	PUNCT
iajs-2675	78	1	(	(	PUNCT
iajs-2675	78	2	apprentice	apprentice	NOUN
iajs-2675	78	3	)	)	PUNCT
iajs-2675	78	4	c	c	NOUN
iajs-2675	78	5	-	-	PUNCT
iajs-2675	78	6	reactive	reactive	ADJ
iajs-2675	78	7	protein	protein	NOUN
iajs-2675	78	8	is	be	AUX
iajs-2675	78	9	the	the	DET
iajs-2675	78	10	best	well	ADV
iajs-2675	78	11	featured	feature	VERB
iajs-2675	78	12	and	and	CCONJ
iajs-2675	78	13	well	well	ADV
iajs-2675	78	14	standardized	standardized	ADJ
iajs-2675	78	15	inflammatory	inflammatory	ADJ
iajs-2675	78	16	biomarker	biomarker	NOUN
iajs-2675	78	17	c	c	NOUN
iajs-2675	78	18	-	-	PUNCT
iajs-2675	78	19	reactive	reactive	ADJ
iajs-2675	78	20	protein	protein	NOUN
iajs-2675	78	21	(	(	PUNCT
iajs-2675	78	22	crp	crp	NOUN
iajs-2675	78	23	)	)	PUNCT
iajs-2675	78	24	many	many	ADJ
iajs-2675	78	25	reported	report	VERB
iajs-2675	78	26	studies	study	NOUN
iajs-2675	78	27	have	have	AUX
iajs-2675	78	28	now	now	ADV
iajs-2675	78	29	confirmed	confirm	VERB
iajs-2675	78	30	that	that	SCONJ
iajs-2675	78	31	in	in	ADP
iajs-2675	78	32	mets	met	NOUN
iajs-2675	78	33	patients	patient	NOUN
iajs-2675	78	34	,	,	PUNCT
iajs-2675	78	35	crp	crp	PROPN
iajs-2675	78	36	levels	level	VERB
iajs-2675	78	37	https://www.sciencedirect.com/topics/medicine-and-dentistry/angiotensinogen	https://www.sciencedirect.com/topics/medicine-and-dentistry/angiotensinogen	PROPN
iajs-2675	78	38	ibn	ibn	PROPN
iajs-2675	78	39	al	al	PROPN
iajs-2675	78	40	-	-	PUNCT
iajs-2675	78	41	haitham	haitham	PROPN
iajs-2675	78	42	jour	jour	X
iajs-2675	78	43	.	.	PROPN
iajs-2675	79	1	for	for	ADP
iajs-2675	79	2	pure	pure	ADJ
iajs-2675	79	3	&	&	CCONJ
iajs-2675	79	4	appl	appl	PROPN
iajs-2675	79	5	.	.	PUNCT
iajs-2675	80	1	sci	sci	PROPN
iajs-2675	80	2	.	.	PROPN
iajs-2675	81	1	34(3)2021	34(3)2021	NUM
iajs-2675	81	2	29	29	NUM
iajs-2675	81	3	were	be	AUX
iajs-2675	81	4	high	high	ADJ
iajs-2675	81	5	.	.	PUNCT
iajs-2675	82	1	in	in	ADP
iajs-2675	82	2	addition	addition	NOUN
iajs-2675	82	3	,	,	PUNCT
iajs-2675	82	4	high	high	ADJ
iajs-2675	82	5	-	-	PUNCT
iajs-2675	82	6	sensitivity	sensitivity	NOUN
iajs-2675	82	7	crps	crps	NOUN
iajs-2675	82	8	(	(	PUNCT
iajs-2675	82	9	hscrps	hscrps	PROPN
iajs-2675	82	10	)	)	PUNCT
iajs-2675	82	11	were	be	AUX
iajs-2675	82	12	proposed	propose	VERB
iajs-2675	82	13	as	as	ADP
iajs-2675	82	14	a	a	DET
iajs-2675	82	15	clinical	clinical	ADJ
iajs-2675	82	16	criterion	criterion	NOUN
iajs-2675	82	17	for	for	ADP
iajs-2675	82	18	the	the	DET
iajs-2675	82	19	development	development	NOUN
iajs-2675	82	20	of	of	ADP
iajs-2675	82	21	mets	met	NOUN
iajs-2675	82	22	and	and	CCONJ
iajs-2675	82	23	hscrp	hscrp	NOUN
iajs-2675	82	24	-	-	PUNCT
iajs-2675	82	25	modified	modify	VERB
iajs-2675	82	26	risk	risk	NOUN
iajs-2675	82	27	rating	rating	NOUN
iajs-2675	82	28	for	for	ADP
iajs-2675	82	29	chds	chds	NOUN
iajs-2675	82	30	[	[	X
iajs-2675	82	31	33	33	NUM
iajs-2675	82	32	]	]	PUNCT
iajs-2675	82	33	.	.	PUNCT
iajs-2675	83	1	in	in	ADP
iajs-2675	83	2	addition	addition	NOUN
iajs-2675	83	3	,	,	PUNCT
iajs-2675	83	4	yudkin	yudkin	NOUN
iajs-2675	83	5	et	et	PROPN
iajs-2675	83	6	al	al	PROPN
iajs-2675	84	1	[	[	X
iajs-2675	84	2	34	34	NUM
iajs-2675	84	3	]	]	PUNCT
iajs-2675	84	4	,	,	PUNCT
iajs-2675	84	5	contained	contain	VERB
iajs-2675	84	6	a	a	DET
iajs-2675	84	7	highly	highly	ADV
iajs-2675	84	8	significant	significant	ADJ
iajs-2675	84	9	correlation	correlation	NOUN
iajs-2675	84	10	among	among	ADP
iajs-2675	84	11	inflammatory	inflammatory	ADJ
iajs-2675	84	12	indicators	indicator	NOUN
iajs-2675	84	13	and	and	CCONJ
iajs-2675	84	14	some	some	DET
iajs-2675	84	15	feasibility	feasibility	NOUN
iajs-2675	84	16	of	of	ADP
iajs-2675	84	17	the	the	DET
iajs-2675	84	18	mets	met	NOUN
iajs-2675	84	19	in	in	ADP
iajs-2675	84	20	107	107	NUM
iajs-2675	84	21	non	non	ADJ
iajs-2675	84	22	-	-	ADJ
iajs-2675	84	23	diabetic	diabetic	ADJ
iajs-2675	84	24	patients	patient	NOUN
iajs-2675	84	25	and	and	CCONJ
iajs-2675	84	26	conducted	conduct	VERB
iajs-2675	84	27	z	z	ADJ
iajs-2675	84	28	-	-	PUNCT
iajs-2675	84	29	score	score	NOUN
iajs-2675	84	30	analytic	analytic	ADJ
iajs-2675	84	31	.	.	PUNCT
iajs-2675	85	1	insulin	insulin	NOUN
iajs-2675	85	2	resistance	resistance	NOUN
iajs-2675	85	3	calculation	calculation	NOUN
iajs-2675	85	4	based	base	VERB
iajs-2675	85	5	on	on	ADP
iajs-2675	85	6	homa	homa	PROPN
iajs-2675	85	7	,	,	PUNCT
iajs-2675	85	8	bp	bp	PROPN
iajs-2675	85	9	,	,	PUNCT
iajs-2675	85	10	low	low	ADJ
iajs-2675	85	11	hdl	hdl	PROPN
iajs-2675	85	12	,	,	PUNCT
iajs-2675	85	13	triglycerides	triglyceride	NOUN
iajs-2675	85	14	,	,	PUNCT
iajs-2675	85	15	and	and	CCONJ
iajs-2675	85	16	proinflammatorial	proinflammatorial	ADJ
iajs-2675	85	17	cytokins	cytokin	NOUN
iajs-2675	85	18	,	,	PUNCT
iajs-2675	85	19	il-6	il-6	NUM
iajs-2675	85	20	and	and	CCONJ
iajs-2675	85	21	tumor	tumor	NOUN
iajs-2675	85	22	necrosis	necrosis	NOUN
iajs-2675	85	23	factor	factor	NOUN
iajs-2675	85	24	(	(	PUNCT
iajs-2675	85	25	tnf	tnf	PROPN
iajs-2675	85	26	)	)	PUNCT
iajs-2675	85	27	was	be	AUX
iajs-2675	85	28	shown	show	VERB
iajs-2675	85	29	to	to	PART
iajs-2675	85	30	be	be	AUX
iajs-2675	85	31	strongly	strongly	ADV
iajs-2675	85	32	linked	link	VERB
iajs-2675	85	33	to	to	ADP
iajs-2675	85	34	levels	level	NOUN
iajs-2675	85	35	of	of	ADP
iajs-2675	85	36	crp	crp	PROPN
iajs-2675	85	37	.	.	PUNCT
iajs-2675	86	1	the	the	DET
iajs-2675	86	2	strongest	strong	ADJ
iajs-2675	86	3	determinants	determinant	NOUN
iajs-2675	86	4	of	of	ADP
iajs-2675	86	5	inflammatory	inflammatory	ADJ
iajs-2675	86	6	condition	condition	NOUN
iajs-2675	86	7	were	be	AUX
iajs-2675	86	8	bmi	bmi	NOUN
iajs-2675	86	9	and	and	CCONJ
iajs-2675	86	10	insulin	insulin	NOUN
iajs-2675	86	11	resistance	resistance	NOUN
iajs-2675	86	12	.	.	PUNCT
iajs-2675	87	1	the	the	DET
iajs-2675	87	2	number	number	NOUN
iajs-2675	87	3	of	of	ADP
iajs-2675	87	4	metabolic	metabolic	NOUN
iajs-2675	87	5	characteristics	characteristic	NOUN
iajs-2675	87	6	and	and	CCONJ
iajs-2675	87	7	the	the	DET
iajs-2675	87	8	hscrp	hscrp	PROPN
iajs-2675	87	9	levels	level	NOUN
iajs-2675	87	10	were	be	AUX
iajs-2675	87	11	linearly	linearly	ADV
iajs-2675	87	12	linked	link	VERB
iajs-2675	87	13	.	.	PUNCT
iajs-2675	88	1	in	in	ADP
iajs-2675	88	2	addition	addition	NOUN
iajs-2675	88	3	,	,	PUNCT
iajs-2675	88	4	festa	festa	X
iajs-2675	88	5	et	et	NOUN
iajs-2675	88	6	al	al	PROPN
iajs-2675	89	1	[	[	X
iajs-2675	89	2	35	35	NUM
iajs-2675	89	3	]	]	PUNCT
iajs-2675	89	4	,	,	PUNCT
iajs-2675	89	5	have	have	AUX
iajs-2675	89	6	shown	show	VERB
iajs-2675	89	7	that	that	SCONJ
iajs-2675	89	8	hscrp	hscrp	NOUN
iajs-2675	89	9	was	be	AUX
iajs-2675	89	10	positive	positive	ADJ
iajs-2675	89	11	in	in	ADP
iajs-2675	89	12	bmi	bmi	NOUN
iajs-2675	89	13	,	,	PUNCT
iajs-2675	89	14	waist	waist	NOUN
iajs-2675	89	15	circumference	circumference	NOUN
iajs-2675	89	16	,	,	PUNCT
iajs-2675	89	17	bp	bp	PROPN
iajs-2675	89	18	,	,	PUNCT
iajs-2675	89	19	triglycerides	triglyceride	NOUN
iajs-2675	89	20	,	,	PUNCT
iajs-2675	89	21	cholesterol	cholesterol	NOUN
iajs-2675	89	22	,	,	PUNCT
iajs-2675	89	23	ldl	ldl	NOUN
iajs-2675	89	24	cholesterol	cholesterol	NOUN
iajs-2675	89	25	,	,	PUNCT
iajs-2675	89	26	plasma	plasma	NOUN
iajs-2675	89	27	glucose	glucose	NOUN
iajs-2675	89	28	,	,	PUNCT
iajs-2675	89	29	and	and	CCONJ
iajs-2675	89	30	fasting	fast	VERB
iajs-2675	89	31	insulin	insulin	NOUN
iajs-2675	89	32	correlating	correlate	VERB
iajs-2675	89	33	with	with	ADP
iajs-2675	89	34	hdl	hdl	PROPN
iajs-2675	89	35	cholesterol	cholesterol	PROPN
iajs-2675	89	36	and	and	CCONJ
iajs-2675	89	37	insulin	insulin	NOUN
iajs-2675	89	38	sensitivity	sensitivity	NOUN
iajs-2675	89	39	index	index	NOUN
iajs-2675	89	40	,	,	PUNCT
iajs-2675	89	41	in	in	ADP
iajs-2675	89	42	the	the	DET
iajs-2675	89	43	insulin	insulin	NOUN
iajs-2675	89	44	resistance	resistance	NOUN
iajs-2675	89	45	and	and	CCONJ
iajs-2675	89	46	atherosclerosis	atherosclerosis	NOUN
iajs-2675	89	47	studies	study	NOUN
iajs-2675	89	48	(	(	PUNCT
iajs-2675	89	49	iras	ira	NOUN
iajs-2675	89	50	)	)	PUNCT
iajs-2675	89	51	.	.	PUNCT
iajs-2675	90	1	crp	crp	PROPN
iajs-2675	90	2	levels	level	NOUN
iajs-2675	90	3	,	,	PUNCT
iajs-2675	90	4	the	the	DET
iajs-2675	90	5	central	central	ADJ
iajs-2675	90	6	adiposity	adiposity	NOUN
iajs-2675	90	7	and	and	CCONJ
iajs-2675	90	8	insulin	insulin	NOUN
iajs-2675	90	9	resistance	resistance	NOUN
iajs-2675	90	10	were	be	AUX
iajs-2675	90	11	most	most	ADV
iajs-2675	90	12	closely	closely	ADV
iajs-2675	90	13	related	relate	VERB
iajs-2675	90	14	.	.	PUNCT
iajs-2675	91	1	the	the	DET
iajs-2675	91	2	nhanes	nhanes	PROPN
iajs-2675	91	3	iii	iii	PROPN
iajs-2675	91	4	study	study	PROPN
iajs-2675	91	5	[	[	X
iajs-2675	91	6	36	36	NUM
iajs-2675	91	7	]	]	PUNCT
iajs-2675	91	8	has	have	AUX
iajs-2675	91	9	been	be	AUX
iajs-2675	91	10	the	the	DET
iajs-2675	91	11	largest	large	ADJ
iajs-2675	91	12	study	study	NOUN
iajs-2675	91	13	to	to	ADP
iajs-2675	91	14	date	date	NOUN
iajs-2675	91	15	examining	examine	VERB
iajs-2675	91	16	the	the	DET
iajs-2675	91	17	relationship	relationship	NOUN
iajs-2675	91	18	between	between	ADP
iajs-2675	91	19	inflammation	inflammation	NOUN
iajs-2675	91	20	and	and	CCONJ
iajs-2675	91	21	the	the	DET
iajs-2675	91	22	mets	met	NOUN
iajs-2675	91	23	.	.	PUNCT
iajs-2675	92	1	the	the	DET
iajs-2675	92	2	mets	met	NOUN
iajs-2675	92	3	patient	patient	VERB
iajs-2675	92	4	with	with	ADP
iajs-2675	92	5	atpiii	atpiii	NOUN
iajs-2675	92	6	criteria	criterion	NOUN
iajs-2675	92	7	was	be	AUX
iajs-2675	92	8	more	more	ADV
iajs-2675	92	9	likely	likely	ADJ
iajs-2675	92	10	than	than	ADP
iajs-2675	92	11	patients	patient	NOUN
iajs-2675	92	12	without	without	ADP
iajs-2675	92	13	the	the	DET
iajs-2675	92	14	syndrome	syndrome	NOUN
iajs-2675	92	15	to	to	PART
iajs-2675	92	16	have	have	VERB
iajs-2675	92	17	elevated	elevate	VERB
iajs-2675	92	18	inflammation	inflammation	ADJ
iajs-2675	92	19	markers	marker	NOUN
iajs-2675	92	20	like	like	ADP
iajs-2675	92	21	crp	crp	PROPN
iajs-2675	92	22	,	,	PUNCT
iajs-2675	92	23	fibrinogens	fibrinogen	VERB
iajs-2675	92	24	,	,	PUNCT
iajs-2675	92	25	and	and	CCONJ
iajs-2675	92	26	leucocytes	leucocyte	NOUN
iajs-2675	92	27	,	,	PUNCT
iajs-2675	92	28	in	in	ADP
iajs-2675	92	29	the	the	DET
iajs-2675	92	30	typical	typical	ADJ
iajs-2675	92	31	sample	sample	NOUN
iajs-2675	92	32	of	of	ADP
iajs-2675	92	33	the	the	DET
iajs-2675	92	34	us	us	PROPN
iajs-2675	92	35	population	population	NOUN
iajs-2675	92	36	(	(	PUNCT
iajs-2675	92	37	8570	8570	NUM
iajs-2675	92	38	participants	participant	NOUN
iajs-2675	92	39	above	above	ADP
iajs-2675	92	40	20	20	NUM
iajs-2675	92	41	years	year	NOUN
iajs-2675	92	42	old	old	ADJ
iajs-2675	92	43	)	)	PUNCT
iajs-2675	92	44	.	.	PUNCT
iajs-2675	93	1	atpiii	atpiii	PROPN
iajs-2675	93	2	criteria	criterion	NOUN
iajs-2675	93	3	were	be	AUX
iajs-2675	93	4	used	use	VERB
iajs-2675	93	5	.	.	PUNCT
iajs-2675	94	1	therefore	therefore	ADV
iajs-2675	94	2	,	,	PUNCT
iajs-2675	94	3	the	the	DET
iajs-2675	94	4	amount	amount	NOUN
iajs-2675	94	5	of	of	ADP
iajs-2675	94	6	metabolic	metabolic	NOUN
iajs-2675	94	7	features	feature	NOUN
iajs-2675	94	8	and	and	CCONJ
iajs-2675	94	9	the	the	DET
iajs-2675	94	10	growing	grow	VERB
iajs-2675	94	11	levels	level	NOUN
iajs-2675	94	12	of	of	ADP
iajs-2675	94	13	hscrp	hscrp	PROPN
iajs-2675	94	14	appeared	appear	VERB
iajs-2675	94	15	to	to	PART
iajs-2675	94	16	be	be	AUX
iajs-2675	94	17	clearly	clearly	ADV
iajs-2675	94	18	related	relate	VERB
iajs-2675	94	19	.	.	PUNCT
iajs-2675	95	1	furthermore	furthermore	ADV
iajs-2675	95	2	,	,	PUNCT
iajs-2675	95	3	in	in	ADP
iajs-2675	95	4	predicting	predict	VERB
iajs-2675	95	5	mets	met	NOUN
iajs-2675	95	6	using	use	VERB
iajs-2675	95	7	receptors	receptor	NOUN
iajs-2675	95	8	operating	operating	NOUN
iajs-2675	95	9	features	feature	NOUN
iajs-2675	95	10	(	(	PUNCT
iajs-2675	95	11	rof	rof	NOUN
iajs-2675	95	12	)	)	PUNCT
iajs-2675	95	13	testing	testing	NOUN
iajs-2675	95	14	,	,	PUNCT
iajs-2675	95	15	we	we	PRON
iajs-2675	95	16	have	have	AUX
iajs-2675	95	17	shown	show	VERB
iajs-2675	95	18	that	that	SCONJ
iajs-2675	95	19	crp	crp	PROPN
iajs-2675	95	20	values	value	NOUN
iajs-2675	95	21	were	be	AUX
iajs-2675	95	22	consistent	consistent	ADJ
iajs-2675	95	23	with	with	ADP
iajs-2675	95	24	the	the	DET
iajs-2675	95	25	ratio	ratio	NOUN
iajs-2675	95	26	of	of	ADP
iajs-2675	95	27	high	high	ADJ
iajs-2675	95	28	-	-	PUNCT
iajs-2675	95	29	molecular	molecular	ADJ
iajs-2675	95	30	weight	weight	NOUN
iajs-2675	95	31	(	(	PUNCT
iajs-2675	95	32	hmw	hmw	NOUN
iajs-2675	95	33	)	)	PUNCT
iajs-2675	95	34	adiponectin	adiponectin	NOUN
iajs-2675	95	35	to	to	ADP
iajs-2675	95	36	crp	crp	PROPN
iajs-2675	96	1	[	[	X
iajs-2675	96	2	37	37	NUM
iajs-2675	96	3	]	]	PUNCT
iajs-2675	96	4	.	.	PUNCT
iajs-2675	97	1	in	in	ADP
iajs-2675	97	2	several	several	ADJ
iajs-2675	97	3	metabolic	metabolic	NOUN
iajs-2675	97	4	processes	process	NOUN
iajs-2675	97	5	as	as	ADP
iajs-2675	97	6	autocrine	autocrine	NOUN
iajs-2675	97	7	and	and	CCONJ
iajs-2675	97	8	paracrine	paracrine	NOUN
iajs-2675	97	9	functions	function	NOUN
iajs-2675	97	10	of	of	ADP
iajs-2675	97	11	adipocyte	adipocyte	ADJ
iajs-2675	97	12	function	function	NOUN
iajs-2675	97	13	,	,	PUNCT
iajs-2675	97	14	il-6	il-6	PRON
iajs-2675	97	15	(	(	PUNCT
iajs-2675	97	16	pleiotropic	pleiotropic	NOUN
iajs-2675	97	17	cytokine	cytokine	NOUN
iajs-2675	97	18	)	)	PUNCT
iajs-2675	97	19	plays	play	VERB
iajs-2675	97	20	important	important	ADJ
iajs-2675	97	21	roles	role	NOUN
iajs-2675	97	22	[	[	X
iajs-2675	97	23	38	38	NUM
iajs-2675	97	24	]	]	PUNCT
iajs-2675	97	25	.currently	.currently	ADV
iajs-2675	97	26	,	,	PUNCT
iajs-2675	97	27	accumulating	accumulate	VERB
iajs-2675	97	28	evidence	evidence	NOUN
iajs-2675	97	29	shows	show	VERB
iajs-2675	97	30	that	that	SCONJ
iajs-2675	97	31	il-6	il-6	NOUN
iajs-2675	97	32	has	have	VERB
iajs-2675	97	33	a	a	DET
iajs-2675	97	34	strong	strong	ADJ
iajs-2675	97	35	connection	connection	NOUN
iajs-2675	97	36	to	to	ADP
iajs-2675	97	37	metabolic	metabolic	NOUN
iajs-2675	97	38	disorders	disorder	NOUN
iajs-2675	97	39	like	like	ADP
iajs-2675	97	40	ms	ms	NOUN
iajs-2675	97	41	and	and	CCONJ
iajs-2675	97	42	diabetes	diabetes	NOUN
iajs-2675	97	43	of	of	ADP
iajs-2675	97	44	type	type	NOUN
iajs-2675	97	45	2	2	NUM
iajs-2675	97	46	.	.	PUNCT
iajs-2675	97	47	in	in	ADP
iajs-2675	97	48	the	the	DET
iajs-2675	97	49	meantime	meantime	NOUN
iajs-2675	97	50	,	,	PUNCT
iajs-2675	97	51	il-6	il-6	NOUN
iajs-2675	97	52	elevation	elevation	NOUN
iajs-2675	97	53	in	in	ADP
iajs-2675	97	54	adipose	adipose	ADJ
iajs-2675	97	55	tissues	tissue	NOUN
iajs-2675	97	56	in	in	ADP
iajs-2675	97	57	diabetes	diabetes	NOUN
iajs-2675	97	58	mellitus	mellitus	NOUN
iajs-2675	97	59	or	or	CCONJ
iajs-2675	97	60	in	in	ADP
iajs-2675	97	61	patients	patient	NOUN
iajs-2675	97	62	with	with	ADP
iajs-2675	97	63	obesity	obesity	NOUN
iajs-2675	97	64	was	be	AUX
iajs-2675	97	65	documented	document	VERB
iajs-2675	97	66	,	,	PUNCT
iajs-2675	97	67	particularly	particularly	ADV
iajs-2675	97	68	in	in	ADP
iajs-2675	97	69	those	those	PRON
iajs-2675	97	70	with	with	ADP
iajs-2675	97	71	ms	ms	PROPN
iajs-2675	97	72	characteristics	characteristic	NOUN
iajs-2675	97	73	[	[	X
iajs-2675	97	74	39	39	NUM
iajs-2675	97	75	]	]	PUNCT
iajs-2675	97	76	.	.	PUNCT
iajs-2675	98	1	eckel	eckel	NOUN
iajs-2675	98	2	et	et	PROPN
iajs-2675	98	3	al	al	PROPN
iajs-2675	98	4	.	.	PROPN
iajs-2675	98	5	,	,	PUNCT
iajs-2675	98	6	considered	consider	VERB
iajs-2675	98	7	that	that	SCONJ
iajs-2675	98	8	the	the	DET
iajs-2675	98	9	increase	increase	NOUN
iajs-2675	98	10	in	in	ADP
iajs-2675	98	11	il-6	il-6	NOUN
iajs-2675	98	12	in	in	ADP
iajs-2675	98	13	ms	ms	PROPN
iajs-2675	98	14	appeared	appear	VERB
iajs-2675	98	15	to	to	PART
iajs-2675	98	16	act	act	VERB
iajs-2675	98	17	on	on	ADP
iajs-2675	98	18	several	several	ADJ
iajs-2675	98	19	important	important	ADJ
iajs-2675	98	20	factors	factor	NOUN
iajs-2675	98	21	that	that	PRON
iajs-2675	98	22	contributed	contribute	VERB
iajs-2675	98	23	to	to	ADP
iajs-2675	98	24	insulin	insulin	NOUN
iajs-2675	98	25	resistance	resistance	NOUN
iajs-2675	98	26	,	,	PUNCT
iajs-2675	98	27	increased	increase	VERB
iajs-2675	98	28	liver	liver	NOUN
iajs-2675	98	29	glucose	glucose	NOUN
iajs-2675	98	30	production	production	NOUN
iajs-2675	98	31	,	,	PUNCT
iajs-2675	98	32	insulin	insulin	NOUN
iajs-2675	98	33	-	-	PUNCT
iajs-2675	98	34	mediated	mediate	VERB
iajs-2675	98	35	glucose	glucose	NOUN
iajs-2675	98	36	absorption	absorption	NOUN
iajs-2675	98	37	in	in	ADP
iajs-2675	98	38	the	the	DET
iajs-2675	98	39	skeletal	skeletal	ADJ
iajs-2675	98	40	muscle	muscle	NOUN
iajs-2675	98	41	,	,	PUNCT
iajs-2675	98	42	and	and	CCONJ
iajs-2675	98	43	facilitated	facilitated	ADJ
iajs-2675	98	44	hypertension	hypertension	NOUN
iajs-2675	98	45	[	[	X
iajs-2675	98	46	40	40	NUM
iajs-2675	98	47	]	]	PUNCT
iajs-2675	98	48	moreover	moreover	ADV
iajs-2675	98	49	,	,	PUNCT
iajs-2675	98	50	the	the	DET
iajs-2675	98	51	polymorphism	polymorphism	NOUN
iajs-2675	98	52	of	of	ADP
iajs-2675	98	53	the	the	DET
iajs-2675	98	54	il-6	il-6	NOUN
iajs-2675	98	55	gene	gene	NOUN
iajs-2675	98	56	was	be	AUX
iajs-2675	98	57	considered	consider	VERB
iajs-2675	98	58	an	an	DET
iajs-2675	98	59	aggravating	aggravating	ADJ
iajs-2675	98	60	factor	factor	NOUN
iajs-2675	98	61	in	in	ADP
iajs-2675	98	62	cardiovascular	cardiovascular	ADJ
iajs-2675	98	63	development	development	NOUN
iajs-2675	98	64	and	and	CCONJ
iajs-2675	98	65	progression	progression	NOUN
iajs-2675	98	66	.	.	PUNCT
iajs-2675	99	1	[	[	X
iajs-2675	99	2	41	41	NUM
iajs-2675	99	3	]	]	PUNCT
iajs-2675	99	4	.	.	PUNCT
iajs-2675	100	1	the	the	DET
iajs-2675	100	2	report	report	NOUN
iajs-2675	100	3	of	of	ADP
iajs-2675	100	4	the	the	DET
iajs-2675	100	5	council	council	PROPN
iajs-2675	100	6	of	of	ADP
iajs-2675	100	7	europe	europe	PROPN
iajs-2675	100	8	lectin	lectin	PROPN
iajs-2675	100	9	-	-	PUNCT
iajs-2675	100	10	likes	like	NOUN
iajs-2675	100	11	ldl	ldl	NOUN
iajs-2675	100	12	has	have	AUX
iajs-2675	100	13	been	be	AUX
iajs-2675	100	14	the	the	DET
iajs-2675	100	15	receptor	receptor	NOUN
iajs-2675	100	16	of	of	ADP
iajs-2675	100	17	atherogenic	atherogenic	ADJ
iajs-2675	100	18	low	low	ADJ
iajs-2675	100	19	-	-	PUNCT
iajs-2675	100	20	density	density	NOUN
iajs-2675	100	21	lipoprotein	lipoprotein	ADJ
iajs-2675	100	22	(	(	PUNCT
iajs-2675	100	23	ox	ox	ADJ
iajs-2675	100	24	-	-	NOUN
iajs-2675	100	25	ldl	ldl	NOUN
iajs-2675	100	26	)	)	PUNCT
iajs-2675	100	27	that	that	PRON
iajs-2675	100	28	was	be	AUX
iajs-2675	100	29	not	not	PART
iajs-2675	100	30	constitutive	constitutive	ADJ
iajs-2675	100	31	,	,	PUNCT
iajs-2675	100	32	but	but	CCONJ
iajs-2675	100	33	dynamically	dynamically	ADV
iajs-2675	100	34	induced	induce	VERB
iajs-2675	100	35	by	by	ADP
iajs-2675	100	36	proinflammatory	proinflammatory	ADJ
iajs-2675	100	37	stimuli	stimulus	NOUN
iajs-2675	100	38	,	,	PUNCT
iajs-2675	100	39	angiotensin	angiotensin	NOUN
iajs-2675	100	40	ii	ii	PROPN
iajs-2675	100	41	or	or	CCONJ
iajs-2675	100	42	ox	ox	ADJ
iajs-2675	100	43	-	-	NOUN
iajs-2675	100	44	ldl	ldl	NOUN
iajs-2675	100	45	which	which	PRON
iajs-2675	100	46	affected	affect	VERB
iajs-2675	100	47	atheroscleric	atheroscleric	ADJ
iajs-2675	100	48	growth	growth	NOUN
iajs-2675	100	49	and	and	CCONJ
iajs-2675	100	50	plate	plate	NOUN
iajs-2675	100	51	vulnerability	vulnerability	NOUN
iajs-2675	100	52	[	[	X
iajs-2675	100	53	42,43	42,43	NOUN
iajs-2675	100	54	]	]	X
iajs-2675	100	55	.	.	PUNCT
iajs-2675	101	1	the	the	DET
iajs-2675	101	2	long	long	ADV
iajs-2675	101	3	-	-	PUNCT
iajs-2675	101	4	lasting	last	VERB
iajs-2675	101	5	depression	depression	NOUN
iajs-2675	101	6	(	(	PUNCT
iajs-2675	101	7	lld	lld	PROPN
iajs-2675	101	8	)	)	PUNCT
iajs-2675	101	9	receptor	receptor	NOUN
iajs-2675	101	10	long	long	ADV
iajs-2675	101	11	-	-	PUNCT
iajs-2675	101	12	lasting	last	VERB
iajs-2675	101	13	depression	depression	NOUN
iajs-2675	101	14	(	(	PUNCT
iajs-2675	101	15	lld)-1	lld)-1	NOUN
iajs-2675	101	16	receptor	receptor	NOUN
iajs-2675	101	17	receptor	receptor	NOUN
iajs-2675	101	18	is	be	AUX
iajs-2675	101	19	a	a	DET
iajs-2675	101	20	receptor	receptor	NOUN
iajs-2675	101	21	that	that	PRON
iajs-2675	101	22	affects	affect	VERB
iajs-2675	101	23	both	both	PRON
iajs-2675	101	24	atherosclerotic	atherosclerotic	ADJ
iajs-2675	101	25	progression	progression	NOUN
iajs-2675	101	26	and	and	CCONJ
iajs-2675	101	27	plaque	plaque	NOUN
iajs-2675	101	28	vulnerability	vulnerability	NOUN
iajs-2675	101	29	.	.	PUNCT
iajs-2675	102	1	lectin	lectin	ADJ
iajs-2675	102	2	-	-	PUNCT
iajs-2675	102	3	like	like	ADJ
iajs-2675	102	4	oxidized	oxidize	VERB
iajs-2675	102	5	low	low	ADJ
iajs-2675	102	6	-	-	PUNCT
iajs-2675	102	7	density	density	NOUN
iajs-2675	102	8	lipoprotein	lipoprotein	ADJ
iajs-2675	102	9	receptor	receptor	NOUN
iajs-2675	102	10	(	(	PUNCT
iajs-2675	102	11	lox-1	lox-1	NOUN
iajs-2675	102	12	)	)	PUNCT
iajs-2675	102	13	occurs	occur	VERB
iajs-2675	102	14	prominently	prominently	ADV
iajs-2675	102	15	in	in	ADP
iajs-2675	102	16	intimate	intimate	ADJ
iajs-2675	102	17	smooth	smooth	ADJ
iajs-2675	102	18	muscle	muscle	NOUN
iajs-2675	102	19	cells	cell	NOUN
iajs-2675	102	20	and	and	CCONJ
iajs-2675	102	21	lipid	lipid	NOUN
iajs-2675	102	22	-	-	PUNCT
iajs-2675	102	23	laden	laden	ADJ
iajs-2675	102	24	macrophages	macrophage	NOUN
iajs-2675	102	25	in	in	ADP
iajs-2675	102	26	advanced	advanced	ADJ
iajs-2675	102	27	plaques	plaque	NOUN
iajs-2675	102	28	in	in	ADP
iajs-2675	102	29	human	human	ADJ
iajs-2675	102	30	atherosclerotic	atherosclerotic	ADJ
iajs-2675	102	31	lesions	lesion	NOUN
iajs-2675	102	32	[	[	X
iajs-2675	102	33	44	44	NUM
iajs-2675	102	34	]	]	PUNCT
iajs-2675	102	35	.	.	PUNCT
iajs-2675	103	1	moreover	moreover	ADV
iajs-2675	103	2	in	in	ADP
iajs-2675	103	3	the	the	DET
iajs-2675	103	4	production	production	NOUN
iajs-2675	103	5	of	of	ADP
iajs-2675	103	6	matrix	matrix	NOUN
iajs-2675	103	7	metalloproteinases	metalloproteinase	NOUN
iajs-2675	103	8	,	,	PUNCT
iajs-2675	103	9	which	which	PRON
iajs-2675	103	10	can	can	AUX
iajs-2675	103	11	straightforwardly	straightforwardly	ADV
iajs-2675	103	12	be	be	AUX
iajs-2675	103	13	connected	connect	VERB
iajs-2675	103	14	to	to	ADP
iajs-2675	103	15	plaque	plaque	NOUN
iajs-2675	103	16	risk	risk	NOUN
iajs-2675	103	17	and	and	CCONJ
iajs-2675	103	18	rupture	rupture	NOUN
iajs-2675	103	19	,	,	PUNCT
iajs-2675	103	20	lox-1	lox-1	PUNCT
iajs-2675	103	21	also	also	ADV
iajs-2675	103	22	plays	play	VERB
iajs-2675	103	23	a	a	DET
iajs-2675	103	24	major	major	ADJ
iajs-2675	103	25	role	role	NOUN
iajs-2675	103	26	in	in	ADP
iajs-2675	103	27	ox	ox	ADJ
iajs-2675	103	28	-	-	ADJ
iajs-2675	103	29	ldl	ldl	ADJ
iajs-2675	103	30	-	-	PUNCT
iajs-2675	103	31	induced	induced	ADJ
iajs-2675	103	32	apoptosis	apoptosis	NOUN
iajs-2675	103	33	of	of	ADP
iajs-2675	103	34	the	the	DET
iajs-2675	103	35	endothelial	endothelial	ADJ
iajs-2675	103	36	and	and	CCONJ
iajs-2675	103	37	smooth	smooth	ADJ
iajs-2675	103	38	cells	cell	NOUN
iajs-2675	103	39	[	[	X
iajs-2675	103	40	45	45	NUM
iajs-2675	103	41	-	-	SYM
iajs-2675	103	42	47	47	NUM
iajs-2675	103	43	]	]	PUNCT
iajs-2675	103	44	.	.	PUNCT
iajs-2675	104	1	in	in	ADP
iajs-2675	104	2	addition	addition	NOUN
iajs-2675	104	3	,	,	PUNCT
iajs-2675	104	4	loxibn	loxibn	PROPN
iajs-2675	104	5	al	al	PROPN
iajs-2675	104	6	-	-	PUNCT
iajs-2675	104	7	haitham	haitham	PROPN
iajs-2675	104	8	jour	jour	X
iajs-2675	104	9	.	.	PROPN
iajs-2675	105	1	for	for	ADP
iajs-2675	105	2	pure	pure	ADJ
iajs-2675	105	3	&	&	CCONJ
iajs-2675	105	4	appl	appl	PROPN
iajs-2675	105	5	.	.	PUNCT
iajs-2675	106	1	sci	sci	PROPN
iajs-2675	106	2	.	.	PROPN
iajs-2675	107	1	34(3)2021	34(3)2021	NUM
iajs-2675	107	2	30	30	NUM
iajs-2675	107	3	1	1	NUM
iajs-2675	107	4	expression	expression	NOUN
iajs-2675	107	5	has	have	AUX
iajs-2675	107	6	been	be	AUX
iajs-2675	107	7	connected	connect	VERB
iajs-2675	107	8	with	with	ADP
iajs-2675	107	9	the	the	DET
iajs-2675	107	10	instability	instability	NOUN
iajs-2675	107	11	in	in	ADP
iajs-2675	107	12	the	the	DET
iajs-2675	107	13	hypercholesterolemic	hypercholesterolemic	ADJ
iajs-2675	107	14	pattern	pattern	NOUN
iajs-2675	107	15	of	of	ADP
iajs-2675	107	16	atherosclerotic	atherosclerotic	ADJ
iajs-2675	107	17	plaques	plaque	NOUN
iajs-2675	107	18	[	[	X
iajs-2675	107	19	48	48	NUM
iajs-2675	107	20	-	-	SYM
iajs-2675	107	21	50	50	NUM
iajs-2675	107	22	]	]	PUNCT
iajs-2675	107	23	.	.	PUNCT
iajs-2675	108	1	an	an	DET
iajs-2675	108	2	activated	activate	VERB
iajs-2675	108	3	systemic	systemic	ADJ
iajs-2675	108	4	raas	raas	NOUN
iajs-2675	108	5	is	be	AUX
iajs-2675	108	6	critical	critical	ADJ
iajs-2675	108	7	for	for	ADP
iajs-2675	108	8	the	the	DET
iajs-2675	108	9	pathogenesis	pathogenesis	NOUN
iajs-2675	108	10	of	of	ADP
iajs-2675	108	11	htn	htn	PROPN
iajs-2675	108	12	and	and	CCONJ
iajs-2675	108	13	other	other	ADJ
iajs-2675	108	14	crs	crs	PROPN
iajs-2675	108	15	components	component	NOUN
iajs-2675	108	16	in	in	ADP
iajs-2675	108	17	insulin	insulin	NOUN
iajs-2675	108	18	resistance	resistance	NOUN
iajs-2675	108	19	states	state	NOUN
iajs-2675	108	20	such	such	ADJ
iajs-2675	108	21	as	as	ADP
iajs-2675	108	22	obesity	obesity	NOUN
iajs-2675	108	23	[	[	X
iajs-2675	108	24	51	51	NUM
iajs-2675	108	25	]	]	PUNCT
iajs-2675	108	26	.	.	PUNCT
iajs-2675	109	1	increasingly	increasingly	ADV
iajs-2675	109	2	,	,	PUNCT
iajs-2675	109	3	expanded	expand	VERB
iajs-2675	109	4	visceral	visceral	ADJ
iajs-2675	109	5	and	and	CCONJ
iajs-2675	109	6	adipocyte	adipocyte	ADJ
iajs-2675	109	7	perivascular	perivascular	ADJ
iajs-2675	109	8	tissue	tissue	NOUN
iajs-2675	109	9	is	be	AUX
iajs-2675	109	10	essential	essential	ADJ
iajs-2675	109	11	to	to	PART
iajs-2675	109	12	activate	activate	VERB
iajs-2675	109	13	the	the	DET
iajs-2675	109	14	raas	raas	NOUN
iajs-2675	109	15	.	.	PUNCT
iajs-2675	110	1	the	the	DET
iajs-2675	110	2	production	production	NOUN
iajs-2675	110	3	of	of	ADP
iajs-2675	110	4	angiotensinogen	angiotensinogen	NOUN
iajs-2675	110	5	by	by	ADP
iajs-2675	110	6	adipocyte	adipocyte	NOUN
iajs-2675	110	7	can	can	AUX
iajs-2675	110	8	contribute	contribute	VERB
iajs-2675	110	9	up	up	ADP
iajs-2675	110	10	to	to	PART
iajs-2675	110	11	30	30	NUM
iajs-2675	110	12	%	%	NOUN
iajs-2675	110	13	of	of	ADP
iajs-2675	110	14	angiotensinogen	angiotensinogen	NOUN
iajs-2675	110	15	circulating	circulate	VERB
iajs-2675	110	16	[	[	X
iajs-2675	110	17	52	52	NUM
iajs-2675	110	18	]	]	PUNCT
iajs-2675	110	19	.	.	PUNCT
iajs-2675	111	1	the	the	DET
iajs-2675	111	2	idea	idea	NOUN
iajs-2675	111	3	that	that	PRON
iajs-2675	111	4	angiotensinogen	angiotensinogen	NOUN
iajs-2675	111	5	adipocyte	adipocyte	NOUN
iajs-2675	111	6	production	production	NOUN
iajs-2675	111	7	contributes	contribute	VERB
iajs-2675	111	8	to	to	ADP
iajs-2675	111	9	an	an	DET
iajs-2675	111	10	activated	activate	VERB
iajs-2675	111	11	raas	raas	NOUN
iajs-2675	111	12	is	be	AUX
iajs-2675	111	13	enhanced	enhance	VERB
iajs-2675	111	14	by	by	ADP
iajs-2675	111	15	observations	observation	NOUN
iajs-2675	111	16	of	of	ADP
iajs-2675	111	17	angiotensinogen	angiotensinogen	NOUN
iajs-2675	111	18	knock	knock	VERB
iajs-2675	111	19	-	-	PUNCT
iajs-2675	111	20	out	out	ADP
iajs-2675	111	21	mousses	mousse	NOUN
iajs-2675	111	22	that	that	PRON
iajs-2675	111	23	are	be	AUX
iajs-2675	111	24	immune	immune	ADJ
iajs-2675	111	25	to	to	ADP
iajs-2675	111	26	obesity	obesity	NOUN
iajs-2675	111	27	,	,	PUNCT
iajs-2675	111	28	insulation	insulation	NOUN
iajs-2675	111	29	and	and	CCONJ
iajs-2675	111	30	htn	htn	PROPN
iajs-2675	111	31	development	development	NOUN
iajs-2675	112	1	[	[	X
iajs-2675	112	2	53,54	53,54	NUM
iajs-2675	112	3	]	]	X
iajs-2675	112	4	.	.	PUNCT
iajs-2675	113	1	there	there	PRON
iajs-2675	113	2	has	have	AUX
iajs-2675	113	3	been	be	AUX
iajs-2675	113	4	no	no	DET
iajs-2675	113	5	obesity	obesity	NOUN
iajs-2675	113	6	-	-	PUNCT
iajs-2675	113	7	related	relate	VERB
iajs-2675	113	8	htn	htn	NOUN
iajs-2675	113	9	in	in	ADP
iajs-2675	113	10	other	other	ADJ
iajs-2675	113	11	murine	murine	ADJ
iajs-2675	113	12	studies	study	NOUN
iajs-2675	113	13	of	of	ADP
iajs-2675	113	14	the	the	DET
iajs-2675	113	15	ablation	ablation	NOUN
iajs-2675	113	16	of	of	ADP
iajs-2675	113	17	adiposederived	adiposederive	VERB
iajs-2675	113	18	angiotensinogen	angiotensinogen	NOUN
iajs-2675	113	19	.	.	PUNCT
iajs-2675	114	1	(	(	PUNCT
iajs-2675	114	2	55	55	NUM
iajs-2675	114	3	)	)	PUNCT
iajs-2675	114	4	this	this	DET
iajs-2675	114	5	evolving	evolve	VERB
iajs-2675	114	6	research	research	NOUN
iajs-2675	114	7	highlights	highlight	NOUN
iajs-2675	114	8	the	the	DET
iajs-2675	114	9	important	important	ADJ
iajs-2675	114	10	connection	connection	NOUN
iajs-2675	114	11	between	between	ADP
iajs-2675	114	12	angiotensinogen	angiotensinogen	NOUN
iajs-2675	114	13	derived	derive	VERB
iajs-2675	114	14	from	from	ADP
iajs-2675	114	15	adipocytes	adipocyte	NOUN
iajs-2675	114	16	and	and	CCONJ
iajs-2675	114	17	htn	htn	NOUN
iajs-2675	114	18	,	,	PUNCT
iajs-2675	114	19	particularly	particularly	ADV
iajs-2675	114	20	in	in	ADP
iajs-2675	114	21	the	the	DET
iajs-2675	114	22	context	context	NOUN
iajs-2675	114	23	of	of	ADP
iajs-2675	114	24	crs	crs	PROPN
iajs-2675	115	1	[	[	X
iajs-2675	115	2	56	56	NUM
iajs-2675	115	3	]	]	PUNCT
iajs-2675	115	4	.	.	PUNCT
iajs-2675	116	1	there	there	PRON
iajs-2675	116	2	is	be	VERB
iajs-2675	116	3	growing	grow	VERB
iajs-2675	116	4	evidence	evidence	NOUN
iajs-2675	116	5	that	that	SCONJ
iajs-2675	116	6	adipocytes	adipocyte	NOUN
iajs-2675	116	7	are	be	AUX
iajs-2675	116	8	a	a	DET
iajs-2675	116	9	major	major	ADJ
iajs-2675	116	10	source	source	NOUN
iajs-2675	116	11	of	of	ADP
iajs-2675	116	12	extra	extra	ADJ
iajs-2675	116	13	-	-	ADJ
iajs-2675	116	14	adrenal	adrenal	ADJ
iajs-2675	116	15	aldosterone	aldosterone	NOUN
iajs-2675	116	16	[	[	X
iajs-2675	116	17	57	57	NUM
iajs-2675	116	18	]	]	PUNCT
iajs-2675	116	19	.	.	PUNCT
iajs-2675	117	1	the	the	DET
iajs-2675	117	2	observation	observation	NOUN
iajs-2675	117	3	that	that	PRON
iajs-2675	117	4	obese	obese	ADJ
iajs-2675	117	5	people	people	NOUN
iajs-2675	117	6	,	,	PUNCT
iajs-2675	117	7	in	in	ADP
iajs-2675	117	8	particular	particular	ADJ
iajs-2675	117	9	females	female	NOUN
iajs-2675	117	10	,	,	PUNCT
iajs-2675	117	11	have	have	AUX
iajs-2675	117	12	increased	increase	VERB
iajs-2675	117	13	aldosterone	aldosterone	NOUN
iajs-2675	117	14	circulation	circulation	NOUN
iajs-2675	117	15	supports	support	VERB
iajs-2675	117	16	this	this	DET
iajs-2675	117	17	concept	concept	NOUN
iajs-2675	117	18	[	[	X
iajs-2675	117	19	58	58	NUM
iajs-2675	117	20	]	]	PUNCT
iajs-2675	117	21	.	.	PUNCT
iajs-2675	118	1	studies	study	NOUN
iajs-2675	118	2	have	have	AUX
iajs-2675	118	3	shown	show	VERB
iajs-2675	118	4	that	that	SCONJ
iajs-2675	118	5	the	the	DET
iajs-2675	118	6	activation	activation	NOUN
iajs-2675	118	7	of	of	ADP
iajs-2675	118	8	aldosteroneinduced	aldosteroneinduce	VERB
iajs-2675	118	9	mineralocorticoid	mineralocorticoid	NOUN
iajs-2675	118	10	receptors	receptor	NOUN
iajs-2675	118	11	(	(	PUNCT
iajs-2675	118	12	mrs	mrs	PROPN
iajs-2675	118	13	)	)	PUNCT
iajs-2675	118	14	in	in	ADP
iajs-2675	118	15	vascular	vascular	ADJ
iajs-2675	118	16	tissues	tissue	NOUN
iajs-2675	118	17	can	can	AUX
iajs-2675	118	18	itself	itself	PRON
iajs-2675	118	19	be	be	AUX
iajs-2675	118	20	an	an	DET
iajs-2675	118	21	instigator	instigator	NOUN
iajs-2675	118	22	in	in	ADP
iajs-2675	118	23	promoting	promote	VERB
iajs-2675	118	24	oxidative	oxidative	ADJ
iajs-2675	118	25	stress	stress	NOUN
iajs-2675	118	26	,	,	PUNCT
iajs-2675	118	27	inflammation	inflammation	NOUN
iajs-2675	118	28	,	,	PUNCT
iajs-2675	118	29	immune	immune	ADJ
iajs-2675	118	30	modulation	modulation	NOUN
iajs-2675	118	31	and	and	CCONJ
iajs-2675	118	32	fibrosis	fibrosis	NOUN
iajs-2675	118	33	in	in	ADP
iajs-2675	118	34	vascular	vascular	ADJ
iajs-2675	118	35	tissue	tissue	NOUN
iajs-2675	118	36	this	this	DET
iajs-2675	118	37	mr	mr	PROPN
iajs-2675	118	38	activation	activation	NOUN
iajs-2675	118	39	can	can	AUX
iajs-2675	118	40	therefore	therefore	ADV
iajs-2675	118	41	be	be	AUX
iajs-2675	118	42	a	a	DET
iajs-2675	118	43	therapeutic	therapeutic	ADJ
iajs-2675	118	44	aim	aim	NOUN
iajs-2675	118	45	to	to	PART
iajs-2675	118	46	prevent	prevent	VERB
iajs-2675	118	47	developments	development	NOUN
iajs-2675	118	48	in	in	ADP
iajs-2675	118	49	dietary	dietary	ADJ
iajs-2675	118	50	obesity	obesity	NOUN
iajs-2675	118	51	in	in	ADP
iajs-2675	118	52	vascular	vascular	ADJ
iajs-2675	118	53	rigidity	rigidity	NOUN
iajs-2675	118	54	and	and	CCONJ
iajs-2675	118	55	htn	htn	NOUN
iajs-2675	118	56	.	.	PUNCT
iajs-2675	119	1	[	[	X
iajs-2675	119	2	59	59	NUM
iajs-2675	119	3	]	]	PUNCT
iajs-2675	119	4	.	.	PUNCT
iajs-2675	120	1	metabolic	metabolic	PROPN
iajs-2675	120	2	syndrome	syndrome	PROPN
iajs-2675	120	3	stands	stand	VERB
iajs-2675	120	4	for	for	ADP
iajs-2675	120	5	the	the	DET
iajs-2675	120	6	collection	collection	NOUN
iajs-2675	120	7	of	of	ADP
iajs-2675	120	8	cardiovascular	cardiovascular	ADJ
iajs-2675	120	9	risk	risk	NOUN
iajs-2675	120	10	-	-	PUNCT
iajs-2675	120	11	associating	associate	VERB
iajs-2675	120	12	disorders	disorder	NOUN
iajs-2675	120	13	is	be	AUX
iajs-2675	120	14	associated	associate	VERB
iajs-2675	120	15	with	with	ADP
iajs-2675	120	16	obesity	obesity	NOUN
iajs-2675	120	17	.	.	PUNCT
iajs-2675	121	1	metabolic	metabolic	NOUN
iajs-2675	121	2	syndrome	syndrome	NOUN
iajs-2675	121	3	is	be	AUX
iajs-2675	121	4	linked	link	VERB
iajs-2675	121	5	to	to	ADP
iajs-2675	121	6	overproduction	overproduction	NOUN
iajs-2675	121	7	(	(	PUNCT
iajs-2675	121	8	ros	ros	PROPN
iajs-2675	121	9	)	)	PUNCT
iajs-2675	121	10	.	.	PUNCT
iajs-2675	122	1	ros	ros	PROPN
iajs-2675	122	2	helps	help	VERB
iajs-2675	122	3	to	to	PART
iajs-2675	122	4	link	link	VERB
iajs-2675	122	5	metabolic	metabolic	NOUN
iajs-2675	122	6	syndrome	syndrome	NOUN
iajs-2675	122	7	and	and	CCONJ
iajs-2675	122	8	salt	salt	NOUN
iajs-2675	122	9	-	-	PUNCT
iajs-2675	122	10	sensitive	sensitive	ADJ
iajs-2675	122	11	hypertension	hypertension	NOUN
iajs-2675	122	12	,	,	PUNCT
iajs-2675	122	13	both	both	PRON
iajs-2675	122	14	are	be	AUX
iajs-2675	122	15	caused	cause	VERB
iajs-2675	122	16	by	by	ADP
iajs-2675	122	17	obesity	obesity	NOUN
iajs-2675	122	18	and	and	CCONJ
iajs-2675	122	19	the	the	DET
iajs-2675	122	20	excess	excess	NOUN
iajs-2675	122	21	of	of	ADP
iajs-2675	122	22	salt	salt	NOUN
iajs-2675	122	23	intake	intake	NOUN
iajs-2675	122	24	and	and	CCONJ
iajs-2675	122	25	significant	significant	ADJ
iajs-2675	122	26	risks	risk	NOUN
iajs-2675	122	27	to	to	ADP
iajs-2675	122	28	health	health	NOUN
iajs-2675	122	29	in	in	ADP
iajs-2675	122	30	advanced	advanced	ADJ
iajs-2675	122	31	countries	country	NOUN
iajs-2675	122	32	.	.	PUNCT
iajs-2675	123	1	ros	ros	PROPN
iajs-2675	123	2	can	can	AUX
iajs-2675	123	3	cause	cause	VERB
iajs-2675	123	4	insulin	insulin	NOUN
iajs-2675	123	5	resistance	resistance	NOUN
iajs-2675	123	6	,	,	PUNCT
iajs-2675	123	7	an	an	DET
iajs-2675	123	8	essential	essential	ADJ
iajs-2675	123	9	element	element	NOUN
iajs-2675	123	10	in	in	ADP
iajs-2675	123	11	metabolic	metabolic	NOUN
iajs-2675	123	12	syndrome	syndrome	NOUN
iajs-2675	123	13	development	development	NOUN
iajs-2675	123	14	,	,	PUNCT
iajs-2675	123	15	and	and	CCONJ
iajs-2675	123	16	saltsensitive	saltsensitive	ADJ
iajs-2675	123	17	hypertension	hypertension	NOUN
iajs-2675	123	18	promotes	promote	VERB
iajs-2675	123	19	ros	ros	PROPN
iajs-2675	123	20	production	production	NOUN
iajs-2675	123	21	,	,	PUNCT
iajs-2675	123	22	thereby	thereby	ADV
iajs-2675	123	23	encouraging	encourage	VERB
iajs-2675	123	24	metabolic	metabolic	NOUN
iajs-2675	123	25	syndrome	syndrome	NOUN
iajs-2675	123	26	development	development	NOUN
iajs-2675	123	27	.	.	PUNCT
iajs-2675	124	1	in	in	ADP
iajs-2675	124	2	addition	addition	NOUN
iajs-2675	124	3	,	,	PUNCT
iajs-2675	124	4	ros	ros	PROPN
iajs-2675	124	5	activates	activate	VERB
iajs-2675	124	6	(	(	PUNCT
iajs-2675	124	7	mrs	mrs	PROPN
iajs-2675	124	8	)	)	PUNCT
iajs-2675	124	9	and	and	CCONJ
iajs-2675	124	10	a	a	DET
iajs-2675	124	11	sympathetic	sympathetic	ADJ
iajs-2675	124	12	nervous	nervous	ADJ
iajs-2675	124	13	system	system	NOUN
iajs-2675	124	14	that	that	PRON
iajs-2675	124	15	can	can	AUX
iajs-2675	124	16	contribute	contribute	VERB
iajs-2675	124	17	to	to	ADP
iajs-2675	124	18	metabolic	metabolic	NOUN
iajs-2675	124	19	and	and	CCONJ
iajs-2675	124	20	salt	salt	NOUN
iajs-2675	124	21	-	-	PUNCT
iajs-2675	124	22	sensitive	sensitive	ADJ
iajs-2675	124	23	hypertension	hypertension	NOUN
iajs-2675	124	24	syndrome	syndrome	NOUN
iajs-2675	124	25	development	development	NOUN
iajs-2675	124	26	.	.	PUNCT
iajs-2675	125	1	in	in	ADP
iajs-2675	125	2	animal	animal	NOUN
iajs-2675	125	3	models	model	NOUN
iajs-2675	125	4	with	with	ADP
iajs-2675	125	5	metabolic	metabolic	NOUN
iajs-2675	125	6	syndroma	syndroma	NOUN
iajs-2675	125	7	,	,	PUNCT
iajs-2675	125	8	salt	salt	NOUN
iajs-2675	125	9	-	-	PUNCT
iajs-2675	125	10	induced	induce	VERB
iajs-2675	125	11	progression	progression	NOUN
iajs-2675	125	12	of	of	ADP
iajs-2675	125	13	(	(	PUNCT
iajs-2675	125	14	cvd	cvd	PROPN
iajs-2675	125	15	)	)	PUNCT
iajs-2675	125	16	,	,	PUNCT
iajs-2675	125	17	probably	probably	ADV
iajs-2675	125	18	due	due	ADJ
iajs-2675	125	19	to	to	ADP
iajs-2675	125	20	further	further	ADJ
iajs-2675	125	21	ros	ros	PROPN
iajs-2675	125	22	stimulation	stimulation	NOUN
iajs-2675	125	23	and	and	CCONJ
iajs-2675	125	24	subsequent	subsequent	ADJ
iajs-2675	125	25	ros	ros	PROPN
iajs-2675	125	26	-	-	PUNCT
iajs-2675	125	27	induced	induce	VERB
iajs-2675	125	28	active	active	ADJ
iajs-2675	125	29	mr	mr	PROPN
iajs-2675	125	30	and	and	CCONJ
iajs-2675	125	31	sympatric	sympatric	ADJ
iajs-2675	125	32	arousal	arousal	NOUN
iajs-2675	125	33	,	,	PUNCT
iajs-2675	125	34	is	be	AUX
iajs-2675	125	35	also	also	ADV
iajs-2675	125	36	accelerated	accelerate	VERB
iajs-2675	125	37	.	.	PUNCT
iajs-2675	126	1	ros	ros	PROPN
iajs-2675	126	2	thus	thus	ADV
iajs-2675	126	3	contributes	contribute	VERB
iajs-2675	126	4	to	to	ADP
iajs-2675	126	5	the	the	DET
iajs-2675	126	6	development	development	NOUN
iajs-2675	126	7	of	of	ADP
iajs-2675	126	8	a	a	DET
iajs-2675	126	9	metabolic	metabolic	NOUN
iajs-2675	126	10	syndrome	syndrome	NOUN
iajs-2675	126	11	itself	itself	PRON
iajs-2675	126	12	and	and	CCONJ
iajs-2675	126	13	the	the	DET
iajs-2675	126	14	accompanying	accompanying	ADJ
iajs-2675	126	15	cvd	cvd	NOUN
iajs-2675	126	16	,	,	PUNCT
iajs-2675	126	17	especially	especially	ADV
iajs-2675	126	18	when	when	SCONJ
iajs-2675	126	19	consuming	consume	VERB
iajs-2675	126	20	excessive	excessive	ADJ
iajs-2675	126	21	salt	salt	NOUN
iajs-2675	126	22	[	[	X
iajs-2675	126	23	60	60	NUM
iajs-2675	126	24	-	-	SYM
iajs-2675	126	25	63	63	NUM
iajs-2675	126	26	]	]	PUNCT
iajs-2675	126	27	.	.	PUNCT
iajs-2675	127	1	the	the	DET
iajs-2675	127	2	finest	fine	ADJ
iajs-2675	127	3	candidate	candidate	NOUN
iajs-2675	127	4	for	for	ADP
iajs-2675	127	5	the	the	DET
iajs-2675	127	6	highest	high	ADJ
iajs-2675	127	7	destructive	destructive	ADJ
iajs-2675	127	8	periodontal	periodontal	ADJ
iajs-2675	127	9	disease	disease	NOUN
iajs-2675	127	10	in	in	ADP
iajs-2675	127	11	obesity	obesity	NOUN
iajs-2675	127	12	or	or	CCONJ
iajs-2675	127	13	metabolic	metabolic	NOUN
iajs-2675	127	14	syndrome	syndrome	NOUN
iajs-2675	127	15	is	be	AUX
iajs-2675	127	16	(	(	PUNCT
iajs-2675	127	17	tnf	tnf	PROPN
iajs-2675	127	18	-	-	PUNCT
iajs-2675	127	19	α	α	NOUN
iajs-2675	127	20	)	)	PUNCT
iajs-2675	127	21	.	.	PUNCT
iajs-2675	128	1	in	in	ADP
iajs-2675	128	2	both	both	PRON
iajs-2675	128	3	obesity	obesity	NOUN
iajs-2675	128	4	and	and	CCONJ
iajs-2675	128	5	metabolic	metabolic	NOUN
iajs-2675	128	6	syndrome	syndrome	NOUN
iajs-2675	128	7	,	,	PUNCT
iajs-2675	128	8	tnf	tnf	PROPN
iajs-2675	128	9	-	-	PUNCT
iajs-2675	128	10	α	α	PROPN
iajs-2675	128	11	levels	level	NOUN
iajs-2675	128	12	are	be	AUX
iajs-2675	128	13	systemically	systemically	ADV
iajs-2675	128	14	elevated	elevate	VERB
iajs-2675	129	1	[	[	X
iajs-2675	129	2	64	64	NUM
iajs-2675	129	3	]	]	PUNCT
iajs-2675	129	4	.	.	PUNCT
iajs-2675	130	1	researches	research	VERB
iajs-2675	130	2	about	about	ADP
iajs-2675	130	3	human	human	ADJ
iajs-2675	130	4	and	and	CCONJ
iajs-2675	130	5	animal	animal	NOUN
iajs-2675	130	6	models	model	NOUN
iajs-2675	130	7	in	in	ADP
iajs-2675	130	8	the	the	DET
iajs-2675	130	9	1990s	1990s	NUM
iajs-2675	130	10	had	have	AUX
iajs-2675	130	11	depicted	depict	VERB
iajs-2675	130	12	that	that	SCONJ
iajs-2675	130	13	adipocytes	adipocytes	ADJ
iajs-2675	130	14	secrete	secrete	NOUN
iajs-2675	130	15	tnf	tnf	PROPN
iajs-2675	130	16	-	-	PUNCT
iajs-2675	130	17	α	α	PROPN
iajs-2675	130	18	and	and	CCONJ
iajs-2675	130	19	therefore	therefore	ADV
iajs-2675	130	20	excess	excess	ADJ
iajs-2675	130	21	fat	fat	NOUN
iajs-2675	130	22	in	in	ADP
iajs-2675	130	23	obesity	obesity	NOUN
iajs-2675	130	24	leads	lead	VERB
iajs-2675	130	25	to	to	ADP
iajs-2675	130	26	chronic	chronic	ADJ
iajs-2675	130	27	systemic	systemic	ADJ
iajs-2675	130	28	swelling	swelling	NOUN
iajs-2675	130	29	[	[	X
iajs-2675	130	30	65	65	NUM
iajs-2675	130	31	]	]	PUNCT
iajs-2675	130	32	.	.	PUNCT
iajs-2675	131	1	in	in	ADP
iajs-2675	131	2	addition	addition	NOUN
iajs-2675	131	3	,	,	PUNCT
iajs-2675	131	4	tnf	tnf	PROPN
iajs-2675	131	5	-	-	PUNCT
iajs-2675	131	6	α	α	PROPN
iajs-2675	131	7	was	be	AUX
iajs-2675	131	8	reported	report	VERB
iajs-2675	131	9	to	to	PART
iajs-2675	131	10	induce	induce	VERB
iajs-2675	131	11	diabetes	diabetes	NOUN
iajs-2675	131	12	and	and	CCONJ
iajs-2675	131	13	obesity	obesity	NOUN
iajs-2675	131	14	to	to	PART
iajs-2675	131	15	resist	resist	VERB
iajs-2675	131	16	insulin	insulin	NOUN
iajs-2675	131	17	[	[	X
iajs-2675	131	18	66	66	NUM
iajs-2675	131	19	]	]	PUNCT
iajs-2675	131	20	.	.	PUNCT
iajs-2675	132	1	it	it	PRON
iajs-2675	132	2	is	be	AUX
iajs-2675	132	3	known	know	VERB
iajs-2675	132	4	that	that	SCONJ
iajs-2675	132	5	a	a	DET
iajs-2675	132	6	chronic	chronic	ADJ
iajs-2675	132	7	systemic	systemic	ADJ
iajs-2675	132	8	inflammation	inflammation	NOUN
iajs-2675	132	9	in	in	ADP
iajs-2675	132	10	the	the	DET
iajs-2675	132	11	obesity	obesity	NOUN
iajs-2675	132	12	is	be	AUX
iajs-2675	132	13	also	also	ADV
iajs-2675	132	14	influenced	influence	VERB
iajs-2675	132	15	by	by	ADP
iajs-2675	132	16	other	other	ADJ
iajs-2675	132	17	cytokines	cytokine	NOUN
iajs-2675	132	18	from	from	ADP
iajs-2675	132	19	adipic	adipic	ADJ
iajs-2675	132	20	tissue	tissue	NOUN
iajs-2675	132	21	(	(	PUNCT
iajs-2675	132	22	67	67	NUM
iajs-2675	132	23	)	)	PUNCT
iajs-2675	132	24	.	.	PUNCT
iajs-2675	133	1	4.management	4.management	NUM
iajs-2675	133	2	and	and	CCONJ
iajs-2675	133	3	treatment	treatment	NOUN
iajs-2675	133	4	ibn	ibn	PROPN
iajs-2675	133	5	al	al	PROPN
iajs-2675	133	6	-	-	PUNCT
iajs-2675	133	7	haitham	haitham	PROPN
iajs-2675	133	8	jour	jour	X
iajs-2675	133	9	.	.	PROPN
iajs-2675	133	10	for	for	ADP
iajs-2675	133	11	pure	pure	ADJ
iajs-2675	133	12	&	&	CCONJ
iajs-2675	133	13	appl	appl	PROPN
iajs-2675	133	14	.	.	PUNCT
iajs-2675	134	1	sci	sci	PROPN
iajs-2675	134	2	.	.	PROPN
iajs-2675	135	1	34(3)2021	34(3)2021	NUM
iajs-2675	135	2	31	31	NUM
iajs-2675	135	3	overweight	overweight	NOUN
iajs-2675	135	4	and	and	CCONJ
iajs-2675	135	5	obesity	obesity	NOUN
iajs-2675	135	6	,	,	PUNCT
iajs-2675	135	7	physical	physical	ADJ
iajs-2675	135	8	inactivity	inactivity	NOUN
iajs-2675	135	9	and	and	CCONJ
iajs-2675	135	10	atherogenic	atherogenic	ADJ
iajs-2675	135	11	diet	diet	NOUN
iajs-2675	135	12	are	be	AUX
iajs-2675	135	13	the	the	DET
iajs-2675	135	14	underlying	underlie	VERB
iajs-2675	135	15	risk	risk	NOUN
iajs-2675	135	16	factors	factor	NOUN
iajs-2675	135	17	that	that	PRON
iajs-2675	135	18	promote	promote	VERB
iajs-2675	135	19	the	the	DET
iajs-2675	135	20	growth	growth	NOUN
iajs-2675	135	21	of	of	ADP
iajs-2675	135	22	metabolism	metabolism	NOUN
iajs-2675	135	23	.	.	PUNCT
iajs-2675	136	1	every	every	DET
iajs-2675	136	2	current	current	ADJ
iajs-2675	136	3	guideline	guideline	NOUN
iajs-2675	136	4	on	on	ADP
iajs-2675	136	5	management	management	NOUN
iajs-2675	136	6	of	of	ADP
iajs-2675	136	7	(	(	PUNCT
iajs-2675	136	8	mets	met	NOUN
iajs-2675	136	9	)	)	PUNCT
iajs-2675	136	10	components	component	NOUN
iajs-2675	136	11	emphasizes	emphasize	VERB
iajs-2675	136	12	that	that	SCONJ
iajs-2675	136	13	the	the	DET
iajs-2675	136	14	first	first	ADJ
iajs-2675	136	15	line	line	NOUN
iajs-2675	136	16	of	of	ADP
iajs-2675	136	17	treatment	treatment	NOUN
iajs-2675	136	18	is	be	AUX
iajs-2675	136	19	lifestyle	lifestyle	NOUN
iajs-2675	136	20	modification	modification	NOUN
iajs-2675	137	1	[	[	X
iajs-2675	137	2	68	68	NUM
iajs-2675	137	3	]	]	PUNCT
iajs-2675	137	4	.	.	PUNCT
iajs-2675	138	1	in	in	ADP
iajs-2675	138	2	an	an	DET
iajs-2675	138	3	attempt	attempt	NOUN
iajs-2675	138	4	to	to	PART
iajs-2675	138	5	highlight	highlight	VERB
iajs-2675	138	6	the	the	DET
iajs-2675	138	7	need	need	NOUN
iajs-2675	138	8	for	for	ADP
iajs-2675	138	9	more	more	ADV
iajs-2675	138	10	intensive	intensive	ADJ
iajs-2675	138	11	lifestyle	lifestyle	NOUN
iajs-2675	138	12	therapy	therapy	NOUN
iajs-2675	138	13	to	to	PART
iajs-2675	138	14	prevent	prevent	VERB
iajs-2675	138	15	cvds	cvds	NOUN
iajs-2675	138	16	in	in	ADP
iajs-2675	138	17	higher	high	ADJ
iajs-2675	138	18	risk	risk	NOUN
iajs-2675	138	19	patients	patient	NOUN
iajs-2675	138	20	,	,	PUNCT
iajs-2675	138	21	atp	atp	PROPN
iajs-2675	138	22	iii	iii	PROPN
iajs-2675	138	23	included	include	VERB
iajs-2675	138	24	the	the	DET
iajs-2675	138	25	concept	concept	NOUN
iajs-2675	138	26	of	of	ADP
iajs-2675	138	27	metabolic	metabolic	NOUN
iajs-2675	138	28	syndrome	syndrome	NOUN
iajs-2675	138	29	in	in	ADP
iajs-2675	138	30	its	its	PRON
iajs-2675	138	31	cholesterol	cholesterol	NOUN
iajs-2675	138	32	guidelines	guideline	NOUN
iajs-2675	138	33	[	[	X
iajs-2675	138	34	69	69	NUM
iajs-2675	138	35	]	]	PUNCT
iajs-2675	138	36	.	.	PUNCT
iajs-2675	139	1	a	a	DET
iajs-2675	139	2	target	target	NOUN
iajs-2675	139	3	blood	blood	NOUN
iajs-2675	139	4	pressure	pressure	NOUN
iajs-2675	139	5	for	for	ADP
iajs-2675	139	6	a	a	DET
iajs-2675	139	7	general	general	ADJ
iajs-2675	139	8	population	population	NOUN
iajs-2675	139	9	must	must	AUX
iajs-2675	139	10	be	be	AUX
iajs-2675	139	11	140/90mmhg	140/90mmhg	NUM
iajs-2675	139	12	,	,	PUNCT
iajs-2675	139	13	and	and	CCONJ
iajs-2675	139	14	the	the	DET
iajs-2675	139	15	target	target	NOUN
iajs-2675	139	16	for	for	ADP
iajs-2675	139	17	diabetes	diabetes	NOUN
iajs-2675	139	18	mellitus	mellitus	NOUN
iajs-2675	139	19	patients	patient	NOUN
iajs-2675	139	20	should	should	AUX
iajs-2675	139	21	be	be	AUX
iajs-2675	139	22	less	less	ADJ
iajs-2675	139	23	than	than	ADP
iajs-2675	139	24	130/80mmhg	130/80mmhg	NUM
iajs-2675	139	25	,	,	PUNCT
iajs-2675	139	26	according	accord	VERB
iajs-2675	139	27	to	to	ADP
iajs-2675	139	28	the	the	DET
iajs-2675	139	29	recent	recent	ADJ
iajs-2675	139	30	guidelines	guideline	NOUN
iajs-2675	139	31	for	for	ADP
iajs-2675	139	32	the	the	DET
iajs-2675	139	33	joint	joint	ADJ
iajs-2675	139	34	national	national	PROPN
iajs-2675	139	35	committee	committee	PROPN
iajs-2675	139	36	(	(	PUNCT
iajs-2675	139	37	jnc	jnc	PROPN
iajs-2675	139	38	)	)	PUNCT
iajs-2675	139	39	.	.	PUNCT
iajs-2675	140	1	the	the	DET
iajs-2675	140	2	recent	recent	ADJ
iajs-2675	140	3	guidelines	guideline	NOUN
iajs-2675	140	4	from	from	ADP
iajs-2675	140	5	the	the	DET
iajs-2675	140	6	joint	joint	ADJ
iajs-2675	140	7	national	national	ADJ
iajs-2675	140	8	committee-8	committee-8	NUM
iajs-2675	140	9	have	have	AUX
iajs-2675	140	10	also	also	ADV
iajs-2675	140	11	indicated	indicate	VERB
iajs-2675	140	12	that	that	SCONJ
iajs-2675	140	13	the	the	DET
iajs-2675	140	14	target	target	NOUN
iajs-2675	140	15	should	should	AUX
iajs-2675	140	16	be	be	AUX
iajs-2675	140	17	less	less	ADJ
iajs-2675	140	18	than	than	ADP
iajs-2675	140	19	150/90	150/90	NUM
iajs-2675	140	20	mmhg	mmhg	NOUN
iajs-2675	140	21	in	in	ADP
iajs-2675	140	22	patients	patient	NOUN
iajs-2675	140	23	aged	age	VERB
iajs-2675	140	24	60	60	NUM
iajs-2675	140	25	or	or	CCONJ
iajs-2675	140	26	older	old	ADJ
iajs-2675	140	27	[	[	X
iajs-2675	140	28	70	70	NUM
iajs-2675	140	29	]	]	PUNCT
iajs-2675	140	30	.	.	PUNCT
iajs-2675	141	1	tests	test	NOUN
iajs-2675	141	2	should	should	AUX
iajs-2675	141	3	include	include	VERB
iajs-2675	141	4	the	the	DET
iajs-2675	141	5	check	check	NOUN
iajs-2675	141	6	-	-	PUNCT
iajs-2675	141	7	up	up	NOUN
iajs-2675	141	8	on	on	ADP
iajs-2675	141	9	full	full	ADJ
iajs-2675	141	10	-	-	PUNCT
iajs-2675	141	11	flow	flow	NOUN
iajs-2675	141	12	analytic	analytic	ADJ
iajs-2675	141	13	fat	fat	NOUN
iajs-2675	141	14	,	,	PUNCT
iajs-2675	141	15	thyroid	thyroid	NOUN
iajs-2675	141	16	stimulating	stimulate	VERB
iajs-2675	141	17	hormone	hormone	NOUN
iajs-2675	141	18	level	level	NOUN
iajs-2675	141	19	,	,	PUNCT
iajs-2675	141	20	urinalysis	urinalysis	NOUN
iajs-2675	141	21	,	,	PUNCT
iajs-2675	141	22	and	and	CCONJ
iajs-2675	141	23	liver	liver	NOUN
iajs-2675	141	24	function	function	NOUN
iajs-2675	141	25	tests	test	NOUN
iajs-2675	141	26	in	in	ADP
iajs-2675	141	27	patients	patient	NOUN
iajs-2675	141	28	with	with	ADP
iajs-2675	141	29	hypertriglyceridemia	hypertriglyceridemia	NOUN
iajs-2675	141	30	defined	define	VERB
iajs-2675	141	31	by	by	ADP
iajs-2675	141	32	triglycerides	triglyceride	NOUN
iajs-2675	142	1	over	over	ADP
iajs-2675	142	2	150	150	NUM
iajs-2675	142	3	mg	mg	PROPN
iajs-2675	142	4	/	/	SYM
iajs-2675	142	5	dl	dl	PROPN
iajs-2675	142	6	.	.	PUNCT
iajs-2675	142	7	patients	patient	NOUN
iajs-2675	142	8	must	must	AUX
iajs-2675	142	9	first	first	ADV
iajs-2675	142	10	be	be	AUX
iajs-2675	142	11	advised	advise	VERB
iajs-2675	142	12	on	on	ADP
iajs-2675	142	13	lifestyle	lifestyle	NOUN
iajs-2675	142	14	variations	variation	NOUN
iajs-2675	142	15	,	,	PUNCT
iajs-2675	142	16	involving	involve	VERB
iajs-2675	142	17	withdrawal	withdrawal	NOUN
iajs-2675	142	18	from	from	ADP
iajs-2675	142	19	smoking	smoking	NOUN
iajs-2675	142	20	,	,	PUNCT
iajs-2675	142	21	loss	loss	NOUN
iajs-2675	142	22	of	of	ADP
iajs-2675	142	23	weight	weight	NOUN
iajs-2675	142	24	and	and	CCONJ
iajs-2675	142	25	diet	diet	NOUN
iajs-2675	142	26	and	and	CCONJ
iajs-2675	142	27	changes	change	NOUN
iajs-2675	142	28	to	to	PART
iajs-2675	142	29	exercise	exercise	VERB
iajs-2675	142	30	,	,	PUNCT
iajs-2675	142	31	following	follow	VERB
iajs-2675	142	32	an	an	DET
iajs-2675	142	33	extensive	extensive	ADJ
iajs-2675	142	34	analysis	analysis	NOUN
iajs-2675	142	35	.	.	PUNCT
iajs-2675	143	1	doctor	doctor	NOUN
iajs-2675	143	2	treatment	treatment	NOUN
iajs-2675	143	3	begins	begin	VERB
iajs-2675	143	4	with	with	ADP
iajs-2675	143	5	hypertriglyceridemia	hypertriglyceridemia	NOUN
iajs-2675	143	6	once	once	ADV
iajs-2675	143	7	a	a	DET
iajs-2675	143	8	level	level	NOUN
iajs-2675	143	9	is	be	AUX
iajs-2675	143	10	greater	great	ADJ
iajs-2675	143	11	than	than	ADP
iajs-2675	143	12	500	500	NUM
iajs-2675	143	13	mg	mg	NUM
iajs-2675	143	14	/	/	SYM
iajs-2675	143	15	dl	dl	PROPN
iajs-2675	143	16	and	and	CCONJ
iajs-2675	143	17	patients	patient	NOUN
iajs-2675	143	18	typically	typically	ADV
iajs-2675	143	19	have	have	VERB
iajs-2675	143	20	a	a	DET
iajs-2675	143	21	mixed	mixed	ADJ
iajs-2675	143	22	disorder	disorder	NOUN
iajs-2675	143	23	of	of	ADP
iajs-2675	143	24	dyslipidemia	dyslipidemia	NOUN
iajs-2675	143	25	by	by	ADP
iajs-2675	143	26	then	then	ADV
iajs-2675	143	27	.	.	PUNCT
iajs-2675	144	1	patients	patient	NOUN
iajs-2675	144	2	are	be	AUX
iajs-2675	144	3	usually	usually	ADV
iajs-2675	144	4	first	first	ADV
iajs-2675	144	5	treated	treat	VERB
iajs-2675	144	6	for	for	ADP
iajs-2675	144	7	moderate	moderate	ADJ
iajs-2675	144	8	to	to	PART
iajs-2675	144	9	high	high	ADJ
iajs-2675	144	10	-	-	PUNCT
iajs-2675	144	11	intensity	intensity	NOUN
iajs-2675	144	12	statins	statin	NOUN
iajs-2675	144	13	but	but	CCONJ
iajs-2675	144	14	also	also	ADV
iajs-2675	144	15	for	for	ADP
iajs-2675	144	16	the	the	DET
iajs-2675	144	17	treatment	treatment	NOUN
iajs-2675	144	18	of	of	ADP
iajs-2675	144	19	hypertriglyceridemia	hypertriglyceridemia	NOUN
iajs-2675	144	20	fibrates	fibrate	NOUN
iajs-2675	144	21	,	,	PUNCT
iajs-2675	144	22	niacin	niacin	NOUN
iajs-2675	144	23	and	and	CCONJ
iajs-2675	144	24	omega	omega	NOUN
iajs-2675	144	25	acids	acid	NOUN
iajs-2675	144	26	are	be	AUX
iajs-2675	144	27	as	as	ADV
iajs-2675	144	28	well	well	ADV
iajs-2675	144	29	available	available	ADJ
iajs-2675	144	30	.	.	PUNCT
iajs-2675	145	1	higher	high	ADJ
iajs-2675	145	2	ldl	ldl	NOUN
iajs-2675	145	3	must	must	AUX
iajs-2675	145	4	also	also	ADV
iajs-2675	145	5	be	be	AUX
iajs-2675	145	6	managed	manage	VERB
iajs-2675	145	7	too	too	ADV
iajs-2675	145	8	much	much	ADJ
iajs-2675	145	9	in	in	ADP
iajs-2675	145	10	patients	patient	NOUN
iajs-2675	145	11	,	,	PUNCT
iajs-2675	145	12	in	in	ADP
iajs-2675	145	13	particular	particular	ADJ
iajs-2675	145	14	when	when	SCONJ
iajs-2675	145	15	a	a	DET
iajs-2675	145	16	risk	risk	NOUN
iajs-2675	145	17	of	of	ADP
iajs-2675	145	18	ascvd	ascvd	NOUN
iajs-2675	145	19	is	be	AUX
iajs-2675	145	20	above	above	ADP
iajs-2675	145	21	7.5	7.5	NUM
iajs-2675	145	22	%	%	NOUN
iajs-2675	145	23	,	,	PUNCT
iajs-2675	145	24	which	which	PRON
iajs-2675	145	25	determines	determine	VERB
iajs-2675	145	26	the	the	DET
iajs-2675	145	27	10	10	NUM
iajs-2675	145	28	-	-	PUNCT
iajs-2675	145	29	year	year	NOUN
iajs-2675	145	30	ascvd	ascvd	NOUN
iajs-2675	145	31	risk	risk	NOUN
iajs-2675	145	32	of	of	ADP
iajs-2675	145	33	the	the	DET
iajs-2675	145	34	patient	patient	NOUN
iajs-2675	145	35	.	.	PUNCT
iajs-2675	146	1	the	the	DET
iajs-2675	146	2	goal	goal	NOUN
iajs-2675	146	3	is	be	AUX
iajs-2675	146	4	to	to	PART
iajs-2675	146	5	decrease	decrease	VERB
iajs-2675	146	6	ldl	ldl	VERB
iajs-2675	146	7	by	by	ADP
iajs-2675	146	8	50	50	NUM
iajs-2675	146	9	%	%	NOUN
iajs-2675	146	10	in	in	ADP
iajs-2675	146	11	those	those	DET
iajs-2675	146	12	patients	patient	NOUN
iajs-2675	146	13	with	with	ADP
iajs-2675	146	14	high	high	ADJ
iajs-2675	146	15	-	-	PUNCT
iajs-2675	146	16	intensity	intensity	NOUN
iajs-2675	146	17	statin	statin	ADJ
iajs-2675	146	18	treatment	treatment	NOUN
iajs-2675	146	19	[	[	X
iajs-2675	146	20	71	71	NUM
iajs-2675	146	21	]	]	PUNCT
iajs-2675	146	22	.	.	PUNCT
iajs-2675	147	1	bariatric	bariatric	ADJ
iajs-2675	147	2	surgery	surgery	NOUN
iajs-2675	147	3	can	can	AUX
iajs-2675	147	4	be	be	AUX
iajs-2675	147	5	used	use	VERB
iajs-2675	147	6	in	in	ADP
iajs-2675	147	7	patients	patient	NOUN
iajs-2675	147	8	with	with	ADP
iajs-2675	147	9	severe	severe	ADJ
iajs-2675	147	10	obesity	obesity	NOUN
iajs-2675	147	11	.	.	PUNCT
iajs-2675	148	1	the	the	DET
iajs-2675	148	2	most	most	ADV
iajs-2675	148	3	efficient	efficient	ADJ
iajs-2675	148	4	singletherapy	singletherapy	NOUN
iajs-2675	148	5	metabolic	metabolic	NOUN
iajs-2675	148	6	syndrome	syndrome	NOUN
iajs-2675	148	7	is	be	AUX
iajs-2675	148	8	considered	consider	VERB
iajs-2675	148	9	a	a	DET
iajs-2675	148	10	bariatric	bariatric	ADJ
iajs-2675	148	11	surgery	surgery	NOUN
iajs-2675	148	12	.	.	PUNCT
iajs-2675	149	1	laparoscopically	laparoscopically	ADV
iajs-2675	149	2	adjustable	adjustable	ADJ
iajs-2675	149	3	gastric	gastric	ADJ
iajs-2675	149	4	banding	banding	NOUN
iajs-2675	149	5	,	,	PUNCT
iajs-2675	149	6	laparoscopic	laparoscopic	ADJ
iajs-2675	149	7	gastric	gastric	ADJ
iajs-2675	149	8	circumvention	circumvention	NOUN
iajs-2675	149	9	of	of	ADP
iajs-2675	149	10	roux	roux	NOUN
iajs-2675	149	11	-	-	PUNCT
iajs-2675	149	12	en	en	NOUN
iajs-2675	149	13	-	-	PUNCT
iajs-2675	149	14	y	y	ADJ
iajs-2675	149	15	and	and	CCONJ
iajs-2675	149	16	laparoscopic	laparoscopic	ADJ
iajs-2675	149	17	gastric	gastric	ADJ
iajs-2675	149	18	sleeves	sleeve	NOUN
iajs-2675	149	19	are	be	AUX
iajs-2675	149	20	the	the	DET
iajs-2675	149	21	most	most	ADV
iajs-2675	149	22	frequent	frequent	ADJ
iajs-2675	149	23	procedures	procedure	NOUN
iajs-2675	149	24	.	.	PUNCT
iajs-2675	150	1	in	in	ADP
iajs-2675	150	2	patients	patient	NOUN
iajs-2675	150	3	with	with	ADP
iajs-2675	150	4	bmi	bmi	PROPN
iajs-2675	150	5	daily	daily	ADV
iajs-2675	150	6	at	at	ADP
iajs-2675	150	7	40	40	NUM
iajs-2675	150	8	kg	kg	NOUN
iajs-2675	150	9	/	/	SYM
iajs-2675	150	10	m2	m2	PROPN
iajs-2675	150	11	or	or	CCONJ
iajs-2675	150	12	with	with	ADP
iajs-2675	150	13	a	a	DET
iajs-2675	150	14	bmi	bmi	NOUN
iajs-2675	150	15	daily	daily	ADJ
iajs-2675	150	16	35	35	NUM
iajs-2675	150	17	kg	kg	NOUN
iajs-2675	150	18	/	/	SYM
iajs-2675	150	19	m2	m2	PROPN
iajs-2675	150	20	or	or	CCONJ
iajs-2675	150	21	in	in	ADP
iajs-2675	150	22	other	other	ADJ
iajs-2675	150	23	comorbidities	comorbiditie	NOUN
iajs-2675	150	24	,	,	PUNCT
iajs-2675	150	25	bariatric	bariatric	ADJ
iajs-2675	150	26	surgery	surgery	NOUN
iajs-2675	150	27	is	be	AUX
iajs-2675	150	28	recommended	recommend	VERB
iajs-2675	150	29	.	.	PUNCT
iajs-2675	151	1	in	in	ADP
iajs-2675	151	2	order	order	NOUN
iajs-2675	151	3	to	to	PART
iajs-2675	151	4	avoid	avoid	VERB
iajs-2675	151	5	operative	operative	ADJ
iajs-2675	151	6	,	,	PUNCT
iajs-2675	151	7	nutritional	nutritional	ADJ
iajs-2675	151	8	and	and	CCONJ
iajs-2675	151	9	psychiatric	psychiatric	ADJ
iajs-2675	151	10	complications	complication	NOUN
iajs-2675	151	11	,	,	PUNCT
iajs-2675	151	12	patients	patient	NOUN
iajs-2675	151	13	need	need	VERB
iajs-2675	151	14	a	a	DET
iajs-2675	151	15	longterm	longterm	ADJ
iajs-2675	151	16	follow	follow	NOUN
iajs-2675	151	17	-	-	PUNCT
iajs-2675	151	18	up	up	NOUN
iajs-2675	151	19	after	after	ADP
iajs-2675	151	20	surgery	surgery	NOUN
iajs-2675	151	21	[	[	X
iajs-2675	151	22	72	72	NUM
iajs-2675	151	23	]	]	PUNCT
iajs-2675	151	24	.	.	PUNCT
iajs-2675	152	1	5.conclusion	5.conclusion	NUM
iajs-2675	152	2	metabalic	metabalic	ADJ
iajs-2675	152	3	syndrome	syndrome	NOUN
iajs-2675	152	4	stands	stand	VERB
iajs-2675	152	5	for	for	ADP
iajs-2675	152	6	the	the	DET
iajs-2675	152	7	constellation	constellation	NOUN
iajs-2675	152	8	of	of	ADP
iajs-2675	152	9	cardiovascular	cardiovascular	ADJ
iajs-2675	152	10	risk	risk	NOUN
iajs-2675	152	11	factors	factor	NOUN
iajs-2675	152	12	that	that	PRON
iajs-2675	152	13	raise	raise	VERB
iajs-2675	152	14	the	the	DET
iajs-2675	152	15	risk	risk	NOUN
iajs-2675	152	16	of	of	ADP
iajs-2675	152	17	cardiovascular	cardiovascular	ADJ
iajs-2675	152	18	arteriosclerosis	arteriosclerosis	NOUN
iajs-2675	152	19	and	and	CCONJ
iajs-2675	152	20	type	type	NOUN
iajs-2675	152	21	2	2	NUM
iajs-2675	152	22	diabetes	diabetes	NOUN
iajs-2675	152	23	.	.	PUNCT
iajs-2675	153	1	type	type	NOUN
iajs-2675	153	2	2	2	NUM
iajs-2675	153	3	diabetes	diabetes	NOUN
iajs-2675	153	4	is	be	AUX
iajs-2675	153	5	a	a	DET
iajs-2675	153	6	major	major	ADJ
iajs-2675	153	7	global	global	ADJ
iajs-2675	153	8	public	public	ADJ
iajs-2675	153	9	health	health	NOUN
iajs-2675	153	10	issue	issue	NOUN
iajs-2675	153	11	with	with	ADP
iajs-2675	153	12	more	more	ADJ
iajs-2675	153	13	than	than	ADP
iajs-2675	153	14	300	300	NUM
iajs-2675	153	15	million	million	NUM
iajs-2675	153	16	people	people	NOUN
iajs-2675	153	17	projected	project	VERB
iajs-2675	153	18	in	in	ADP
iajs-2675	153	19	2025	2025	NUM
iajs-2675	153	20	.	.	PUNCT
iajs-2675	154	1	therefore	therefore	ADV
iajs-2675	154	2	,	,	PUNCT
iajs-2675	154	3	the	the	DET
iajs-2675	154	4	tide	tide	NOUN
iajs-2675	154	5	of	of	ADP
iajs-2675	154	6	this	this	DET
iajs-2675	154	7	dangerous	dangerous	ADJ
iajs-2675	154	8	trend	trend	NOUN
iajs-2675	154	9	will	will	AUX
iajs-2675	154	10	help	help	VERB
iajs-2675	154	11	to	to	PART
iajs-2675	154	12	stop	stop	VERB
iajs-2675	154	13	the	the	DET
iajs-2675	154	14	risk	risk	NOUN
iajs-2675	154	15	stratification	stratification	NOUN
iajs-2675	154	16	,	,	PUNCT
iajs-2675	154	17	early	early	ADJ
iajs-2675	154	18	identification	identification	NOUN
iajs-2675	154	19	and	and	CCONJ
iajs-2675	154	20	radical	radical	ADJ
iajs-2675	154	21	intervention	intervention	NOUN
iajs-2675	154	22	.	.	PUNCT
iajs-2675	155	1	reference	reference	NOUN
iajs-2675	155	2	1	1	NUM
iajs-2675	155	3	.	.	PUNCT
iajs-2675	156	1	simmons	simmon	NOUN
iajs-2675	156	2	,	,	PUNCT
iajs-2675	156	3	r.	r.	PROPN
iajs-2675	156	4	k.	k.	PROPN
iajs-2675	156	5	;	;	PUNCT
iajs-2675	156	6	alberti	alberti	PROPN
iajs-2675	156	7	,	,	PUNCT
iajs-2675	156	8	k.g.m	k.g.m	PROPN
iajs-2675	156	9	.	.	PUNCT
iajs-2675	156	10	;	;	PUNCT
iajs-2675	157	1	gale	gale	NOUN
iajs-2675	157	2	,	,	PUNCT
iajs-2675	157	3	e.a.m	e.a.m	X
iajs-2675	157	4	.	.	PUNCT
iajs-2675	157	5	;	;	PUNCT
iajs-2675	157	6	collages	collage	NOUN
iajs-2675	157	7	,	,	PUNCT
iajs-2675	157	8	s.	s.	PROPN
iajs-2675	157	9	;	;	PUNCT
iajs-2675	157	10	tuomilehto	tuomilehto	NOUN
iajs-2675	157	11	,	,	PUNCT
iajs-2675	157	12	j.	j.	PROPN
iajs-2675	157	13	;	;	PUNCT
iajs-2675	157	14	qiao	qiao	PROPN
iajs-2675	157	15	,	,	PUNCT
iajs-2675	157	16	q.	q.	PROPN
iajs-2675	157	17	;	;	PUNCT
iajs-2675	157	18	ramachandran	ramachandran	PROPN
iajs-2675	157	19	,	,	PUNCT
iajs-2675	157	20	a.	a.	NOUN
iajs-2675	157	21	;	;	PUNCT
iajs-2675	157	22	tajima	tajima	PROPN
iajs-2675	157	23	,	,	PUNCT
iajs-2675	157	24	n.	n.	PROPN
iajs-2675	157	25	;	;	PUNCT
iajs-2675	157	26	mirchov	mirchov	PROPN
iajs-2675	157	27	,	,	PUNCT
iajs-2675	157	28	i.b	i.b	PROPN
iajs-2675	157	29	.	.	PROPN
iajs-2675	157	30	;	;	PUNCT
iajs-2675	157	31	ben	ben	PROPN
iajs-2675	157	32	-	-	PUNCT
iajs-2675	157	33	nakhi	nakhi	PROPN
iajs-2675	157	34	,	,	PUNCT
iajs-2675	157	35	a.	a.	NOUN
iajs-2675	157	36	,	,	PUNCT
iajs-2675	157	37	reaven	reaven	VERB
iajs-2675	157	38	,	,	PUNCT
iajs-2675	157	39	g.	g.	PROPN
iajs-2675	157	40	;	;	PUNCT
iajs-2675	157	41	sambo	sambo	PROPN
iajs-2675	157	42	,	,	PUNCT
iajs-2675	157	43	h.b	h.b	PROPN
iajs-2675	157	44	.	.	PROPN
iajs-2675	157	45	;	;	PUNCT
iajs-2675	157	46	ibn	ibn	PROPN
iajs-2675	157	47	al	al	PROPN
iajs-2675	157	48	-	-	PUNCT
iajs-2675	157	49	haitham	haitham	PROPN
iajs-2675	157	50	jour	jour	X
iajs-2675	157	51	.	.	PROPN
iajs-2675	157	52	for	for	ADP
iajs-2675	157	53	pure	pure	ADJ
iajs-2675	157	54	&	&	CCONJ
iajs-2675	157	55	appl	appl	PROPN
iajs-2675	157	56	.	.	PUNCT
iajs-2675	158	1	sci	sci	PROPN
iajs-2675	158	2	.	.	PROPN
iajs-2675	159	1	34(3)2021	34(3)2021	NUM
iajs-2675	159	2	32	32	NUM
iajs-2675	159	3	mendis	mendi	NOUN
iajs-2675	159	4	,	,	PUNCT
iajs-2675	159	5	s.	s.	PROPN
iajs-2675	159	6	;	;	PUNCT
iajs-2675	159	7	roglic	roglic	ADJ
iajs-2675	159	8	,	,	PUNCT
iajs-2675	159	9	g.	g.	PROPN
iajs-2675	159	10	the	the	DET
iajs-2675	159	11	metabolic	metabolic	NOUN
iajs-2675	159	12	syndrome	syndrome	NOUN
iajs-2675	159	13	:	:	PUNCT
iajs-2675	159	14	useful	useful	ADJ
iajs-2675	159	15	concept	concept	NOUN
iajs-2675	159	16	or	or	CCONJ
iajs-2675	159	17	clinical	clinical	ADJ
iajs-2675	159	18	tool	tool	NOUN
iajs-2675	159	19	?	?	PUNCT
iajs-2675	160	1	report	report	NOUN
iajs-2675	160	2	of	of	ADP
iajs-2675	160	3	a	a	PRON
iajs-2675	160	4	who	who	PRON
iajs-2675	160	5	expert	expert	VERB
iajs-2675	160	6	consultation	consultation	NOUN
iajs-2675	160	7	.	.	PUNCT
iajs-2675	161	1	diabetologia	diabetologia	NOUN
iajs-2675	161	2	.	.	PUNCT
iajs-2675	162	1	2010	2010	NUM
iajs-2675	162	2	,	,	PUNCT
iajs-2675	162	3	53	53	NUM
iajs-2675	162	4	,	,	PUNCT
iajs-2675	162	5	600–605	600–605	NUM
iajs-2675	162	6	,	,	PUNCT
iajs-2675	162	7	doi:10.1007	doi:10.1007	ADJ
iajs-2675	162	8	/	/	SYM
iajs-2675	162	9	s00125	s00125	NOUN
iajs-2675	162	10	-	-	PUNCT
iajs-2675	162	11	009	009	NUM
iajs-2675	162	12	-	-	SYM
iajs-2675	162	13	16204	16204	NUM
iajs-2675	162	14	.	.	PUNCT
iajs-2675	163	1	2	2	X
iajs-2675	163	2	.	.	X
iajs-2675	163	3	huang	huang	PROPN
iajs-2675	163	4	,	,	PUNCT
iajs-2675	163	5	p.l	p.l	PROPN
iajs-2675	163	6	.	.	PROPN
iajs-2675	164	1	a	a	DET
iajs-2675	164	2	comprehensive	comprehensive	ADJ
iajs-2675	164	3	definition	definition	NOUN
iajs-2675	164	4	for	for	ADP
iajs-2675	164	5	metabolic	metabolic	NOUN
iajs-2675	164	6	syndrome	syndrome	NOUN
iajs-2675	164	7	.	.	PUNCT
iajs-2675	165	1	dis	dis	PROPN
iajs-2675	165	2	.	.	PUNCT
iajs-2675	165	3	model	model	PROPN
iajs-2675	165	4	.	.	PUNCT
iajs-2675	166	1	2009,2,231	2009,2,231	NUM
iajs-2675	166	2	237	237	NUM
iajs-2675	166	3	,	,	PUNCT
iajs-2675	166	4	doi:10.1242	doi:10.1242	NOUN
iajs-2675	166	5	/	/	SYM
iajs-2675	166	6	dmm.001180	dmm.001180	X
iajs-2675	166	7	.	.	PUNCT
iajs-2675	167	1	3	3	X
iajs-2675	167	2	.	.	X
iajs-2675	167	3	sattar	sattar	PROPN
iajs-2675	167	4	,	,	PUNCT
iajs-2675	167	5	n.	n.	PROPN
iajs-2675	167	6	;	;	PUNCT
iajs-2675	167	7	alex	alex	PROPN
iajs-2675	167	8	mcconnachie	mcconnachie	PROPN
iajs-2675	167	9	,	,	PUNCT
iajs-2675	167	10	a.	a.	NOUN
iajs-2675	167	11	;	;	PUNCT
iajs-2675	167	12	shaper	shaper	NOUN
iajs-2675	167	13	,	,	PUNCT
iajs-2675	167	14	a.g	a.g	PROPN
iajs-2675	167	15	.	.	PROPN
iajs-2675	167	16	;	;	PUNCT
iajs-2675	167	17	blauw	blauw	PROPN
iajs-2675	167	18	,	,	PUNCT
iajs-2675	167	19	g.j	g.j	PROPN
iajs-2675	167	20	.	.	PROPN
iajs-2675	167	21	;	;	PUNCT
iajs-2675	167	22	buckley	buckley	PROPN
iajs-2675	167	23	,	,	PUNCT
iajs-2675	167	24	b.m	b.m	PROPN
iajs-2675	167	25	.	.	PROPN
iajs-2675	167	26	;	;	PUNCT
iajs-2675	167	27	anton	anton	PROPN
iajs-2675	167	28	j	j	PROPN
iajs-2675	167	29	de	de	PROPN
iajs-2675	167	30	craen	craen	PROPN
iajs-2675	167	31	,	,	PUNCT
iajs-2675	167	32	a.j	a.j	PROPN
iajs-2675	167	33	.	.	PROPN
iajs-2675	167	34	;	;	PUNCT
iajs-2675	167	35	ford	ford	PROPN
iajs-2675	167	36	,	,	PUNCT
iajs-2675	167	37	i.	i.	PROPN
iajs-2675	167	38	;	;	PUNCT
iajs-2675	167	39	forouhi	forouhi	PROPN
iajs-2675	167	40	,	,	PUNCT
iajs-2675	167	41	n.g	n.g	PROPN
iajs-2675	167	42	.	.	PROPN
iajs-2675	167	43	;	;	PUNCT
iajs-2675	167	44	freeman	freeman	PROPN
iajs-2675	167	45	,	,	PUNCT
iajs-2675	167	46	d.j	d.j	PROPN
iajs-2675	167	47	.	.	PROPN
iajs-2675	167	48	;	;	PUNCT
iajs-2675	167	49	jukema	jukema	PROPN
iajs-2675	167	50	,	,	PUNCT
iajs-2675	167	51	j.w	j.w	PROPN
iajs-2675	167	52	.	.	PROPN
iajs-2675	167	53	;	;	PUNCT
iajs-2675	167	54	lennon	lennon	PROPN
iajs-2675	167	55	,	,	PUNCT
iajs-2675	167	56	l.	l.	PROPN
iajs-2675	167	57	;	;	PUNCT
iajs-2675	167	58	macfarlane	macfarlane	PROPN
iajs-2675	167	59	.	.	PUNCT
iajs-2675	168	1	p.w	p.w	AUX
iajs-2675	168	2	.	.	PROPN
iajs-2675	168	3	;	;	PUNCT
iajs-2675	168	4	murphy	murphy	PROPN
iajs-2675	168	5	,	,	PUNCT
iajs-2675	168	6	m.b	m.b	PROPN
iajs-2675	168	7	.	.	PROPN
iajs-2675	168	8	;	;	PUNCT
iajs-2675	168	9	packard	packard	PROPN
iajs-2675	168	10	,	,	PUNCT
iajs-2675	168	11	c.j	c.j	PROPN
iajs-2675	168	12	.	.	PROPN
iajs-2675	168	13	;	;	PUNCT
iajs-2675	168	14	stott	stott	PROPN
iajs-2675	168	15	,	,	PUNCT
iajs-2675	168	16	d.j	d.j	PROPN
iajs-2675	168	17	.	.	PROPN
iajs-2675	168	18	;	;	PUNCT
iajs-2675	168	19	westendorp	westendorp	PROPN
iajs-2675	168	20	,	,	PUNCT
iajs-2675	168	21	r.g	r.g	PROPN
iajs-2675	168	22	.	.	PROPN
iajs-2675	168	23	;	;	PUNCT
iajs-2675	168	24	whincup	whincup	INTJ
iajs-2675	168	25	,	,	PUNCT
iajs-2675	168	26	p.h	p.h	PROPN
iajs-2675	168	27	.	.	PROPN
iajs-2675	168	28	;	;	PUNCT
iajs-2675	168	29	shepherd	shepherd	NOUN
iajs-2675	168	30	,	,	PUNCT
iajs-2675	168	31	j.	j.	PROPN
iajs-2675	168	32	;	;	PUNCT
iajs-2675	168	33	wannamethee	wannamethee	NOUN
iajs-2675	168	34	,	,	PUNCT
iajs-2675	168	35	s.g	s.g	PROPN
iajs-2675	168	36	.	.	PROPN
iajs-2675	168	37	can	can	AUX
iajs-2675	168	38	metabolic	metabolic	VERB
iajs-2675	168	39	syndrome	syndrome	PROPN
iajs-2675	168	40	usefully	usefully	ADV
iajs-2675	168	41	predict	predict	VERB
iajs-2675	168	42	cardiovascular	cardiovascular	ADJ
iajs-2675	168	43	disease	disease	NOUN
iajs-2675	168	44	and	and	CCONJ
iajs-2675	168	45	diabetes	diabetes	NOUN
iajs-2675	168	46	?	?	PUNCT
iajs-2675	169	1	outcome	outcome	NOUN
iajs-2675	169	2	data	datum	NOUN
iajs-2675	169	3	from	from	ADP
iajs-2675	169	4	two	two	NUM
iajs-2675	169	5	prospective	prospective	ADJ
iajs-2675	169	6	studies	study	NOUN
iajs-2675	169	7	.	.	PUNCT
iajs-2675	170	1	lancet	lancet	PROPN
iajs-2675	170	2	.2008	.2008	PROPN
iajs-2675	170	3	,	,	PUNCT
iajs-2675	170	4	371	371	NUM
iajs-2675	170	5	,	,	PUNCT
iajs-2675	170	6	1927	1927	NUM
iajs-2675	170	7	–	–	PUNCT
iajs-2675	170	8	1935	1935	NUM
iajs-2675	170	9	,	,	PUNCT
iajs-2675	170	10	doi:10.1016	doi:10.1016	PROPN
iajs-2675	170	11	/	/	SYM
iajs-2675	170	12	s0140	s0140	PROPN
iajs-2675	170	13	-	-	PUNCT
iajs-2675	170	14	6736(08)60602	6736(08)60602	NUM
iajs-2675	170	15	-	-	SYM
iajs-2675	170	16	9	9	NUM
iajs-2675	170	17	.	.	NOUN
iajs-2675	170	18	4	4	NUM
iajs-2675	170	19	.	.	X
iajs-2675	170	20	hanson	hanson	PROPN
iajs-2675	170	21	,	,	PUNCT
iajs-2675	170	22	r.	r.	PROPN
iajs-2675	170	23	l.	l.	PROPN
iajs-2675	170	24	;	;	PUNCT
iajs-2675	170	25	imperatore	imperatore	PROPN
iajs-2675	170	26	,	,	PUNCT
iajs-2675	170	27	g.	g.	PROPN
iajs-2675	170	28	;	;	PUNCT
iajs-2675	170	29	bennett	bennett	PROPN
iajs-2675	170	30	,	,	PUNCT
iajs-2675	170	31	p.	p.	PROPN
iajs-2675	170	32	h.	h.	PROPN
iajs-2675	170	33	;	;	PUNCT
iajs-2675	170	34	knowler	knowler	PROPN
iajs-2675	170	35	,	,	PUNCT
iajs-2675	170	36	w.	w.	PROPN
iajs-2675	170	37	c.	c.	PROPN
iajs-2675	170	38	components	component	NOUN
iajs-2675	170	39	of	of	ADP
iajs-2675	170	40	the	the	DET
iajs-2675	170	41	metabolic	metabolic	NOUN
iajs-2675	170	42	syndrome	syndrome	NOUN
iajs-2675	170	43	and	and	CCONJ
iajs-2675	170	44	incidence	incidence	NOUN
iajs-2675	170	45	of	of	ADP
iajs-2675	170	46	type	type	NOUN
iajs-2675	170	47	2	2	NUM
iajs-2675	170	48	diabetes	diabetes	NOUN
iajs-2675	170	49	.	.	PUNCT
iajs-2675	171	1	diabetes	diabetes	PROPN
iajs-2675	171	2	.2002	.2002	PROPN
iajs-2675	171	3	,	,	PUNCT
iajs-2675	171	4	51	51	NUM
iajs-2675	171	5	,	,	PUNCT
iajs-2675	171	6	3120	3120	NUM
iajs-2675	171	7	–	–	PUNCT
iajs-2675	171	8	3127	3127	NUM
iajs-2675	171	9	,	,	PUNCT
iajs-2675	171	10	doi:10.2337	doi:10.2337	NOUN
iajs-2675	171	11	/	/	SYM
iajs-2675	171	12	diabetes.51.10.3120	diabetes.51.10.3120	ADJ
iajs-2675	171	13	.	.	PUNCT
iajs-2675	172	1	5	5	X
iajs-2675	172	2	.	.	X
iajs-2675	172	3	nakanishi	nakanishi	PROPN
iajs-2675	172	4	,	,	PUNCT
iajs-2675	172	5	n.	n.	PROPN
iajs-2675	172	6	;	;	PUNCT
iajs-2675	172	7	takatorige	takatorige	PROPN
iajs-2675	172	8	,	,	PUNCT
iajs-2675	172	9	t.	t.	PROPN
iajs-2675	172	10	;	;	PUNCT
iajs-2675	172	11	fukuda	fukuda	PROPN
iajs-2675	172	12	,	,	PUNCT
iajs-2675	172	13	h.	h.	PROPN
iajs-2675	172	14	;	;	PUNCT
iajs-2675	172	15	shirai	shirai	PROPN
iajs-2675	172	16	,	,	PUNCT
iajs-2675	172	17	k.	k.	PROPN
iajs-2675	172	18	;	;	PUNCT
iajs-2675	173	1	li	li	PROPN
iajs-2675	173	2	,	,	PUNCT
iajs-2675	173	3	w.	w.	PROPN
iajs-2675	173	4	;	;	PUNCT
iajs-2675	173	5	okamoto	okamoto	PROPN
iajs-2675	173	6	,	,	PUNCT
iajs-2675	173	7	m.	m.	NOUN
iajs-2675	173	8	;	;	PUNCT
iajs-2675	173	9	hiroshi	hiroshi	PROPN
iajs-2675	173	10	yoshida	yoshida	PROPN
iajs-2675	173	11	,	,	PUNCT
iajs-2675	173	12	h.	h.	PROPN
iajs-2675	173	13	;	;	PUNCT
iajs-2675	173	14	matsuo	matsuo	PROPN
iajs-2675	173	15	,	,	PUNCT
iajs-2675	173	16	y.	y.	PROPN
iajs-2675	173	17	;	;	PUNCT
iajs-2675	173	18	suzuki	suzuki	PROPN
iajs-2675	173	19	,	,	PUNCT
iajs-2675	173	20	k.	k.	PROPN
iajs-2675	173	21	;	;	PUNCT
iajs-2675	173	22	tatara	tatara	PROPN
iajs-2675	173	23	,	,	PUNCT
iajs-2675	173	24	k.	k.	PROPN
iajs-2675	173	25	components	component	NOUN
iajs-2675	173	26	of	of	ADP
iajs-2675	173	27	the	the	DET
iajs-2675	173	28	metabolic	metabolic	NOUN
iajs-2675	173	29	syndrome	syndrome	NOUN
iajs-2675	173	30	as	as	ADP
iajs-2675	173	31	predictors	predictor	NOUN
iajs-2675	173	32	of	of	ADP
iajs-2675	173	33	cardiovascular	cardiovascular	ADJ
iajs-2675	173	34	disease	disease	NOUN
iajs-2675	173	35	and	and	CCONJ
iajs-2675	173	36	type	type	NOUN
iajs-2675	173	37	2	2	NUM
iajs-2675	173	38	diabetes	diabetes	NOUN
iajs-2675	173	39	in	in	ADP
iajs-2675	173	40	middle	middle	ADJ
iajs-2675	173	41	-	-	PUNCT
iajs-2675	173	42	aged	aged	ADJ
iajs-2675	173	43	japanese	japanese	ADJ
iajs-2675	173	44	men	man	NOUN
iajs-2675	173	45	.	.	PUNCT
iajs-2675	174	1	diabetes	diabetes	NOUN
iajs-2675	174	2	res	re	VERB
iajs-2675	174	3	clin	clin	PROPN
iajs-2675	174	4	pract	pract	PROPN
iajs-2675	174	5	.2004	.2004	PROPN
iajs-2675	174	6	,	,	PUNCT
iajs-2675	174	7	64	64	NUM
iajs-2675	174	8	,	,	PUNCT
iajs-2675	174	9	59–70	59–70	NUM
iajs-2675	174	10	,	,	PUNCT
iajs-2675	174	11	doi.org/10.1016/j.diabres.2003.10.001	doi.org/10.1016/j.diabres.2003.10.001	NOUN
iajs-2675	174	12	.	.	PUNCT
iajs-2675	175	1	6	6	X
iajs-2675	175	2	.	.	X
iajs-2675	175	3	shaw	shaw	PROPN
iajs-2675	175	4	,	,	PUNCT
iajs-2675	175	5	j.e	j.e	PROPN
iajs-2675	175	6	.	.	PROPN
iajs-2675	175	7	;	;	PUNCT
iajs-2675	175	8	chisholm	chisholm	PROPN
iajs-2675	175	9	,	,	PUNCT
iajs-2675	175	10	d.j	d.j	PROPN
iajs-2675	175	11	.	.	PROPN
iajs-2675	175	12	epidemiology	epidemiology	NOUN
iajs-2675	175	13	and	and	CCONJ
iajs-2675	175	14	prevention	prevention	NOUN
iajs-2675	175	15	of	of	ADP
iajs-2675	175	16	type	type	NOUN
iajs-2675	175	17	2	2	NUM
iajs-2675	175	18	diabetes	diabetes	NOUN
iajs-2675	175	19	and	and	CCONJ
iajs-2675	175	20	the	the	DET
iajs-2675	175	21	metabolic	metabolic	NOUN
iajs-2675	175	22	syndrome	syndrome	NOUN
iajs-2675	175	23	.	.	PUNCT
iajs-2675	176	1	med	med	PROPN
iajs-2675	176	2	j	j	PROPN
iajs-2675	176	3	aust	aust	PROPN
iajs-2675	176	4	.	.	PUNCT
iajs-2675	177	1	2003,179(7),379	2003,179(7),379	NUM
iajs-2675	177	2	-	-	SYM
iajs-2675	177	3	83	83	NUM
iajs-2675	177	4	.	.	PUNCT
iajs-2675	178	1	https://doi.org/10.5694/j.13265377.2003.tb05677.x	https://doi.org/10.5694/j.13265377.2003.tb05677.x	NOUN
iajs-2675	178	2	.	.	PUNCT
iajs-2675	179	1	7	7	X
iajs-2675	179	2	.	.	X
iajs-2675	179	3	kylin	kylin	PROPN
iajs-2675	179	4	,	,	PUNCT
iajs-2675	179	5	e.	e.	PROPN
iajs-2675	179	6	studies	study	NOUN
iajs-2675	179	7	of	of	ADP
iajs-2675	179	8	the	the	DET
iajs-2675	179	9	hypertension	hypertension	NOUN
iajs-2675	179	10	-	-	PUNCT
iajs-2675	179	11	hyperglycemia	hyperglycemia	NOUN
iajs-2675	179	12	-	-	PUNCT
iajs-2675	179	13	hyperuricemia	hyperuricemia	NOUN
iajs-2675	179	14	syndrome	syndrome	NOUN
iajs-2675	179	15	(	(	PUNCT
iajs-2675	179	16	german	german	ADJ
iajs-2675	179	17	)	)	PUNCT
iajs-2675	179	18	.	.	PUNCT
iajs-2675	180	1	zentralblatt	zentralblatt	PROPN
iajs-2675	180	2	fuer	fuer	PROPN
iajs-2675	180	3	innere	innere	PROPN
iajs-2675	180	4	medizin	medizin	PROPN
iajs-2675	180	5	.	.	PUNCT
iajs-2675	181	1	1923	1923	NUM
iajs-2675	181	2	,	,	PUNCT
iajs-2675	181	3	44,105–127	44,105–127	NUM
iajs-2675	181	4	.	.	PUNCT
iajs-2675	182	1	8.vague	8.vague	NUM
iajs-2675	182	2	,	,	PUNCT
iajs-2675	182	3	j.	j.	PROPN
iajs-2675	182	4	sexual	sexual	ADJ
iajs-2675	182	5	differentiation	differentiation	NOUN
iajs-2675	182	6	.	.	PUNCT
iajs-2675	183	1	a	a	DET
iajs-2675	183	2	factor	factor	NOUN
iajs-2675	183	3	affecting	affect	VERB
iajs-2675	183	4	the	the	DET
iajs-2675	183	5	forms	form	NOUN
iajs-2675	183	6	of	of	ADP
iajs-2675	183	7	obesity	obesity	NOUN
iajs-2675	183	8	.	.	PUNCT
iajs-2675	184	1	presse	presse	PROPN
iajs-2675	184	2	medicale	medicale	PROPN
iajs-2675	184	3	.	.	PROPN
iajs-2675	185	1	1947	1947	NUM
iajs-2675	185	2	,	,	PUNCT
iajs-2675	185	3	55,30,s39	55,30,s39	NUM
iajs-2675	185	4	–	–	PUNCT
iajs-2675	185	5	s40	s40	NOUN
iajs-2675	185	6	.	.	PUNCT
iajs-2675	186	1	9	9	NUM
iajs-2675	186	2	.	.	X
iajs-2675	186	3	avogaro	avogaro	PROPN
iajs-2675	186	4	,	,	PUNCT
iajs-2675	186	5	p.	p.	NOUN
iajs-2675	186	6	;	;	PUNCT
iajs-2675	187	1	crepaldi	crepaldi	PROPN
iajs-2675	187	2	,	,	PUNCT
iajs-2675	187	3	g.	g.	PROPN
iajs-2675	187	4	essential	essential	ADJ
iajs-2675	187	5	hyperlipidemia	hyperlipidemia	NOUN
iajs-2675	187	6	,	,	PUNCT
iajs-2675	187	7	obesity	obesity	NOUN
iajs-2675	187	8	and	and	CCONJ
iajs-2675	187	9	diabetes	diabetes	NOUN
iajs-2675	187	10	.	.	PUNCT
iajs-2675	188	1	diabetologia.1965,1	diabetologia.1965,1	NOUN
iajs-2675	188	2	,	,	PUNCT
iajs-2675	188	3	137	137	NUM
iajs-2675	188	4	.	.	PUNCT
iajs-2675	189	1	10	10	NUM
iajs-2675	189	2	.	.	X
iajs-2675	190	1	reaven	reaven	VERB
iajs-2675	190	2	,	,	PUNCT
iajs-2675	190	3	g.m	g.m	PROPN
iajs-2675	190	4	.	.	PROPN
iajs-2675	190	5	role	role	NOUN
iajs-2675	190	6	of	of	ADP
iajs-2675	190	7	insulin	insulin	NOUN
iajs-2675	190	8	resistance	resistance	NOUN
iajs-2675	190	9	in	in	ADP
iajs-2675	190	10	human	human	ADJ
iajs-2675	190	11	disease	disease	NOUN
iajs-2675	190	12	.	.	PUNCT
iajs-2675	191	1	reaven	reaven	VERB
iajs-2675	191	2	gm	gm	PROPN
iajs-2675	191	3	diabetes	diabetes	NOUN
iajs-2675	191	4	.	.	PUNCT
iajs-2675	192	1	1988	1988	NUM
iajs-2675	192	2	,	,	PUNCT
iajs-2675	192	3	37(12),1595	37(12),1595	NOUN
iajs-2675	192	4	-	-	SYM
iajs-2675	192	5	1607	1607	NUM
iajs-2675	192	6	,	,	PUNCT
iajs-2675	192	7	https://doi.org/10.2337/diab.37.12.1595	https://doi.org/10.2337/diab.37.12.1595	PROPN
iajs-2675	192	8	11	11	NUM
iajs-2675	192	9	.	.	PUNCT
iajs-2675	193	1	kaplan	kaplan	PROPN
iajs-2675	193	2	,	,	PUNCT
iajs-2675	193	3	n.m.the	n.m.the	DET
iajs-2675	193	4	deadly	deadly	ADJ
iajs-2675	193	5	quartet	quartet	NOUN
iajs-2675	193	6	.	.	PUNCT
iajs-2675	194	1	upper	upper	ADJ
iajs-2675	194	2	-	-	PUNCT
iajs-2675	194	3	body	body	NOUN
iajs-2675	194	4	obesity	obesity	NOUN
iajs-2675	194	5	,	,	PUNCT
iajs-2675	194	6	glucose	glucose	NOUN
iajs-2675	194	7	intolerance	intolerance	NOUN
iajs-2675	194	8	,	,	PUNCT
iajs-2675	194	9	hypertriglyceridemia	hypertriglyceridemia	NOUN
iajs-2675	194	10	,	,	PUNCT
iajs-2675	194	11	and	and	CCONJ
iajs-2675	194	12	hypertension	hypertension	NOUN
iajs-2675	194	13	.	.	PUNCT
iajs-2675	195	1	arch	arch	ADJ
iajs-2675	195	2	intern	intern	PROPN
iajs-2675	195	3	med	med	PROPN
iajs-2675	195	4	.	.	PROPN
iajs-2675	195	5	1989	1989	NUM
iajs-2675	195	6	,	,	PUNCT
iajs-2675	195	7	149(7),1514	149(7),1514	PROPN
iajs-2675	195	8	-	-	SYM
iajs-2675	195	9	20	20	NUM
iajs-2675	195	10	,	,	PUNCT
iajs-2675	195	11	doi	doi	NOUN
iajs-2675	195	12	:	:	PUNCT
iajs-2675	195	13	10.1001	10.1001	NUM
iajs-2675	195	14	/	/	SYM
iajs-2675	195	15	archinte.149.7.1514	archinte.149.7.1514	NOUN
iajs-2675	195	16	.	.	PROPN
iajs-2675	195	17	12	12	NUM
iajs-2675	195	18	.	.	PUNCT
iajs-2675	196	1	haffner	haffner	PROPN
iajs-2675	196	2	,	,	PUNCT
iajs-2675	196	3	s.m	s.m	PROPN
iajs-2675	196	4	.	.	PROPN
iajs-2675	196	5	;	;	PUNCT
iajs-2675	197	1	valdez	valdez	PROPN
iajs-2675	197	2	,	,	PUNCT
iajs-2675	197	3	r.a	r.a	PROPN
iajs-2675	197	4	.	.	PROPN
iajs-2675	197	5	;	;	PUNCT
iajs-2675	197	6	hazuda	hazuda	NOUN
iajs-2675	197	7	,	,	PUNCT
iajs-2675	197	8	h.p	h.p	PROPN
iajs-2675	197	9	.	.	PROPN
iajs-2675	197	10	;	;	PUNCT
iajs-2675	197	11	mitchell	mitchell	PROPN
iajs-2675	197	12	,	,	PUNCT
iajs-2675	197	13	b.d	b.d	PROPN
iajs-2675	197	14	.	.	PROPN
iajs-2675	197	15	;	;	PUNCT
iajs-2675	197	16	morales	morale	NOUN
iajs-2675	197	17	,	,	PUNCT
iajs-2675	197	18	p.a	p.a	PROPN
iajs-2675	197	19	.	.	PROPN
iajs-2675	197	20	;	;	PUNCT
iajs-2675	197	21	stern	stern	ADJ
iajs-2675	197	22	,	,	PUNCT
iajs-2675	197	23	m.p	m.p	PROPN
iajs-2675	197	24	.	.	PROPN
iajs-2675	197	25	prospective	prospective	ADJ
iajs-2675	197	26	analysis	analysis	NOUN
iajs-2675	197	27	of	of	ADP
iajs-2675	197	28	the	the	DET
iajs-2675	197	29	insulin	insulin	NOUN
iajs-2675	197	30	-	-	PUNCT
iajs-2675	197	31	resistance	resistance	NOUN
iajs-2675	197	32	syndrome	syndrome	NOUN
iajs-2675	197	33	(	(	PUNCT
iajs-2675	197	34	syndrome	syndrome	NOUN
iajs-2675	197	35	x	x	NOUN
iajs-2675	197	36	)	)	PUNCT
iajs-2675	197	37	.	.	PUNCT
iajs-2675	198	1	diabetes	diabetes	NOUN
iajs-2675	198	2	.	.	PUNCT
iajs-2675	199	1	1992	1992	NUM
iajs-2675	199	2	,	,	PUNCT
iajs-2675	199	3	41(6),715	41(6),715	NOUN
iajs-2675	199	4	-	-	SYM
iajs-2675	199	5	22	22	NUM
iajs-2675	199	6	,	,	PUNCT
iajs-2675	199	7	doi	doi	NOUN
iajs-2675	199	8	:	:	PUNCT
iajs-2675	199	9	10.2337	10.2337	NUM
iajs-2675	199	10	/	/	SYM
iajs-2675	199	11	diab.41.6.715	diab.41.6.715	NOUN
iajs-2675	199	12	.	.	PUNCT
iajs-2675	200	1	13	13	NUM
iajs-2675	200	2	.	.	X
iajs-2675	200	3	eckel	eckel	PROPN
iajs-2675	200	4	,	,	PUNCT
iajs-2675	200	5	r.h	r.h	PROPN
iajs-2675	200	6	.	.	PROPN
iajs-2675	200	7	;	;	PUNCT
iajs-2675	200	8	grundy	grundy	PROPN
iajs-2675	200	9	,	,	PUNCT
iajs-2675	200	10	s.m	s.m	PROPN
iajs-2675	200	11	.	.	PROPN
iajs-2675	200	12	;	;	PUNCT
iajs-2675	200	13	zimmet	zimmet	NOUN
iajs-2675	200	14	,	,	PUNCT
iajs-2675	200	15	p.z	p.z	PROPN
iajs-2675	200	16	.	.	PUNCT
iajs-2675	201	1	the	the	DET
iajs-2675	201	2	metabolic	metabolic	NOUN
iajs-2675	201	3	syndrome	syndrome	NOUN
iajs-2675	201	4	.	.	PUNCT
iajs-2675	202	1	lancet	lancet	VERB
iajs-2675	202	2	.	.	PUNCT
iajs-2675	203	1	2005,365(9468),1415	2005,365(9468),1415	NUM
iajs-2675	203	2	-	-	PUNCT
iajs-2675	203	3	1428	1428	NUM
iajs-2675	203	4	,	,	PUNCT
iajs-2675	203	5	doi.org/10.1016/s0140-6736(05)66378-7	doi.org/10.1016/s0140-6736(05)66378-7	PROPN
iajs-2675	203	6	https://doi.org/10.1007/s00125-009-1620-4	https://doi.org/10.1007/s00125-009-1620-4	NUM
iajs-2675	203	7	https://doi.org/10.1007/s00125-009-1620-4	https://doi.org/10.1007/s00125-009-1620-4	NUM
iajs-2675	203	8	https://doi.org/10.1242/dmm.001180	https://doi.org/10.1242/dmm.001180	PROPN
iajs-2675	203	9	https://doi.org/10.1016/s0140-6736(08)60602-9	https://doi.org/10.1016/s0140-6736(08)60602-9	NOUN
iajs-2675	203	10	https://doi.org/10.2337/diabetes.51.10.3120	https://doi.org/10.2337/diabetes.51.10.3120	X
iajs-2675	203	11	https://doi.org/10.1016/j.diabres.2003.10.001	https://doi.org/10.1016/j.diabres.2003.10.001	NOUN
iajs-2675	203	12	https://doi.org/10.5694/j.1326-5377.2003.tb05677.x	https://doi.org/10.5694/j.1326-5377.2003.tb05677.x	PROPN
iajs-2675	203	13	https://doi.org/10.5694/j.1326-5377.2003.tb05677.x	https://doi.org/10.5694/j.1326-5377.2003.tb05677.x	PROPN
iajs-2675	203	14	ibn	ibn	PROPN
iajs-2675	203	15	al	al	PROPN
iajs-2675	203	16	-	-	PUNCT
iajs-2675	203	17	haitham	haitham	PROPN
iajs-2675	203	18	jour	jour	X
iajs-2675	203	19	.	.	PROPN
iajs-2675	203	20	for	for	ADP
iajs-2675	203	21	pure	pure	ADJ
iajs-2675	203	22	&	&	CCONJ
iajs-2675	203	23	appl	appl	PROPN
iajs-2675	203	24	.	.	PUNCT
iajs-2675	204	1	sci	sci	PROPN
iajs-2675	204	2	.	.	PROPN
iajs-2675	205	1	34(3)2021	34(3)2021	NUM
iajs-2675	205	2	33	33	NUM
iajs-2675	205	3	14	14	NUM
iajs-2675	205	4	.	.	PUNCT
iajs-2675	206	1	alberti	alberti	PROPN
iajs-2675	206	2	,	,	PUNCT
iajs-2675	206	3	k.g	k.g	PROPN
iajs-2675	206	4	.	.	PROPN
iajs-2675	206	5	;	;	PUNCT
iajs-2675	206	6	zimmet	zimmet	NOUN
iajs-2675	206	7	,	,	PUNCT
iajs-2675	206	8	p.z	p.z	PROPN
iajs-2675	206	9	.	.	PROPN
iajs-2675	206	10	.definition	.definition	NOUN
iajs-2675	206	11	,	,	PUNCT
iajs-2675	206	12	diagnosis	diagnosis	NOUN
iajs-2675	206	13	and	and	CCONJ
iajs-2675	206	14	classification	classification	NOUN
iajs-2675	206	15	of	of	ADP
iajs-2675	206	16	diabetes	diabetes	NOUN
iajs-2675	206	17	mellitus	mellitus	NOUN
iajs-2675	206	18	and	and	CCONJ
iajs-2675	206	19	its	its	PRON
iajs-2675	206	20	complications	complication	NOUN
iajs-2675	206	21	.	.	PUNCT
iajs-2675	207	1	part	part	NOUN
iajs-2675	207	2	1	1	NUM
iajs-2675	207	3	:	:	PUNCT
iajs-2675	207	4	diagnosis	diagnosis	NOUN
iajs-2675	207	5	and	and	CCONJ
iajs-2675	207	6	classification	classification	NOUN
iajs-2675	207	7	of	of	ADP
iajs-2675	207	8	diabetes	diabetes	NOUN
iajs-2675	207	9	mellitus	mellitus	NOUN
iajs-2675	207	10	provisional	provisional	ADJ
iajs-2675	207	11	report	report	NOUN
iajs-2675	207	12	of	of	ADP
iajs-2675	207	13	a	a	DET
iajs-2675	207	14	who	who	PRON
iajs-2675	207	15	consultation	consultation	NOUN
iajs-2675	207	16	.	.	PUNCT
iajs-2675	208	1	diabet	diabet	PROPN
iajs-2675	208	2	med	med	PROPN
iajs-2675	208	3	.	.	PROPN
iajs-2675	208	4	1998,15(7	1998,15(7	PROPN
iajs-2675	208	5	)	)	PUNCT
iajs-2675	208	6	,	,	PUNCT
iajs-2675	208	7	539	539	NUM
iajs-2675	208	8	-	-	SYM
iajs-2675	208	9	553	553	NUM
iajs-2675	208	10	,	,	PUNCT
iajs-2675	208	11	doi	doi	NOUN
iajs-2675	208	12	:	:	PUNCT
iajs-2675	208	13	10.1002/(sici)10969136(199807)15:7	10.1002/(sici)10969136(199807)15:7	NUM
iajs-2675	208	14	.	.	PUNCT
iajs-2675	209	1	15	15	NUM
iajs-2675	209	2	.	.	X
iajs-2675	210	1	balkau	balkau	NOUN
iajs-2675	210	2	,	,	PUNCT
iajs-2675	210	3	b	b	NOUN
iajs-2675	210	4	;	;	PUNCT
iajs-2675	210	5	charles	charles	PROPN
iajs-2675	210	6	,	,	PUNCT
iajs-2675	210	7	m.a	m.a	PROPN
iajs-2675	210	8	.	.	PROPN
iajs-2675	210	9	comment	comment	NOUN
iajs-2675	210	10	on	on	ADP
iajs-2675	210	11	the	the	DET
iajs-2675	210	12	provisional	provisional	ADJ
iajs-2675	210	13	report	report	NOUN
iajs-2675	210	14	from	from	ADP
iajs-2675	210	15	the	the	DET
iajs-2675	210	16	who	who	PRON
iajs-2675	210	17	consultation	consultation	NOUN
iajs-2675	210	18	.	.	PUNCT
iajs-2675	211	1	european	european	ADJ
iajs-2675	211	2	group	group	NOUN
iajs-2675	211	3	for	for	ADP
iajs-2675	211	4	the	the	DET
iajs-2675	211	5	study	study	NOUN
iajs-2675	211	6	of	of	ADP
iajs-2675	211	7	insulin	insulin	NOUN
iajs-2675	211	8	resistance	resistance	NOUN
iajs-2675	211	9	(	(	PUNCT
iajs-2675	211	10	egir	egir	PROPN
iajs-2675	211	11	)	)	PUNCT
iajs-2675	211	12	diabet	diabet	NOUN
iajs-2675	211	13	med	med	PROPN
iajs-2675	211	14	.	.	PUNCT
iajs-2675	212	1	1999,16(5),442	1999,16(5),442	NUM
iajs-2675	212	2	-	-	PUNCT
iajs-2675	212	3	3	3	NUM
iajs-2675	212	4	,	,	PUNCT
iajs-2675	212	5	doi	doi	NOUN
iajs-2675	212	6	:	:	PUNCT
iajs-2675	212	7	10.1046	10.1046	NUM
iajs-2675	212	8	/	/	SYM
iajs-2675	212	9	j.1464	j.1464	ADP
iajs-2675	212	10	-	-	PUNCT
iajs-2675	212	11	5491.1999.00059.x	5491.1999.00059.x	NOUN
iajs-2675	212	12	.	.	PUNCT
iajs-2675	213	1	16	16	NUM
iajs-2675	213	2	.	.	PUNCT
iajs-2675	214	1	executive	executive	ADJ
iajs-2675	214	2	summary	summary	NOUN
iajs-2675	214	3	of	of	ADP
iajs-2675	214	4	the	the	DET
iajs-2675	214	5	third	third	ADJ
iajs-2675	214	6	report	report	NOUN
iajs-2675	214	7	of	of	ADP
iajs-2675	214	8	the	the	DET
iajs-2675	214	9	national	national	ADJ
iajs-2675	214	10	cholesterol	cholesterol	PROPN
iajs-2675	214	11	education	education	NOUN
iajs-2675	214	12	program	program	NOUN
iajs-2675	214	13	(	(	PUNCT
iajs-2675	214	14	ncep	ncep	NOUN
iajs-2675	214	15	)	)	PUNCT
iajs-2675	214	16	expert	expert	NOUN
iajs-2675	214	17	panel	panel	NOUN
iajs-2675	214	18	on	on	ADP
iajs-2675	214	19	detection	detection	NOUN
iajs-2675	214	20	,	,	PUNCT
iajs-2675	214	21	evaluation	evaluation	NOUN
iajs-2675	214	22	,	,	PUNCT
iajs-2675	214	23	and	and	CCONJ
iajs-2675	214	24	treatment	treatment	NOUN
iajs-2675	214	25	of	of	ADP
iajs-2675	214	26	high	high	ADJ
iajs-2675	214	27	blood	blood	NOUN
iajs-2675	214	28	cholesterol	cholesterol	NOUN
iajs-2675	214	29	in	in	ADP
iajs-2675	214	30	adults	adult	NOUN
iajs-2675	214	31	(	(	PUNCT
iajs-2675	214	32	adult	adult	NOUN
iajs-2675	214	33	treatment	treatment	NOUN
iajs-2675	214	34	panel	panel	NOUN
iajs-2675	214	35	iii	iii	PROPN
iajs-2675	214	36	)	)	PUNCT
iajs-2675	214	37	.	.	PUNCT
iajs-2675	215	1	jama	jama	PROPN
iajs-2675	215	2	.	.	PUNCT
iajs-2675	216	1	2001	2001	NUM
iajs-2675	216	2	,	,	PUNCT
iajs-2675	216	3	16	16	NUM
iajs-2675	216	4	;	;	PUNCT
iajs-2675	216	5	285(19	285(19	NUM
iajs-2675	216	6	)	)	PUNCT
iajs-2675	216	7	,	,	PUNCT
iajs-2675	216	8	2486	2486	NUM
iajs-2675	216	9	-	-	SYM
iajs-2675	216	10	2497	2497	NUM
iajs-2675	216	11	,	,	PUNCT
iajs-2675	216	12	doi	doi	NOUN
iajs-2675	216	13	:	:	PUNCT
iajs-2675	216	14	10.1001	10.1001	NUM
iajs-2675	216	15	/	/	SYM
iajs-2675	216	16	jama.285.19.2486	jama.285.19.2486	ADJ
iajs-2675	216	17	.	.	PUNCT
iajs-2675	217	1	17	17	NUM
iajs-2675	217	2	.	.	PUNCT
iajs-2675	218	1	einhorn	einhorn	PROPN
iajs-2675	218	2	,	,	PUNCT
iajs-2675	218	3	d.	d.	PROPN
iajs-2675	218	4	;	;	PUNCT
iajs-2675	218	5	reaven	reaven	PROPN
iajs-2675	218	6	,	,	PUNCT
iajs-2675	218	7	g.m	g.m	PROPN
iajs-2675	218	8	.	.	PROPN
iajs-2675	218	9	;	;	PUNCT
iajs-2675	218	10	cobin	cobin	PROPN
iajs-2675	218	11	,	,	PUNCT
iajs-2675	218	12	r.h	r.h	PROPN
iajs-2675	218	13	.	.	PROPN
iajs-2675	218	14	;	;	PUNCT
iajs-2675	218	15	ford	ford	PROPN
iajs-2675	218	16	,	,	PUNCT
iajs-2675	218	17	e.	e.	PROPN
iajs-2675	218	18	;	;	PUNCT
iajs-2675	218	19	ganda	ganda	PROPN
iajs-2675	218	20	,	,	PUNCT
iajs-2675	218	21	o.p	o.p	PROPN
iajs-2675	218	22	.	.	PROPN
iajs-2675	218	23	;	;	PUNCT
iajs-2675	218	24	handelsman	handelsman	PROPN
iajs-2675	218	25	,	,	PUNCT
iajs-2675	218	26	y.	y.	PROPN
iajs-2675	218	27	;	;	PUNCT
iajs-2675	218	28	hellman	hellman	PROPN
iajs-2675	218	29	,	,	PUNCT
iajs-2675	218	30	r.	r.	PROPN
iajs-2675	218	31	;	;	PUNCT
iajs-2675	218	32	jellinger	jellinger	PROPN
iajs-2675	218	33	.	.	PUNCT
iajs-2675	219	1	p.s	p.s	PROPN
iajs-2675	219	2	.	.	PROPN
iajs-2675	219	3	;	;	PUNCT
iajs-2675	220	1	kendall	kendall	PROPN
iajs-2675	220	2	.	.	PUNCT
iajs-2675	220	3	d.	d.	PROPN
iajs-2675	220	4	;	;	PUNCT
iajs-2675	221	1	krauss	krauss	PROPN
iajs-2675	221	2	.	.	PROPN
iajs-2675	221	3	rm	rm	PROPN
iajs-2675	221	4	.	.	PUNCT
iajs-2675	221	5	;	;	PUNCT
iajs-2675	221	6	neufeld	neufeld	PROPN
iajs-2675	221	7	,	,	PUNCT
iajs-2675	221	8	n.d	n.d	PROPN
iajs-2675	221	9	.	.	PROPN
iajs-2675	221	10	;	;	PUNCT
iajs-2675	221	11	petak	petak	PROPN
iajs-2675	221	12	,	,	PUNCT
iajs-2675	221	13	s.m	s.m	PROPN
iajs-2675	221	14	.	.	PROPN
iajs-2675	221	15	;	;	PUNCT
iajs-2675	221	16	rodbard	rodbard	NOUN
iajs-2675	221	17	,	,	PUNCT
iajs-2675	221	18	h.w	h.w	PROPN
iajs-2675	221	19	.	.	PROPN
iajs-2675	221	20	;	;	PUNCT
iajs-2675	221	21	seibel	seibel	PROPN
iajs-2675	221	22	,	,	PUNCT
iajs-2675	221	23	j.a	j.a	PROPN
iajs-2675	221	24	.	.	PROPN
iajs-2675	221	25	;	;	PUNCT
iajs-2675	221	26	smith	smith	PROPN
iajs-2675	221	27	,	,	PUNCT
iajs-2675	221	28	d.a.;wilson	d.a.;wilson	PROPN
iajs-2675	221	29	,	,	PUNCT
iajs-2675	221	30	p.w	p.w	PROPN
iajs-2675	221	31	.	.	PROPN
iajs-2675	221	32	american	american	PROPN
iajs-2675	221	33	college	college	PROPN
iajs-2675	221	34	of	of	ADP
iajs-2675	221	35	endocrinology	endocrinology	NOUN
iajs-2675	221	36	position	position	NOUN
iajs-2675	221	37	statement	statement	NOUN
iajs-2675	221	38	on	on	ADP
iajs-2675	221	39	the	the	DET
iajs-2675	221	40	insulin	insulin	NOUN
iajs-2675	221	41	resistance	resistance	NOUN
iajs-2675	221	42	syndrome	syndrome	NOUN
iajs-2675	221	43	.	.	PUNCT
iajs-2675	222	1	endocr	endocr	PROPN
iajs-2675	222	2	pract	pract	PROPN
iajs-2675	222	3	.	.	PUNCT
iajs-2675	223	1	2003	2003	NUM
iajs-2675	223	2	,	,	PUNCT
iajs-2675	223	3	9(3),237	9(3),237	NUM
iajs-2675	223	4	-	-	SYM
iajs-2675	223	5	52	52	NUM
iajs-2675	223	6	.	.	NOUN
iajs-2675	224	1	18	18	NUM
iajs-2675	224	2	.	.	PUNCT
iajs-2675	225	1	carobbio	carobbio	PROPN
iajs-2675	225	2	,	,	PUNCT
iajs-2675	225	3	s.	s.	PROPN
iajs-2675	225	4	;	;	PUNCT
iajs-2675	225	5	pellegrinelli	pellegrinelli	PROPN
iajs-2675	225	6	,	,	PUNCT
iajs-2675	225	7	v.	v.	ADV
iajs-2675	225	8	;	;	PUNCT
iajs-2675	225	9	vidal	vidal	NOUN
iajs-2675	225	10	-	-	PUNCT
iajs-2675	225	11	puig	puig	NOUN
iajs-2675	225	12	,	,	PUNCT
iajs-2675	225	13	a.	a.	NOUN
iajs-2675	225	14	adipose	adipose	NOUN
iajs-2675	225	15	tissue	tissue	NOUN
iajs-2675	225	16	function	function	NOUN
iajs-2675	225	17	and	and	CCONJ
iajs-2675	225	18	expandability	expandability	NOUN
iajs-2675	225	19	as	as	ADP
iajs-2675	225	20	determinants	determinant	NOUN
iajs-2675	225	21	of	of	ADP
iajs-2675	225	22	lipotoxicity	lipotoxicity	NOUN
iajs-2675	225	23	and	and	CCONJ
iajs-2675	225	24	the	the	DET
iajs-2675	225	25	metabolic	metabolic	NOUN
iajs-2675	225	26	syndrome	syndrome	NOUN
iajs-2675	225	27	.	.	PUNCT
iajs-2675	226	1	adv	adv	PROPN
iajs-2675	226	2	exp	exp	NOUN
iajs-2675	226	3	med	med	ADJ
iajs-2675	226	4	biol	biol	NOUN
iajs-2675	226	5	.	.	PUNCT
iajs-2675	227	1	2017,960,161–96	2017,960,161–96	NUM
iajs-2675	227	2	,	,	PUNCT
iajs-2675	227	3	doi	doi	NOUN
iajs-2675	227	4	:	:	PUNCT
iajs-2675	227	5	10.1007/978	10.1007/978	NUM
iajs-2675	227	6	-	-	SYM
iajs-2675	227	7	3	3	NUM
iajs-2675	227	8	-	-	NUM
iajs-2675	227	9	319	319	NUM
iajs-2675	227	10	-	-	PUNCT
iajs-2675	227	11	48382	48382	NUM
iajs-2675	227	12	-	-	PUNCT
iajs-2675	227	13	5_7	5_7	NUM
iajs-2675	227	14	.	.	NOUN
iajs-2675	228	1	19	19	NUM
iajs-2675	228	2	.	.	PUNCT
iajs-2675	228	3	nielsen	nielsen	PROPN
iajs-2675	228	4	,	,	PUNCT
iajs-2675	228	5	j	j	PROPN
iajs-2675	228	6	:	:	PUNCT
iajs-2675	228	7	systems	system	NOUN
iajs-2675	228	8	biology	biology	NOUN
iajs-2675	228	9	of	of	ADP
iajs-2675	228	10	metabolism	metabolism	NOUN
iajs-2675	228	11	:	:	PUNCT
iajs-2675	228	12	a	a	DET
iajs-2675	228	13	driver	driver	NOUN
iajs-2675	228	14	for	for	ADP
iajs-2675	228	15	developing	develop	VERB
iajs-2675	228	16	personalized	personalize	VERB
iajs-2675	228	17	and	and	CCONJ
iajs-2675	228	18	precision	precision	NOUN
iajs-2675	228	19	medicine	medicine	NOUN
iajs-2675	228	20	.	.	PUNCT
iajs-2675	229	1	cell	cell	NOUN
iajs-2675	229	2	metab	metab	NOUN
iajs-2675	229	3	.	.	PUNCT
iajs-2675	230	1	2017,25(3),572–9	2017,25(3),572–9	NOUN
iajs-2675	230	2	,	,	PUNCT
iajs-2675	230	3	doi:10.1016	doi:10.1016	PROPN
iajs-2675	230	4	/	/	SYM
iajs-2675	230	5	j.cmet.2017.02.002	j.cmet.2017.02.002	PROPN
iajs-2675	230	6	.	.	PROPN
iajs-2675	231	1	20	20	NUM
iajs-2675	231	2	.	.	PUNCT
iajs-2675	231	3	lovric	lovric	VERB
iajs-2675	231	4	,	,	PUNCT
iajs-2675	231	5	a.	a.	NOUN
iajs-2675	231	6	;	;	PUNCT
iajs-2675	231	7	granér	granér	NOUN
iajs-2675	231	8	,	,	PUNCT
iajs-2675	231	9	m.	m.	NOUN
iajs-2675	231	10	;	;	PUNCT
iajs-2675	231	11	bjornson	bjornson	PROPN
iajs-2675	231	12	,	,	PUNCT
iajs-2675	231	13	e.	e.	PROPN
iajs-2675	231	14	;	;	PUNCT
iajs-2675	231	15	arif	arif	PROPN
iajs-2675	231	16	,	,	PUNCT
iajs-2675	231	17	m.	m.	NOUN
iajs-2675	231	18	;	;	PUNCT
iajs-2675	231	19	benfeitas	benfeita	NOUN
iajs-2675	231	20	,	,	PUNCT
iajs-2675	231	21	r.	r.	PROPN
iajs-2675	231	22	;	;	PUNCT
iajs-2675	231	23	nyman	nyman	PROPN
iajs-2675	231	24	,	,	PUNCT
iajs-2675	231	25	k.	k.	PROPN
iajs-2675	231	26	;	;	PUNCT
iajs-2675	231	27	ståhlman	ståhlman	NOUN
iajs-2675	231	28	,	,	PUNCT
iajs-2675	231	29	m.	m.	NOUN
iajs-2675	231	30	;	;	PUNCT
iajs-2675	231	31	pentikäinen	pentikäinen	NOUN
iajs-2675	231	32	,	,	PUNCT
iajs-2675	231	33	m.o	m.o	PROPN
iajs-2675	231	34	.	.	PROPN
iajs-2675	231	35	;	;	PUNCT
iajs-2675	232	1	lundbom	lundbom	PROPN
iajs-2675	232	2	,	,	PUNCT
iajs-2675	232	3	j.	j.	PROPN
iajs-2675	232	4	;	;	PUNCT
iajs-2675	232	5	hakkarainen	hakkarainen	PROPN
iajs-2675	232	6	,	,	PUNCT
iajs-2675	232	7	a.	a.	NOUN
iajs-2675	232	8	;	;	PUNCT
iajs-2675	232	9	sirén	sirén	PROPN
iajs-2675	232	10	,	,	PUNCT
iajs-2675	232	11	r.	r.	PROPN
iajs-2675	232	12	;	;	PUNCT
iajs-2675	232	13	nieminen	nieminen	PROPN
iajs-2675	232	14	,	,	PUNCT
iajs-2675	232	15	m.s	m.s	PROPN
iajs-2675	232	16	.	.	PROPN
iajs-2675	232	17	;	;	PUNCT
iajs-2675	232	18	lundbom	lundbom	PROPN
iajs-2675	232	19	,	,	PUNCT
iajs-2675	232	20	n.	n.	NOUN
iajs-2675	232	21	;	;	PUNCT
iajs-2675	232	22	lauerma	lauerma	PROPN
iajs-2675	232	23	,	,	PUNCT
iajs-2675	232	24	k.	k.	PROPN
iajs-2675	232	25	;	;	PUNCT
iajs-2675	232	26	taskinen	taskinen	PROPN
iajs-2675	232	27	,	,	PUNCT
iajs-2675	232	28	m.r	m.r	PROPN
iajs-2675	232	29	.	.	PROPN
iajs-2675	232	30	;	;	PUNCT
iajs-2675	232	31	mardinoglu	mardinoglu	PROPN
iajs-2675	232	32	,	,	PUNCT
iajs-2675	232	33	a.	a.	NOUN
iajs-2675	232	34	;	;	PUNCT
iajs-2675	232	35	boren	boren	PROPN
iajs-2675	232	36	,	,	PUNCT
iajs-2675	232	37	j.	j.	PROPN
iajs-2675	232	38	characterization	characterization	NOUN
iajs-2675	232	39	of	of	ADP
iajs-2675	232	40	different	different	ADJ
iajs-2675	232	41	fat	fat	ADJ
iajs-2675	232	42	depots	depot	NOUN
iajs-2675	232	43	in	in	ADP
iajs-2675	232	44	nafld	nafld	ADV
iajs-2675	232	45	using	use	VERB
iajs-2675	232	46	inflammation	inflammation	NOUN
iajs-2675	232	47	-	-	PUNCT
iajs-2675	232	48	associated	associate	VERB
iajs-2675	232	49	proteome	proteome	NOUN
iajs-2675	232	50	,	,	PUNCT
iajs-2675	232	51	lipidome	lipidome	NOUN
iajs-2675	232	52	and	and	CCONJ
iajs-2675	232	53	metabolome	metabolome	NOUN
iajs-2675	232	54	.	.	PUNCT
iajs-2675	233	1	sci	sci	PROPN
iajs-2675	233	2	rep	rep	PROPN
iajs-2675	233	3	.	.	PROPN
iajs-2675	233	4	2018,8(1),14200	2018,8(1),14200	NUM
iajs-2675	233	5	,	,	PUNCT
iajs-2675	233	6	doi:10.1038	doi:10.1038	NOUN
iajs-2675	233	7	/	/	SYM
iajs-2675	233	8	s41598	s41598	NOUN
iajs-2675	233	9	-	-	PUNCT
iajs-2675	233	10	018	018	NUM
iajs-2675	233	11	-	-	PUNCT
iajs-2675	233	12	31865	31865	NUM
iajs-2675	233	13	-	-	PUNCT
iajs-2675	233	14	w.	w.	PROPN
iajs-2675	233	15	21	21	NUM
iajs-2675	233	16	.	.	PUNCT
iajs-2675	234	1	liu	liu	PROPN
iajs-2675	234	2	,	,	PUNCT
iajs-2675	234	3	z.	z.	PROPN
iajs-2675	234	4	;	;	PUNCT
iajs-2675	234	5	zhang	zhang	PROPN
iajs-2675	234	6	,	,	PUNCT
iajs-2675	234	7	c.	c.	PROPN
iajs-2675	234	8	;	;	PUNCT
iajs-2675	234	9	lee	lee	PROPN
iajs-2675	234	10	,	,	PUNCT
iajs-2675	234	11	s.	s.	PROPN
iajs-2675	234	12	;	;	PUNCT
iajs-2675	234	13	kim	kim	PROPN
iajs-2675	234	14	,	,	PUNCT
iajs-2675	234	15	w.	w.	PROPN
iajs-2675	234	16	;	;	PUNCT
iajs-2675	234	17	klevstig	klevstig	PROPN
iajs-2675	234	18	,	,	PUNCT
iajs-2675	234	19	m.	m.	NOUN
iajs-2675	234	20	;	;	PUNCT
iajs-2675	234	21	harzandi	harzandi	PROPN
iajs-2675	234	22	,	,	PUNCT
iajs-2675	234	23	a.m.	a.m.	ADV
iajs-2675	234	24	;	;	PUNCT
iajs-2675	234	25	sikanic	sikanic	ADJ
iajs-2675	234	26	,	,	PUNCT
iajs-2675	234	27	n.	n.	PROPN
iajs-2675	234	28	;	;	PUNCT
iajs-2675	234	29	arif	arif	PROPN
iajs-2675	234	30	,	,	PUNCT
iajs-2675	234	31	m.	m.	NOUN
iajs-2675	234	32	;	;	PUNCT
iajs-2675	234	33	ståhlman	ståhlman	NOUN
iajs-2675	234	34	,	,	PUNCT
iajs-2675	234	35	m.	m.	NOUN
iajs-2675	234	36	;	;	PUNCT
iajs-2675	234	37	nielsen	nielsen	PROPN
iajs-2675	234	38	,	,	PUNCT
iajs-2675	234	39	j.	j.	PROPN
iajs-2675	234	40	;	;	PUNCT
iajs-2675	234	41	uhlen	uhlen	ADJ
iajs-2675	234	42	,	,	PUNCT
iajs-2675	234	43	m.	m.	NOUN
iajs-2675	234	44	;	;	PUNCT
iajs-2675	234	45	boren	boren	PROPN
iajs-2675	234	46	,	,	PUNCT
iajs-2675	234	47	j.	j.	PROPN
iajs-2675	234	48	;	;	PUNCT
iajs-2675	234	49	mardinoglu	mardinoglu	PROPN
iajs-2675	234	50	,	,	PUNCT
iajs-2675	234	51	a.	a.	NOUN
iajs-2675	234	52	pyruvate	pyruvate	NOUN
iajs-2675	234	53	kinase	kinase	PROPN
iajs-2675	234	54	l	l	PROPN
iajs-2675	234	55	/	/	SYM
iajs-2675	234	56	r	r	NOUN
iajs-2675	234	57	is	be	AUX
iajs-2675	234	58	a	a	DET
iajs-2675	234	59	regulator	regulator	NOUN
iajs-2675	234	60	of	of	ADP
iajs-2675	234	61	lipid	lipid	ADJ
iajs-2675	234	62	metabolism	metabolism	NOUN
iajs-2675	234	63	and	and	CCONJ
iajs-2675	234	64	mitochondrial	mitochondrial	ADJ
iajs-2675	234	65	function	function	NOUN
iajs-2675	234	66	.	.	PUNCT
iajs-2675	235	1	metab	metab	PROPN
iajs-2675	235	2	eng	eng	PROPN
iajs-2675	235	3	.	.	PUNCT
iajs-2675	236	1	2019,52	2019,52	NUM
iajs-2675	236	2	,	,	PUNCT
iajs-2675	236	3	263–272	263–272	NUM
iajs-2675	236	4	,	,	PUNCT
iajs-2675	236	5	doi:10.1016	doi:10.1016	PROPN
iajs-2675	236	6	/	/	SYM
iajs-2675	236	7	j.ymben.2019.01.001	j.ymben.2019.01.001	PROPN
iajs-2675	236	8	.	.	PUNCT
iajs-2675	237	1	22	22	NUM
iajs-2675	237	2	.	.	PUNCT
iajs-2675	237	3	crewe	crewe	PROPN
iajs-2675	237	4	,	,	PUNCT
iajs-2675	237	5	c.	c.	PROPN
iajs-2675	237	6	;	;	PUNCT
iajs-2675	237	7	an	an	PRON
iajs-2675	237	8	,	,	PUNCT
iajs-2675	237	9	ya	ya	PROPN
iajs-2675	237	10	.	.	PUNCT
iajs-2675	237	11	;	;	PUNCT
iajs-2675	237	12	scherer	scherer	PROPN
iajs-2675	237	13	,	,	PUNCT
iajs-2675	237	14	p.e	p.e	PROPN
iajs-2675	237	15	.	.	PROPN
iajs-2675	237	16	the	the	DET
iajs-2675	237	17	ominous	ominous	ADJ
iajs-2675	237	18	triad	triad	NOUN
iajs-2675	237	19	of	of	ADP
iajs-2675	237	20	adipose	adipose	ADJ
iajs-2675	237	21	tissue	tissue	NOUN
iajs-2675	237	22	dysfunction	dysfunction	NOUN
iajs-2675	237	23	:	:	PUNCT
iajs-2675	237	24	inflammation	inflammation	NOUN
iajs-2675	237	25	,	,	PUNCT
iajs-2675	237	26	fibrosis	fibrosis	NOUN
iajs-2675	237	27	,	,	PUNCT
iajs-2675	237	28	and	and	CCONJ
iajs-2675	237	29	impaired	impaired	ADJ
iajs-2675	237	30	angiogenesis	angiogenesis	NOUN
iajs-2675	237	31	.	.	PUNCT
iajs-2675	238	1	j	j	PROPN
iajs-2675	238	2	clin	clin	PROPN
iajs-2675	238	3	invest	invest	VERB
iajs-2675	238	4	.	.	PUNCT
iajs-2675	239	1	2017,127(1),74–82	2017,127(1),74–82	NUM
iajs-2675	239	2	,	,	PUNCT
iajs-2675	239	3	doi:10.1172	doi:10.1172	NOUN
iajs-2675	239	4	/	/	SYM
iajs-2675	239	5	jci88883	jci88883	ADJ
iajs-2675	239	6	.	.	PUNCT
iajs-2675	240	1	23	23	NUM
iajs-2675	240	2	.	.	X
iajs-2675	241	1	welty	welty	PROPN
iajs-2675	241	2	,	,	PUNCT
iajs-2675	241	3	f.k	f.k	PROPN
iajs-2675	241	4	.	.	PROPN
iajs-2675	241	5	;	;	PUNCT
iajs-2675	241	6	alfaddagh	alfaddagh	PROPN
iajs-2675	241	7	,	,	PUNCT
iajs-2675	241	8	a.	a.	NOUN
iajs-2675	241	9	;	;	PUNCT
iajs-2675	241	10	elajami	elajami	PROPN
iajs-2675	241	11	,	,	PUNCT
iajs-2675	241	12	t.k	t.k	PROPN
iajs-2675	241	13	.	.	NOUN
iajs-2675	241	14	targeting	target	VERB
iajs-2675	241	15	inflammation	inflammation	NOUN
iajs-2675	241	16	in	in	ADP
iajs-2675	241	17	metabolic	metabolic	NOUN
iajs-2675	241	18	syndrome	syndrome	NOUN
iajs-2675	241	19	.	.	PUNCT
iajs-2675	242	1	transl	transl	PROPN
iajs-2675	242	2	res	res	PROPN
iajs-2675	242	3	.	.	PUNCT
iajs-2675	243	1	2016,167(1),257–80	2016,167(1),257–80	NUM
iajs-2675	243	2	,	,	PUNCT
iajs-2675	243	3	doi:10.1016	doi:10.1016	PROPN
iajs-2675	243	4	/	/	SYM
iajs-2675	243	5	j.trsl.2015.06.017	j.trsl.2015.06.017	CCONJ
iajs-2675	243	6	.	.	NOUN
iajs-2675	244	1	24	24	NUM
iajs-2675	244	2	.	.	X
iajs-2675	244	3	lackey	lackey	NOUN
iajs-2675	244	4	,	,	PUNCT
iajs-2675	244	5	d.e	d.e	PROPN
iajs-2675	244	6	.	.	PROPN
iajs-2675	244	7	;	;	PUNCT
iajs-2675	244	8	olefsky	olefsky	ADJ
iajs-2675	244	9	,	,	PUNCT
iajs-2675	244	10	j.m	j.m	PROPN
iajs-2675	244	11	.	.	PROPN
iajs-2675	244	12	regulation	regulation	NOUN
iajs-2675	244	13	of	of	ADP
iajs-2675	244	14	metabolism	metabolism	NOUN
iajs-2675	244	15	by	by	ADP
iajs-2675	244	16	the	the	DET
iajs-2675	244	17	innate	innate	ADJ
iajs-2675	244	18	immune	immune	ADJ
iajs-2675	244	19	system	system	NOUN
iajs-2675	244	20	.	.	PUNCT
iajs-2675	245	1	nat	nat	PROPN
iajs-2675	245	2	rev	rev	PROPN
iajs-2675	245	3	endocrinol	endocrinol	NOUN
iajs-2675	245	4	.	.	PUNCT
iajs-2675	246	1	2016,12(1),15–28	2016,12(1),15–28	NUM
iajs-2675	246	2	,	,	PUNCT
iajs-2675	246	3	doi	doi	NOUN
iajs-2675	246	4	:	:	PUNCT
iajs-2675	246	5	10.1038	10.1038	NUM
iajs-2675	246	6	/	/	SYM
iajs-2675	246	7	nrendo.2015.189	nrendo.2015.189	PROPN
iajs-2675	246	8	.	.	PUNCT
iajs-2675	247	1	25	25	NUM
iajs-2675	247	2	.	.	PUNCT
iajs-2675	248	1	petersen	petersen	PROPN
iajs-2675	248	2	,	,	PUNCT
iajs-2675	248	3	m.c	m.c	PROPN
iajs-2675	248	4	.	.	PROPN
iajs-2675	248	5	;	;	PUNCT
iajs-2675	248	6	vatner	vatner	PROPN
iajs-2675	248	7	,	,	PUNCT
iajs-2675	248	8	d.f	d.f	PROPN
iajs-2675	248	9	.	.	PROPN
iajs-2675	248	10	;	;	PUNCT
iajs-2675	248	11	shulman	shulman	PROPN
iajs-2675	248	12	,	,	PUNCT
iajs-2675	248	13	g.i	g.i	PROPN
iajs-2675	248	14	.	.	PROPN
iajs-2675	248	15	regulation	regulation	NOUN
iajs-2675	248	16	of	of	ADP
iajs-2675	248	17	hepatic	hepatic	ADJ
iajs-2675	248	18	glucose	glucose	NOUN
iajs-2675	248	19	metabolism	metabolism	NOUN
iajs-2675	248	20	in	in	ADP
iajs-2675	248	21	health	health	NOUN
iajs-2675	248	22	and	and	CCONJ
iajs-2675	248	23	disease	disease	NOUN
iajs-2675	248	24	.	.	PUNCT
iajs-2675	249	1	nat	nat	PROPN
iajs-2675	249	2	rev	rev	PROPN
iajs-2675	249	3	endocrinol	endocrinol	NOUN
iajs-2675	249	4	.	.	PUNCT
iajs-2675	250	1	2017,13(10),572–87	2017,13(10),572–87	NUM
iajs-2675	250	2	,	,	PUNCT
iajs-2675	250	3	doi:10.1038	doi:10.1038	NOUN
iajs-2675	250	4	/	/	SYM
iajs-2675	250	5	nrendo.2017.80	nrendo.2017.80	NOUN
iajs-2675	250	6	.	.	PUNCT
iajs-2675	251	1	ibn	ibn	PROPN
iajs-2675	251	2	al	al	PROPN
iajs-2675	251	3	-	-	PUNCT
iajs-2675	251	4	haitham	haitham	PROPN
iajs-2675	251	5	jour	jour	X
iajs-2675	251	6	.	.	PROPN
iajs-2675	251	7	for	for	ADP
iajs-2675	251	8	pure	pure	ADJ
iajs-2675	251	9	&	&	CCONJ
iajs-2675	251	10	appl	appl	PROPN
iajs-2675	251	11	.	.	PUNCT
iajs-2675	252	1	sci	sci	PROPN
iajs-2675	252	2	.	.	PROPN
iajs-2675	253	1	34(3)2021	34(3)2021	NUM
iajs-2675	253	2	34	34	NUM
iajs-2675	253	3	26	26	NUM
iajs-2675	253	4	.	.	PUNCT
iajs-2675	254	1	samuel	samuel	PROPN
iajs-2675	254	2	,	,	PUNCT
iajs-2675	254	3	v.t	v.t	PROPN
iajs-2675	254	4	.	.	PROPN
iajs-2675	254	5	;	;	PUNCT
iajs-2675	254	6	shulman	shulman	PROPN
iajs-2675	254	7	,	,	PUNCT
iajs-2675	254	8	g.i	g.i	PROPN
iajs-2675	254	9	.	.	PUNCT
iajs-2675	255	1	the	the	DET
iajs-2675	255	2	pathogenesis	pathogenesis	NOUN
iajs-2675	255	3	of	of	ADP
iajs-2675	255	4	insulin	insulin	NOUN
iajs-2675	255	5	resistance	resistance	NOUN
iajs-2675	255	6	:	:	PUNCT
iajs-2675	255	7	integrating	integrate	VERB
iajs-2675	255	8	signaling	signal	VERB
iajs-2675	255	9	pathways	pathway	NOUN
iajs-2675	255	10	and	and	CCONJ
iajs-2675	255	11	substrate	substrate	NOUN
iajs-2675	255	12	flux	flux	NOUN
iajs-2675	255	13	.	.	PUNCT
iajs-2675	256	1	j	j	PROPN
iajs-2675	256	2	clin	clin	PROPN
iajs-2675	256	3	invest	invest	PROPN
iajs-2675	256	4	.	.	PUNCT
iajs-2675	257	1	2016,126(1),12–22	2016,126(1),12–22	NUM
iajs-2675	257	2	,	,	PUNCT
iajs-2675	257	3	doi:10.1172	doi:10.1172	NOUN
iajs-2675	257	4	/	/	SYM
iajs-2675	257	5	jci77812	jci77812	NOUN
iajs-2675	257	6	.	.	PUNCT
iajs-2675	258	1	27	27	NUM
iajs-2675	258	2	.	.	PUNCT
iajs-2675	259	1	rochlani	rochlani	PROPN
iajs-2675	259	2	,	,	PUNCT
iajs-2675	259	3	y.	y.	PROPN
iajs-2675	259	4	;	;	PUNCT
iajs-2675	259	5	pothineni	pothineni	PROPN
iajs-2675	259	6	,	,	PUNCT
iajs-2675	259	7	n.v	n.v	PROPN
iajs-2675	259	8	.	.	PROPN
iajs-2675	259	9	;	;	PUNCT
iajs-2675	260	1	kovelamudi	kovelamudi	PROPN
iajs-2675	260	2	,	,	PUNCT
iajs-2675	260	3	s.	s.	PROPN
iajs-2675	260	4	;	;	PUNCT
iajs-2675	260	5	mehta	mehta	PROPN
iajs-2675	260	6	,	,	PUNCT
iajs-2675	260	7	l.j	l.j	PROPN
iajs-2675	260	8	.	.	PROPN
iajs-2675	260	9	metabolic	metabolic	PROPN
iajs-2675	260	10	syndrome	syndrome	PROPN
iajs-2675	260	11	:	:	PUNCT
iajs-2675	260	12	pathophysiology	pathophysiology	NOUN
iajs-2675	260	13	,	,	PUNCT
iajs-2675	260	14	management	management	NOUN
iajs-2675	260	15	,	,	PUNCT
iajs-2675	260	16	and	and	CCONJ
iajs-2675	260	17	modulation	modulation	NOUN
iajs-2675	260	18	by	by	ADP
iajs-2675	260	19	natural	natural	ADJ
iajs-2675	260	20	compounds	compound	NOUN
iajs-2675	260	21	.	.	PUNCT
iajs-2675	261	1	ther	ther	PROPN
iajs-2675	261	2	adv	adv	PROPN
iajs-2675	261	3	cardiovasc	cardiovasc	PROPN
iajs-2675	261	4	dis	dis	PROPN
iajs-2675	261	5	.	.	PROPN
iajs-2675	262	1	2017	2017	NUM
iajs-2675	262	2	,	,	PUNCT
iajs-2675	262	3	11(8),215–225	11(8),215–225	PRON
iajs-2675	262	4	,	,	PUNCT
iajs-2675	262	5	doi	doi	NOUN
iajs-2675	262	6	:	:	PUNCT
iajs-2675	262	7	10.1177/1753944717711379	10.1177/1753944717711379	NUM
iajs-2675	262	8	.	.	NOUN
iajs-2675	262	9	28	28	NUM
iajs-2675	262	10	.	.	PUNCT
iajs-2675	262	11	barrier	barrier	NOUN
iajs-2675	262	12	,	,	PUNCT
iajs-2675	262	13	s.	s.	PROPN
iajs-2675	262	14	;	;	PUNCT
iajs-2675	262	15	schling	schle	VERB
iajs-2675	262	16	,	,	PUNCT
iajs-2675	262	17	p.	p.	NOUN
iajs-2675	262	18	;	;	PUNCT
iajs-2675	262	19	gorzelniak	gorzelniak	PROPN
iajs-2675	262	20	,	,	PUNCT
iajs-2675	262	21	k.	k.	PROPN
iajs-2675	262	22	;	;	PUNCT
iajs-2675	262	23	boschmann	boschmann	PROPN
iajs-2675	262	24	,	,	PUNCT
iajs-2675	262	25	m.	m.	NOUN
iajs-2675	262	26	;	;	PUNCT
iajs-2675	262	27	janke	janke	PROPN
iajs-2675	262	28	,	,	PUNCT
iajs-2675	262	29	j.	j.	PROPN
iajs-2675	262	30	;	;	PUNCT
iajs-2675	262	31	ailhaud	ailhaud	PROPN
iajs-2675	262	32	,	,	PUNCT
iajs-2675	262	33	g.	g.	PROPN
iajs-2675	262	34	;	;	PUNCT
iajs-2675	262	35	teboul	teboul	PROPN
iajs-2675	262	36	,	,	PUNCT
iajs-2675	262	37	m.	m.	NOUN
iajs-2675	262	38	;	;	PUNCT
iajs-2675	262	39	massiéra	massiéra	NOUN
iajs-2675	262	40	,	,	PUNCT
iajs-2675	262	41	f.	f.	PROPN
iajs-2675	262	42	;	;	PUNCT
iajs-2675	262	43	sharma	sharma	PROPN
iajs-2675	262	44	,	,	PUNCT
iajs-2675	262	45	a.m.	a.m.	NOUN
iajs-2675	263	1	the	the	DET
iajs-2675	263	2	adipose	adipose	ADJ
iajs-2675	263	3	-	-	PUNCT
iajs-2675	263	4	tissue	tissue	NOUN
iajs-2675	263	5	renin	renin	NOUN
iajs-2675	263	6	–	–	PUNCT
iajs-2675	263	7	angiotensin	angiotensin	NOUN
iajs-2675	263	8	–	–	PUNCT
iajs-2675	263	9	aldosterone	aldosterone	NOUN
iajs-2675	263	10	system	system	NOUN
iajs-2675	263	11	:	:	PUNCT
iajs-2675	263	12	role	role	NOUN
iajs-2675	263	13	in	in	ADP
iajs-2675	263	14	the	the	DET
iajs-2675	263	15	metabolic	metabolic	NOUN
iajs-2675	263	16	syndrome	syndrome	NOUN
iajs-2675	263	17	?	?	PUNCT
iajs-2675	264	1	int	int	PROPN
iajs-2675	264	2	j	j	PROPN
iajs-2675	264	3	biochem	biochem	PROPN
iajs-2675	264	4	cell	cell	NOUN
iajs-2675	264	5	biol	biol	PROPN
iajs-2675	264	6	.	.	PUNCT
iajs-2675	265	1	2003	2003	NUM
iajs-2675	265	2	,	,	PUNCT
iajs-2675	265	3	35	35	NUM
iajs-2675	265	4	,	,	PUNCT
iajs-2675	265	5	807	807	NUM
iajs-2675	265	6	-	-	SYM
iajs-2675	265	7	825	825	NUM
iajs-2675	265	8	,	,	PUNCT
iajs-2675	265	9	doi	doi	NOUN
iajs-2675	265	10	:	:	PUNCT
iajs-2675	265	11	10.1016	10.1016	NUM
iajs-2675	265	12	/	/	SYM
iajs-2675	265	13	s13572725(02)00311	s13572725(02)00311	NOUN
iajs-2675	265	14	-	-	PUNCT
iajs-2675	265	15	4	4	NUM
iajs-2675	265	16	.	.	NOUN
iajs-2675	265	17	29	29	NUM
iajs-2675	265	18	.	.	PUNCT
iajs-2675	266	1	massiéra	massiéra	PROPN
iajs-2675	266	2	,	,	PUNCT
iajs-2675	266	3	f.	f.	PROPN
iajs-2675	266	4	;	;	PUNCT
iajs-2675	266	5	bloch	bloch	PROPN
iajs-2675	266	6	-	-	PUNCT
iajs-2675	266	7	faure	faure	PROPN
iajs-2675	266	8	,	,	PUNCT
iajs-2675	266	9	m.	m.	NOUN
iajs-2675	266	10	;	;	PUNCT
iajs-2675	266	11	ceiler	ceiler	PROPN
iajs-2675	266	12	,	,	PUNCT
iajs-2675	266	13	d.	d.	PROPN
iajs-2675	266	14	;	;	PUNCT
iajs-2675	266	15	murakami	murakami	NOUN
iajs-2675	266	16	,	,	PUNCT
iajs-2675	266	17	k.	k.	PROPN
iajs-2675	266	18	;	;	PUNCT
iajs-2675	266	19	fukamizu	fukamizu	PROPN
iajs-2675	266	20	,	,	PUNCT
iajs-2675	266	21	a.	a.	NOUN
iajs-2675	266	22	;	;	PUNCT
iajs-2675	266	23	gasc	gasc	PROPN
iajs-2675	266	24	,	,	PUNCT
iajs-2675	266	25	j.m	j.m	PROPN
iajs-2675	266	26	.	.	PROPN
iajs-2675	266	27	;	;	PUNCT
iajs-2675	266	28	quignard	quignard	NOUN
iajs-2675	266	29	-	-	PUNCT
iajs-2675	266	30	boulange.i	boulange.i	NOUN
iajs-2675	266	31	.	.	PUNCT
iajs-2675	266	32	;	;	PUNCT
iajs-2675	266	33	negrel.r	negrel.r	NUM
iajs-2675	266	34	.	.	PUNCT
iajs-2675	266	35	;	;	PUNCT
iajs-2675	266	36	ailhaud.g	ailhaud.g	PROPN
iajs-2675	266	37	.	.	PUNCT
iajs-2675	266	38	;	;	PUNCT
iajs-2675	266	39	seydoux.j	seydoux.j	PROPN
iajs-2675	266	40	.	.	PUNCT
iajs-2675	266	41	;	;	PUNCT
iajs-2675	266	42	meneton.p	meneton.p	X
iajs-2675	266	43	.	.	PUNCT
iajs-2675	266	44	;	;	PUNCT
iajs-2675	266	45	teboul.m	teboul.m	X
iajs-2675	266	46	.	.	PUNCT
iajs-2675	267	1	adipose	adipose	PRON
iajs-2675	267	2	angiotensinogen	angiotensinogen	NOUN
iajs-2675	267	3	is	be	AUX
iajs-2675	267	4	involved	involve	VERB
iajs-2675	267	5	in	in	ADP
iajs-2675	267	6	adipose	adipose	PRON
iajs-2675	267	7	tissue	tissue	NOUN
iajs-2675	267	8	growth	growth	NOUN
iajs-2675	267	9	and	and	CCONJ
iajs-2675	267	10	blood	blood	NOUN
iajs-2675	267	11	pressure	pressure	NOUN
iajs-2675	267	12	regulation	regulation	NOUN
iajs-2675	267	13	.	.	PUNCT
iajs-2675	268	1	faseb	faseb	PROPN
iajs-2675	268	2	j.	j.	PROPN
iajs-2675	268	3	2001,15(14	2001,15(14	NUM
iajs-2675	268	4	)	)	PUNCT
iajs-2675	268	5	,	,	PUNCT
iajs-2675	268	6	2727	2727	NUM
iajs-2675	268	7	-	-	SYM
iajs-2675	268	8	2729	2729	NUM
iajs-2675	268	9	,	,	PUNCT
iajs-2675	268	10	doi	doi	NOUN
iajs-2675	268	11	:	:	PUNCT
iajs-2675	268	12	10.1096	10.1096	NUM
iajs-2675	268	13	/	/	SYM
iajs-2675	268	14	fj.01	fj.01	PROPN
iajs-2675	268	15	-	-	PUNCT
iajs-2675	268	16	0457fje	0457fje	NOUN
iajs-2675	268	17	.	.	PUNCT
iajs-2675	268	18	30	30	NUM
iajs-2675	268	19	.	.	PUNCT
iajs-2675	269	1	darimont	darimont	PROPN
iajs-2675	269	2	,	,	PUNCT
iajs-2675	269	3	c.	c.	PROPN
iajs-2675	269	4	;	;	PUNCT
iajs-2675	269	5	g.	g.	PROPN
iajs-2675	269	6	vassaux	vassaux	PROPN
iajs-2675	269	7	,	,	PUNCT
iajs-2675	269	8	g.	g.	PROPN
iajs-2675	269	9	;	;	PUNCT
iajs-2675	269	10	ailhaud	ailhaud	ADJ
iajs-2675	269	11	,	,	PUNCT
iajs-2675	269	12	g.	g.	PROPN
iajs-2675	269	13	differentiation	differentiation	NOUN
iajs-2675	269	14	of	of	ADP
iajs-2675	269	15	preadipose	preadipose	NOUN
iajs-2675	269	16	cells	cell	NOUN
iajs-2675	269	17	:	:	PUNCT
iajs-2675	269	18	role	role	NOUN
iajs-2675	269	19	of	of	ADP
iajs-2675	269	20	prostacyclin	prostacyclin	NOUN
iajs-2675	269	21	upon	upon	SCONJ
iajs-2675	269	22	stimulation	stimulation	NOUN
iajs-2675	269	23	of	of	ADP
iajs-2675	269	24	adipose	adipose	NOUN
iajs-2675	269	25	cells	cell	NOUN
iajs-2675	269	26	by	by	ADP
iajs-2675	269	27	angiotensin	angiotensin	NOUN
iajs-2675	269	28	-	-	PUNCT
iajs-2675	269	29	ii	ii	NOUN
iajs-2675	269	30	.endocrinology.1994	.endocrinology.1994	PROPN
iajs-2675	269	31	,	,	PUNCT
iajs-2675	269	32	135	135	NUM
iajs-2675	269	33	,	,	PUNCT
iajs-2675	269	34	2030	2030	NUM
iajs-2675	269	35	-	-	SYM
iajs-2675	269	36	2036	2036	NUM
iajs-2675	269	37	,	,	PUNCT
iajs-2675	269	38	doi.org/10.1210/en.135.5.2030	doi.org/10.1210/en.135.5.2030	PROPN
iajs-2675	269	39	.	.	PROPN
iajs-2675	270	1	31	31	NUM
iajs-2675	270	2	.	.	X
iajs-2675	271	1	crandall	crandall	PROPN
iajs-2675	271	2	,	,	PUNCT
iajs-2675	271	3	d.l	d.l	PROPN
iajs-2675	271	4	.	.	PROPN
iajs-2675	271	5	;	;	PUNCT
iajs-2675	271	6	armellino	armellino	PROPN
iajs-2675	271	7	,	,	PUNCT
iajs-2675	271	8	d.c	d.c	PROPN
iajs-2675	271	9	.	.	PROPN
iajs-2675	271	10	;	;	PUNCT
iajs-2675	271	11	busler	busler	NOUN
iajs-2675	271	12	,	,	PUNCT
iajs-2675	271	13	d.e	d.e	PROPN
iajs-2675	271	14	.	.	PROPN
iajs-2675	271	15	;	;	PUNCT
iajs-2675	271	16	mchendry	mchendry	PROPN
iajs-2675	271	17	-	-	PUNCT
iajs-2675	271	18	bark.b	bark.b	PROPN
iajs-2675	271	19	.	.	PUNCT
iajs-2675	271	20	;	;	PUNCT
iajs-2675	272	1	kral.g.k	kral.g.k	PROPN
iajs-2675	272	2	.	.	PROPN
iajs-2675	273	1	angiotensin	angiotensin	PROPN
iajs-2675	273	2	ii	ii	PROPN
iajs-2675	273	3	receptors	receptor	NOUN
iajs-2675	273	4	in	in	ADP
iajs-2675	273	5	human	human	ADJ
iajs-2675	273	6	preadipocytes	preadipocyte	NOUN
iajs-2675	273	7	:	:	PUNCT
iajs-2675	273	8	role	role	NOUN
iajs-2675	273	9	in	in	ADP
iajs-2675	273	10	cell	cell	NOUN
iajs-2675	273	11	cycle	cycle	NOUN
iajs-2675	273	12	regulation	regulation	NOUN
iajs-2675	273	13	.	.	PUNCT
iajs-2675	274	1	endocrinology.1999	endocrinology.1999	NOUN
iajs-2675	274	2	,	,	PUNCT
iajs-2675	274	3	140	140	NUM
iajs-2675	274	4	,	,	PUNCT
iajs-2675	274	5	154	154	NUM
iajs-2675	274	6	-	-	SYM
iajs-2675	274	7	158	158	NUM
iajs-2675	274	8	,	,	PUNCT
iajs-2675	274	9	doi.org/10.1210/endo.140.1.6430	doi.org/10.1210/endo.140.1.6430	NOUN
iajs-2675	274	10	32	32	NUM
iajs-2675	274	11	.	.	PUNCT
iajs-2675	275	1	weiland	weiland	PROPN
iajs-2675	275	2	,	,	PUNCT
iajs-2675	275	3	f.	f.	PROPN
iajs-2675	275	4	;	;	PUNCT
iajs-2675	275	5	verspohl	verspohl	PROPN
iajs-2675	275	6	,	,	PUNCT
iajs-2675	275	7	e.j	e.j	PROPN
iajs-2675	275	8	.	.	PROPN
iajs-2675	275	9	variety	variety	NOUN
iajs-2675	275	10	of	of	ADP
iajs-2675	275	11	angiotensin	angiotensin	NOUN
iajs-2675	275	12	receptors	receptor	NOUN
iajs-2675	275	13	in	in	ADP
iajs-2675	275	14	3t3	3t3	NOUN
iajs-2675	275	15	-	-	PUNCT
iajs-2675	275	16	l1	l1	NOUN
iajs-2675	275	17	preadipose	preadipose	NOUN
iajs-2675	275	18	cells	cell	NOUN
iajs-2675	275	19	and	and	CCONJ
iajs-2675	275	20	differentiated	differentiate	VERB
iajs-2675	275	21	adipocytes	adipocyte	NOUN
iajs-2675	275	22	.horm	.horm	ADJ
iajs-2675	275	23	metab	metab	PROPN
iajs-2675	275	24	res.2008	res.2008	PROPN
iajs-2675	275	25	,	,	PUNCT
iajs-2675	275	26	40	40	NUM
iajs-2675	275	27	,	,	PUNCT
iajs-2675	275	28	760	760	NUM
iajs-2675	275	29	-	-	SYM
iajs-2675	275	30	766	766	NUM
iajs-2675	275	31	,	,	PUNCT
iajs-2675	275	32	doi	doi	NOUN
iajs-2675	275	33	:	:	PUNCT
iajs-2675	275	34	10.1055	10.1055	NUM
iajs-2675	275	35	/	/	SYM
iajs-2675	275	36	s-00281082041	s-00281082041	NOUN
iajs-2675	275	37	.	.	PUNCT
iajs-2675	276	1	33.ridker	33.ridker	NUM
iajs-2675	276	2	,	,	PUNCT
iajs-2675	276	3	p.m.	p.m.	NOUN
iajs-2675	276	4	;	;	PUNCT
iajs-2675	276	5	hennekens	hennekens	PROPN
iajs-2675	276	6	,	,	PUNCT
iajs-2675	276	7	c.h	c.h	PROPN
iajs-2675	276	8	.	.	PROPN
iajs-2675	276	9	;	;	PUNCT
iajs-2675	276	10	buring	bur	VERB
iajs-2675	276	11	,	,	PUNCT
iajs-2675	276	12	j.e	j.e	PROPN
iajs-2675	276	13	.	.	PROPN
iajs-2675	276	14	;	;	PUNCT
iajs-2675	276	15	rifai	rifai	NOUN
iajs-2675	276	16	,	,	PUNCT
iajs-2675	276	17	n.	n.	NOUN
iajs-2675	276	18	c	c	NOUN
iajs-2675	276	19	-	-	ADJ
iajs-2675	276	20	reactive	reactive	ADJ
iajs-2675	276	21	protein	protein	NOUN
iajs-2675	276	22	and	and	CCONJ
iajs-2675	276	23	other	other	ADJ
iajs-2675	276	24	markers	marker	NOUN
iajs-2675	276	25	of	of	ADP
iajs-2675	276	26	inflammation	inflammation	NOUN
iajs-2675	276	27	in	in	ADP
iajs-2675	276	28	the	the	DET
iajs-2675	276	29	prediction	prediction	NOUN
iajs-2675	276	30	of	of	ADP
iajs-2675	276	31	cardiovascular	cardiovascular	ADJ
iajs-2675	276	32	disease	disease	NOUN
iajs-2675	276	33	in	in	ADP
iajs-2675	276	34	women	woman	NOUN
iajs-2675	276	35	.	.	PUNCT
iajs-2675	277	1	n.	n.	PROPN
iajs-2675	277	2	engl	engl	PROPN
iajs-2675	277	3	j	j	PROPN
iajs-2675	277	4	med	med	PROPN
iajs-2675	277	5	.	.	PROPN
iajs-2675	277	6	2000	2000	NUM
iajs-2675	277	7	,	,	PUNCT
iajs-2675	277	8	342,836–843	342,836–843	PROPN
iajs-2675	277	9	,	,	PUNCT
iajs-2675	277	10	doi	doi	NOUN
iajs-2675	277	11	:	:	PUNCT
iajs-2675	277	12	10.1056	10.1056	NUM
iajs-2675	277	13	/	/	SYM
iajs-2675	277	14	nejm200003233421202	nejm200003233421202	PROPN
iajs-2675	277	15	.	.	PUNCT
iajs-2675	278	1	34	34	NUM
iajs-2675	278	2	.	.	PUNCT
iajs-2675	278	3	yudkin	yudkin	PROPN
iajs-2675	278	4	,	,	PUNCT
iajs-2675	278	5	j.s	j.s	PROPN
iajs-2675	278	6	.	.	PROPN
iajs-2675	278	7	;	;	PUNCT
iajs-2675	278	8	juhan	juhan	NOUN
iajs-2675	278	9	-	-	PUNCT
iajs-2675	278	10	vague	vague	NOUN
iajs-2675	278	11	,	,	PUNCT
iajs-2675	278	12	i.	i.	NOUN
iajs-2675	278	13	;	;	PUNCT
iajs-2675	278	14	hawe	hawe	ADV
iajs-2675	278	15	,	,	PUNCT
iajs-2675	278	16	e.	e.	PROPN
iajs-2675	278	17	;	;	PUNCT
iajs-2675	278	18	humphries	humphries	PROPN
iajs-2675	278	19	,	,	PUNCT
iajs-2675	278	20	s.e	s.e	PROPN
iajs-2675	278	21	.	.	PROPN
iajs-2675	278	22	;	;	PUNCT
iajs-2675	278	23	minno	minno	PROPN
iajs-2675	278	24	,	,	PUNCT
iajs-2675	278	25	g.	g.	PROPN
iajs-2675	278	26	;	;	PUNCT
iajs-2675	278	27	margaglione	margaglione	NOUN
iajs-2675	278	28	,	,	PUNCT
iajs-2675	278	29	m.	m.	NOUN
iajs-2675	278	30	;	;	PUNCT
iajs-2675	278	31	kooistra	kooistra	PROPN
iajs-2675	278	32	,	,	PUNCT
iajs-2675	278	33	t.	t.	PROPN
iajs-2675	278	34	;	;	PUNCT
iajs-2675	278	35	p	p	PROPN
iajs-2675	278	36	e	e	PROPN
iajs-2675	278	37	morange	morange	PROPN
iajs-2675	278	38	,	,	PUNCT
iajs-2675	278	39	p.e	p.e	PROPN
iajs-2675	278	40	.	.	PROPN
iajs-2675	278	41	;	;	PUNCT
iajs-2675	278	42	p	p	X
iajs-2675	278	43	lundman	lundman	NOUN
iajs-2675	278	44	,	,	PUNCT
iajs-2675	278	45	p.	p.	PROPN
iajs-2675	278	46	;	;	PUNCT
iajs-2675	278	47	ali	ali	PROPN
iajs-2675	278	48	,	,	PUNCT
iajs-2675	278	49	m.	m.	NOUN
iajs-2675	278	50	;	;	PUNCT
iajs-2675	278	51	hamsten	hamsten	PROPN
iajs-2675	278	52	,	,	PUNCT
iajs-2675	278	53	a.	a.	NOUN
iajs-2675	278	54	the	the	DET
iajs-2675	278	55	hifmech	hifmech	PROPN
iajs-2675	278	56	study	study	NOUN
iajs-2675	278	57	group	group	NOUN
iajs-2675	278	58	.	.	PUNCT
iajs-2675	279	1	low	low	ADJ
iajs-2675	279	2	-	-	PUNCT
iajs-2675	279	3	grade	grade	NOUN
iajs-2675	279	4	inflammation	inflammation	NOUN
iajs-2675	279	5	may	may	AUX
iajs-2675	279	6	play	play	VERB
iajs-2675	279	7	a	a	DET
iajs-2675	279	8	role	role	NOUN
iajs-2675	279	9	in	in	ADP
iajs-2675	279	10	the	the	DET
iajs-2675	279	11	etiology	etiology	NOUN
iajs-2675	279	12	of	of	ADP
iajs-2675	279	13	the	the	DET
iajs-2675	279	14	metabolic	metabolic	NOUN
iajs-2675	279	15	syndrome	syndrome	NOUN
iajs-2675	279	16	in	in	ADP
iajs-2675	279	17	patients	patient	NOUN
iajs-2675	279	18	with	with	ADP
iajs-2675	279	19	coronary	coronary	ADJ
iajs-2675	279	20	heart	heart	NOUN
iajs-2675	279	21	disease	disease	NOUN
iajs-2675	279	22	:	:	PUNCT
iajs-2675	279	23	the	the	DET
iajs-2675	279	24	hifmech	hifmech	NOUN
iajs-2675	279	25	study	study	NOUN
iajs-2675	279	26	.	.	PUNCT
iajs-2675	280	1	metabolism	metabolism	NOUN
iajs-2675	280	2	.	.	PUNCT
iajs-2675	281	1	2004	2004	NUM
iajs-2675	281	2	,	,	PUNCT
iajs-2675	281	3	53,852–857,doi	53,852–857,doi	NUM
iajs-2675	281	4	:	:	PUNCT
iajs-2675	281	5	10.1016	10.1016	NUM
iajs-2675	281	6	/	/	SYM
iajs-2675	281	7	j.metabol.2004.02.004	j.metabol.2004.02.004	PROPN
iajs-2675	281	8	.	.	PROPN
iajs-2675	282	1	35	35	NUM
iajs-2675	282	2	.	.	PUNCT
iajs-2675	282	3	festa	festa	X
iajs-2675	282	4	,	,	PUNCT
iajs-2675	282	5	a.	a.	NOUN
iajs-2675	282	6	;	;	PUNCT
iajs-2675	282	7	d’agostino	d’agostino	PROPN
iajs-2675	282	8	,	,	PUNCT
iajs-2675	282	9	r.	r.	PROPN
iajs-2675	282	10	jr	jr	PROPN
iajs-2675	282	11	.	.	PROPN
iajs-2675	282	12	;	;	PUNCT
iajs-2675	283	1	howard	howard	PROPN
iajs-2675	283	2	,	,	PUNCT
iajs-2675	283	3	g.	g.	PROPN
iajs-2675	283	4	;	;	PUNCT
iajs-2675	283	5	l	l	PROPN
iajs-2675	283	6	mykkänen	mykkänen	PROPN
iajs-2675	283	7	,	,	PUNCT
iajs-2675	283	8	l.	l.	PROPN
iajs-2675	283	9	;	;	PUNCT
iajs-2675	283	10	tracy	tracy	PROPN
iajs-2675	283	11	,	,	PUNCT
iajs-2675	283	12	r.p	r.p	PROPN
iajs-2675	283	13	.	.	PROPN
iajs-2675	283	14	;	;	PUNCT
iajs-2675	283	15	haffner	haffner	PROPN
iajs-2675	283	16	,	,	PUNCT
iajs-2675	283	17	s.m	s.m	PROPN
iajs-2675	283	18	.	.	PROPN
iajs-2675	283	19	chronic	chronic	ADJ
iajs-2675	283	20	subclinical	subclinical	ADJ
iajs-2675	283	21	inflammation	inflammation	NOUN
iajs-2675	283	22	as	as	ADP
iajs-2675	283	23	part	part	NOUN
iajs-2675	283	24	of	of	ADP
iajs-2675	283	25	the	the	DET
iajs-2675	283	26	insulin	insulin	NOUN
iajs-2675	283	27	resistance	resistance	NOUN
iajs-2675	283	28	syndrome	syndrome	NOUN
iajs-2675	283	29	:	:	PUNCT
iajs-2675	283	30	the	the	DET
iajs-2675	283	31	insulin	insulin	NOUN
iajs-2675	283	32	resistance	resistance	NOUN
iajs-2675	283	33	atherosclerosis	atherosclerosis	NOUN
iajs-2675	283	34	study	study	NOUN
iajs-2675	283	35	(	(	PUNCT
iajs-2675	283	36	iras	ira	NOUN
iajs-2675	283	37	)	)	PUNCT
iajs-2675	283	38	.	.	PUNCT
iajs-2675	284	1	circulation	circulation	NOUN
iajs-2675	284	2	.	.	PUNCT
iajs-2675	285	1	2000,102,42–47	2000,102,42–47	NUM
iajs-2675	285	2	,	,	PUNCT
iajs-2675	285	3	doi	doi	NOUN
iajs-2675	285	4	:	:	PUNCT
iajs-2675	285	5	10.1161/01.cir.102.1.42	10.1161/01.cir.102.1.42	NUM
iajs-2675	285	6	.	.	PROPN
iajs-2675	286	1	36	36	NUM
iajs-2675	286	2	.	.	PUNCT
iajs-2675	287	1	john	john	PROPN
iajs-2675	287	2	,	,	PUNCT
iajs-2675	287	3	d	d	PROPN
iajs-2675	287	4	vu.j	vu.j	NOUN
iajs-2675	287	5	.	.	PUNCT
iajs-2675	287	6	;	;	PUNCT
iajs-2675	287	7	vu	vu	X
iajs-2675	287	8	,	,	PUNCT
iajs-2675	287	9	j.b	j.b	PROPN
iajs-2675	287	10	.	.	PUNCT
iajs-2675	287	11	;	;	PUNCT
iajs-2675	287	12	pio	pio	PROPN
iajs-2675	287	13	,	,	PUNCT
iajs-2675	287	14	j.r	j.r	PROPN
iajs-2675	287	15	.	.	PROPN
iajs-2675	287	16	;	;	PUNCT
iajs-2675	287	17	malik	malik	PROPN
iajs-2675	287	18	,	,	PUNCT
iajs-2675	287	19	s.	s.	PROPN
iajs-2675	287	20	;	;	PUNCT
iajs-2675	287	21	franklin	franklin	PROPN
iajs-2675	287	22	,	,	PUNCT
iajs-2675	287	23	s.s	s.s	PROPN
iajs-2675	287	24	.	.	PROPN
iajs-2675	287	25	;	;	PUNCT
iajs-2675	287	26	chen	chen	PROPN
iajs-2675	287	27	,	,	PUNCT
iajs-2675	287	28	r.s	r.s	PROPN
iajs-2675	287	29	.	.	PROPN
iajs-2675	287	30	;	;	PUNCT
iajs-2675	287	31	wong	wong	PROPN
iajs-2675	287	32	,	,	PUNCT
iajs-2675	287	33	n.d	n.d	PROPN
iajs-2675	287	34	.	.	PROPN
iajs-2675	287	35	impact	impact	NOUN
iajs-2675	287	36	of	of	ADP
iajs-2675	287	37	c	c	NOUN
iajs-2675	287	38	-	-	PUNCT
iajs-2675	287	39	reactive	reactive	ADJ
iajs-2675	287	40	protein	protein	NOUN
iajs-2675	287	41	on	on	ADP
iajs-2675	287	42	the	the	DET
iajs-2675	287	43	likelihood	likelihood	NOUN
iajs-2675	287	44	of	of	ADP
iajs-2675	287	45	peripheral	peripheral	ADJ
iajs-2675	287	46	arterial	arterial	ADJ
iajs-2675	287	47	disease	disease	NOUN
iajs-2675	287	48	in	in	ADP
iajs-2675	287	49	united	united	PROPN
iajs-2675	287	50	states	states	PROPN
iajs-2675	287	51	adults	adult	NOUN
iajs-2675	287	52	with	with	ADP
iajs-2675	287	53	the	the	DET
iajs-2675	287	54	metabolic	metabolic	NOUN
iajs-2675	287	55	syndrome	syndrome	NOUN
iajs-2675	287	56	,	,	PUNCT
iajs-2675	287	57	diabetes	diabetes	NOUN
iajs-2675	287	58	mellitus	mellitus	NOUN
iajs-2675	287	59	,	,	PUNCT
iajs-2675	287	60	and	and	CCONJ
iajs-2675	287	61	preexisting	preexist	VERB
iajs-2675	287	62	cardiovascular	cardiovascular	ADJ
iajs-2675	287	63	disease	disease	NOUN
iajs-2675	287	64	.	.	PUNCT
iajs-2675	288	1	am	be	AUX
iajs-2675	288	2	j	j	PROPN
iajs-2675	288	3	cardiol	cardiol	NOUN
iajs-2675	288	4	.	.	PUNCT
iajs-2675	289	1	2005	2005	NUM
iajs-2675	289	2	,	,	PUNCT
iajs-2675	289	3	96	96	NUM
iajs-2675	289	4	,	,	PUNCT
iajs-2675	289	5	655–658	655–658	NUM
iajs-2675	289	6	,	,	PUNCT
iajs-2675	289	7	doi	doi	NOUN
iajs-2675	289	8	:	:	PUNCT
iajs-2675	289	9	10.1016	10.1016	NUM
iajs-2675	289	10	/	/	SYM
iajs-2675	289	11	j.amjcard.2005.04.038	j.amjcard.2005.04.038	PROPN
iajs-2675	289	12	.	.	PUNCT
iajs-2675	290	1	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5933580/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5933580/	PROPN
iajs-2675	290	2	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5933580/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5933580/	NUM
iajs-2675	290	3	https://dx.doi.org/10.1177%2f1753944717711379	https://dx.doi.org/10.1177%2f1753944717711379	PROPN
iajs-2675	290	4	ibn	ibn	PROPN
iajs-2675	290	5	al	al	PROPN
iajs-2675	290	6	-	-	PUNCT
iajs-2675	290	7	haitham	haitham	PROPN
iajs-2675	290	8	jour	jour	X
iajs-2675	290	9	.	.	PROPN
iajs-2675	291	1	for	for	ADP
iajs-2675	291	2	pure	pure	ADJ
iajs-2675	291	3	&	&	CCONJ
iajs-2675	291	4	appl	appl	PROPN
iajs-2675	291	5	.	.	PUNCT
iajs-2675	292	1	sci	sci	PROPN
iajs-2675	292	2	.	.	PROPN
iajs-2675	293	1	34(3)2021	34(3)2021	NUM
iajs-2675	293	2	35	35	NUM
iajs-2675	293	3	37	37	NUM
iajs-2675	293	4	.	.	PUNCT
iajs-2675	294	1	devaraj	devaraj	PROPN
iajs-2675	294	2	,	,	PUNCT
iajs-2675	294	3	s.	s.	PROPN
iajs-2675	294	4	;	;	PUNCT
iajs-2675	294	5	swarbrick	swarbrick	PROPN
iajs-2675	294	6	,	,	PUNCT
iajs-2675	294	7	m.m	m.m	PROPN
iajs-2675	294	8	.	.	PROPN
iajs-2675	294	9	;	;	PUNCT
iajs-2675	294	10	singh	singh	PROPN
iajs-2675	294	11	,	,	PUNCT
iajs-2675	294	12	o.	o.	PROPN
iajs-2675	294	13	;	;	PUNCT
iajs-2675	294	14	adams	adams	PROPN
iajs-2675	294	15	-	-	PUNCT
iajs-2675	294	16	huet	huet	PROPN
iajs-2675	294	17	,	,	PUNCT
iajs-2675	294	18	b.	b.	PROPN
iajs-2675	294	19	;	;	PUNCT
iajs-2675	294	20	havel	havel	PROPN
iajs-2675	294	21	,	,	PUNCT
iajs-2675	294	22	p.j	p.j	PROPN
iajs-2675	294	23	.	.	PROPN
iajs-2675	294	24	;	;	PUNCT
iajs-2675	294	25	jialal	jialal	PROPN
iajs-2675	294	26	,	,	PUNCT
iajs-2675	294	27	i.	i.	PROPN
iajs-2675	294	28	crp	crp	PROPN
iajs-2675	294	29	and	and	CCONJ
iajs-2675	294	30	adiponectin	adiponectin	NOUN
iajs-2675	294	31	and	and	CCONJ
iajs-2675	294	32	its	its	PRON
iajs-2675	294	33	oligomers	oligomer	NOUN
iajs-2675	294	34	in	in	ADP
iajs-2675	294	35	the	the	DET
iajs-2675	294	36	metabolic	metabolic	NOUN
iajs-2675	294	37	syndrome	syndrome	NOUN
iajs-2675	294	38	:	:	PUNCT
iajs-2675	294	39	evaluation	evaluation	NOUN
iajs-2675	294	40	of	of	ADP
iajs-2675	294	41	new	new	ADJ
iajs-2675	294	42	laboratorybased	laboratorybase	VERB
iajs-2675	294	43	biomarkers	biomarker	NOUN
iajs-2675	294	44	.	.	PUNCT
iajs-2675	295	1	am	be	AUX
iajs-2675	295	2	j	j	PROPN
iajs-2675	295	3	clin	clin	PROPN
iajs-2675	295	4	pathol	pathol	NOUN
iajs-2675	295	5	.	.	PUNCT
iajs-2675	296	1	2008,129	2008,129	NUM
iajs-2675	296	2	,	,	PUNCT
iajs-2675	296	3	815–822	815–822	NUM
iajs-2675	296	4	,	,	PUNCT
iajs-2675	296	5	doi	doi	NOUN
iajs-2675	296	6	:	:	PUNCT
iajs-2675	296	7	10.1309	10.1309	NUM
iajs-2675	296	8	/	/	SYM
iajs-2675	296	9	rn84k51b2jjy1y0b	rn84k51b2jjy1y0b	NOUN
iajs-2675	296	10	.	.	PUNCT
iajs-2675	297	1	38	38	NUM
iajs-2675	297	2	.	.	PUNCT
iajs-2675	298	1	testa	testa	PROPN
iajs-2675	298	2	,	,	PUNCT
iajs-2675	298	3	r.	r.	PROPN
iajs-2675	298	4	;	;	PUNCT
iajs-2675	298	5	olivieri	olivieri	PROPN
iajs-2675	298	6	,	,	PUNCT
iajs-2675	298	7	f.	f.	PROPN
iajs-2675	298	8	;	;	PUNCT
iajs-2675	298	9	bonfigli	bonfigli	PROPN
iajs-2675	298	10	,	,	PUNCT
iajs-2675	298	11	a.	a.	NOUN
iajs-2675	298	12	;	;	PUNCT
iajs-2675	298	13	sirolla	sirolla	PROPN
iajs-2675	298	14	,	,	PUNCT
iajs-2675	298	15	c.	c.	PROPN
iajs-2675	298	16	;	;	PUNCT
iajs-2675	298	17	boemi	boemi	ADV
iajs-2675	298	18	.	.	PUNCT
iajs-2675	299	1	m.	m.	NOUN
iajs-2675	299	2	;	;	PUNCT
iajs-2675	299	3	marchegiani	marchegiani	PROPN
iajs-2675	299	4	.	.	PUNCT
iajs-2675	300	1	f.	f.	PROPN
iajs-2675	300	2	;	;	PUNCT
iajs-2675	300	3	marra	marra	PROPN
iajs-2675	300	4	.	.	PUNCT
iajs-2675	300	5	m.	m.	NOUN
iajs-2675	300	6	;	;	PUNCT
iajs-2675	300	7	cenerelli	cenerelli	PROPN
iajs-2675	300	8	,	,	PUNCT
iajs-2675	300	9	s.	s.	PROPN
iajs-2675	300	10	;	;	PUNCT
iajs-2675	300	11	antonicelli	antonicelli	PROPN
iajs-2675	300	12	,	,	PUNCT
iajs-2675	300	13	r.	r.	PROPN
iajs-2675	300	14	;	;	PUNCT
iajs-2675	300	15	dolci	dolci	ADJ
iajs-2675	300	16	,	,	PUNCT
iajs-2675	300	17	a.	a.	NOUN
iajs-2675	300	18	interleukin-6	interleukin-6	PROPN
iajs-2675	300	19	-	-	SYM
iajs-2675	300	20	174	174	NUM
iajs-2675	300	21	g	g	NOUN
iajs-2675	300	22	>	>	SYM
iajs-2675	300	23	c	c	PROPN
iajs-2675	300	24	polymorphism	polymorphism	NOUN
iajs-2675	300	25	affects	affect	VERB
iajs-2675	300	26	the	the	DET
iajs-2675	300	27	association	association	NOUN
iajs-2675	300	28	between	between	ADP
iajs-2675	300	29	il-6	il-6	NOUN
iajs-2675	300	30	plasma	plasma	NOUN
iajs-2675	300	31	levels	level	NOUN
iajs-2675	300	32	and	and	CCONJ
iajs-2675	300	33	insulin	insulin	NOUN
iajs-2675	300	34	resistance	resistance	NOUN
iajs-2675	300	35	in	in	ADP
iajs-2675	300	36	type	type	NOUN
iajs-2675	300	37	2	2	NUM
iajs-2675	300	38	diabetic	diabetic	ADJ
iajs-2675	300	39	patients	patient	NOUN
iajs-2675	300	40	.	.	PUNCT
iajs-2675	301	1	diabetes	diabetes	NOUN
iajs-2675	301	2	res	re	VERB
iajs-2675	301	3	clin	clin	PROPN
iajs-2675	301	4	prac	prac	PROPN
iajs-2675	301	5	.	.	PROPN
iajs-2675	302	1	2006	2006	NUM
iajs-2675	302	2	,	,	PUNCT
iajs-2675	302	3	71,299–305	71,299–305	NUM
iajs-2675	302	4	,	,	PUNCT
iajs-2675	302	5	doi	doi	NOUN
iajs-2675	302	6	:	:	PUNCT
iajs-2675	302	7	10.1016	10.1016	NUM
iajs-2675	302	8	/	/	SYM
iajs-2675	302	9	j.diabres.2005.07.007	j.diabres.2005.07.007	PROPN
iajs-2675	302	10	.	.	PROPN
iajs-2675	302	11	39	39	NUM
iajs-2675	302	12	.	.	PUNCT
iajs-2675	303	1	pickup	pickup	NOUN
iajs-2675	303	2	,	,	PUNCT
iajs-2675	303	3	j.	j.	PROPN
iajs-2675	303	4	;	;	PUNCT
iajs-2675	303	5	mattock	mattock	NOUN
iajs-2675	303	6	,	,	PUNCT
iajs-2675	303	7	m.	m.	NOUN
iajs-2675	303	8	;	;	PUNCT
iajs-2675	303	9	chusney	chusney	PROPN
iajs-2675	303	10	,	,	PUNCT
iajs-2675	303	11	g.	g.	PROPN
iajs-2675	303	12	;	;	PUNCT
iajs-2675	303	13	burt	burt	PROPN
iajs-2675	303	14	.	.	PUNCT
iajs-2675	304	1	d.	d.	PROPN
iajs-2675	304	2	niddm	niddm	PROPN
iajs-2675	304	3	as	as	ADP
iajs-2675	304	4	a	a	DET
iajs-2675	304	5	disease	disease	NOUN
iajs-2675	304	6	of	of	ADP
iajs-2675	304	7	the	the	DET
iajs-2675	304	8	innate	innate	ADJ
iajs-2675	304	9	immune	immune	ADJ
iajs-2675	304	10	system	system	NOUN
iajs-2675	304	11	:	:	PUNCT
iajs-2675	304	12	association	association	NOUN
iajs-2675	304	13	of	of	ADP
iajs-2675	304	14	acute	acute	ADJ
iajs-2675	304	15	-	-	PUNCT
iajs-2675	304	16	phase	phase	NOUN
iajs-2675	304	17	reactants	reactant	NOUN
iajs-2675	304	18	and	and	CCONJ
iajs-2675	304	19	interleukin-6	interleukin-6	NUM
iajs-2675	304	20	with	with	ADP
iajs-2675	304	21	metabolic	metabolic	NOUN
iajs-2675	304	22	syndrome	syndrome	NOUN
iajs-2675	304	23	x.	x.	NOUN
iajs-2675	304	24	diabetologia	diabetologia	PROPN
iajs-2675	304	25	.	.	PUNCT
iajs-2675	305	1	1997	1997	NUM
iajs-2675	305	2	,	,	PUNCT
iajs-2675	305	3	40,1286–1292	40,1286–1292	NUM
iajs-2675	305	4	,	,	PUNCT
iajs-2675	305	5	doi	doi	NOUN
iajs-2675	305	6	:	:	PUNCT
iajs-2675	305	7	10.1007	10.1007	NUM
iajs-2675	305	8	/	/	SYM
iajs-2675	305	9	s001250050822	s001250050822	NOUN
iajs-2675	305	10	.	.	PUNCT
iajs-2675	306	1	40	40	NUM
iajs-2675	306	2	.	.	PUNCT
iajs-2675	306	3	eckel	eckel	PROPN
iajs-2675	306	4	,	,	PUNCT
iajs-2675	306	5	r.h	r.h	PROPN
iajs-2675	306	6	.	.	PROPN
iajs-2675	306	7	;	;	PUNCT
iajs-2675	306	8	grundy	grundy	PROPN
iajs-2675	306	9	,	,	PUNCT
iajs-2675	306	10	s.m	s.m	PROPN
iajs-2675	306	11	.	.	PROPN
iajs-2675	306	12	;	;	PUNCT
iajs-2675	307	1	zimmet	zimmet	NOUN
iajs-2675	307	2	,	,	PUNCT
iajs-2675	307	3	p.z	p.z	PROPN
iajs-2675	307	4	.	.	PUNCT
iajs-2675	308	1	the	the	DET
iajs-2675	308	2	metabolic	metabolic	NOUN
iajs-2675	308	3	syndrome	syndrome	NOUN
iajs-2675	308	4	.	.	PUNCT
iajs-2675	309	1	lancet	lancet	PROPN
iajs-2675	309	2	.	.	PUNCT
iajs-2675	310	1	2005	2005	NUM
iajs-2675	310	2	,	,	PUNCT
iajs-2675	310	3	365,1415–1428	365,1415–1428	NUM
iajs-2675	310	4	,	,	PUNCT
iajs-2675	310	5	doi	doi	NOUN
iajs-2675	310	6	:	:	PUNCT
iajs-2675	310	7	10.1016	10.1016	NUM
iajs-2675	310	8	/	/	SYM
iajs-2675	310	9	s0140	s0140	PROPN
iajs-2675	310	10	-	-	PUNCT
iajs-2675	310	11	6736	6736	NUM
iajs-2675	310	12	(	(	PUNCT
iajs-2675	310	13	05	05	NUM
iajs-2675	310	14	)	)	PUNCT
iajs-2675	310	15	66378	66378	NUM
iajs-2675	310	16	-	-	SYM
iajs-2675	310	17	7	7	NUM
iajs-2675	310	18	.	.	NOUN
iajs-2675	310	19	41	41	NUM
iajs-2675	310	20	.	.	PUNCT
iajs-2675	310	21	aker	aker	NOUN
iajs-2675	310	22	,	,	PUNCT
iajs-2675	310	23	s.	s.	PROPN
iajs-2675	310	24	;	;	PUNCT
iajs-2675	310	25	bantis	bantis	PROPN
iajs-2675	310	26	,	,	PUNCT
iajs-2675	310	27	c.	c.	PROPN
iajs-2675	310	28	;	;	PUNCT
iajs-2675	310	29	reis	reis	NOUN
iajs-2675	310	30	,	,	PUNCT
iajs-2675	310	31	p.	p.	NOUN
iajs-2675	310	32	;	;	PUNCT
iajs-2675	310	33	kuhr	kuhr	X
iajs-2675	310	34	,	,	PUNCT
iajs-2675	310	35	n.	n.	NOUN
iajs-2675	310	36	;	;	PUNCT
iajs-2675	310	37	schwandt	schwandt	ADV
iajs-2675	310	38	,	,	PUNCT
iajs-2675	310	39	c.	c.	NOUN
iajs-2675	310	40	;	;	PUNCT
iajs-2675	310	41	grabensee	grabensee	PROPN
iajs-2675	310	42	,	,	PUNCT
iajs-2675	310	43	b.	b.	PROPN
iajs-2675	310	44	;	;	PUNCT
iajs-2675	310	45	heering	heere	VERB
iajs-2675	310	46	,	,	PUNCT
iajs-2675	310	47	p.	p.	NOUN
iajs-2675	310	48	;	;	PUNCT
iajs-2675	310	49	ivens	ivens	PROPN
iajs-2675	310	50	.	.	PUNCT
iajs-2675	311	1	k.	k.	PROPN
iajs-2675	311	2	influence	influence	PROPN
iajs-2675	311	3	of	of	ADP
iajs-2675	311	4	interleukin-6	interleukin-6	NUM
iajs-2675	311	5	g-174c	g-174c	PROPN
iajs-2675	311	6	gene	gene	NOUN
iajs-2675	311	7	polymorphism	polymorphism	NOUN
iajs-2675	311	8	on	on	ADP
iajs-2675	311	9	coronary	coronary	ADJ
iajs-2675	311	10	artery	artery	NOUN
iajs-2675	311	11	disease	disease	NOUN
iajs-2675	311	12	,	,	PUNCT
iajs-2675	311	13	cardiovascular	cardiovascular	ADJ
iajs-2675	311	14	complications	complication	NOUN
iajs-2675	311	15	and	and	CCONJ
iajs-2675	311	16	mortality	mortality	NOUN
iajs-2675	311	17	in	in	ADP
iajs-2675	311	18	dialysis	dialysis	NOUN
iajs-2675	311	19	patients	patient	NOUN
iajs-2675	311	20	.	.	PUNCT
iajs-2675	312	1	nephrol	nephrol	PROPN
iajs-2675	312	2	dial	dial	NOUN
iajs-2675	312	3	transplant	transplant	NOUN
iajs-2675	312	4	.	.	PUNCT
iajs-2675	313	1	2009	2009	NUM
iajs-2675	313	2	,	,	PUNCT
iajs-2675	313	3	24	24	NUM
iajs-2675	313	4	,	,	PUNCT
iajs-2675	313	5	2847–2851	2847–2851	NUM
iajs-2675	313	6	,	,	PUNCT
iajs-2675	313	7	doi	doi	NOUN
iajs-2675	313	8	:	:	PUNCT
iajs-2675	313	9	10.1093	10.1093	NUM
iajs-2675	313	10	/	/	SYM
iajs-2675	313	11	ndt	ndt	PROPN
iajs-2675	313	12	/	/	SYM
iajs-2675	313	13	gfp141	gfp141	NOUN
iajs-2675	313	14	.	.	PUNCT
iajs-2675	314	1	42	42	NUM
iajs-2675	314	2	.	.	PUNCT
iajs-2675	315	1	kume	kume	PROPN
iajs-2675	315	2	,	,	PUNCT
iajs-2675	315	3	n.	n.	PROPN
iajs-2675	315	4	;	;	PUNCT
iajs-2675	315	5	moriwaki	moriwaki	PROPN
iajs-2675	315	6	,	,	PUNCT
iajs-2675	315	7	h.	h.	PROPN
iajs-2675	315	8	;	;	PUNCT
iajs-2675	315	9	kataoka	kataoka	PROPN
iajs-2675	315	10	,	,	PUNCT
iajs-2675	315	11	h.	h.	PROPN
iajs-2675	315	12	;	;	PUNCT
iajs-2675	315	13	minami	minami	PROPN
iajs-2675	315	14	,	,	PUNCT
iajs-2675	315	15	m.	m.	NOUN
iajs-2675	315	16	;	;	PUNCT
iajs-2675	315	17	murase	murase	NOUN
iajs-2675	315	18	,	,	PUNCT
iajs-2675	315	19	t.	t.	PROPN
iajs-2675	315	20	;	;	PUNCT
iajs-2675	315	21	sawamura	sawamura	NOUN
iajs-2675	315	22	,	,	PUNCT
iajs-2675	315	23	t.	t.	PROPN
iajs-2675	315	24	;	;	PUNCT
iajs-2675	315	25	masaki	masaki	PROPN
iajs-2675	315	26	.	.	PUNCT
iajs-2675	316	1	t.	t.	PROPN
iajs-2675	316	2	;	;	PUNCT
iajs-2675	316	3	kita	kita	PROPN
iajs-2675	316	4	,	,	PUNCT
iajs-2675	316	5	t.	t.	NOUN
iajs-2675	316	6	inducible	inducible	ADJ
iajs-2675	316	7	receptor	receptor	NOUN
iajs-2675	316	8	for	for	ADP
iajs-2675	316	9	oxidized	oxidized	ADJ
iajs-2675	316	10	ldl	ldl	NOUN
iajs-2675	316	11	,	,	PUNCT
iajs-2675	316	12	in	in	ADP
iajs-2675	316	13	macrophages	macrophage	NOUN
iajs-2675	316	14	and	and	CCONJ
iajs-2675	316	15	vascular	vascular	ADJ
iajs-2675	316	16	smooth	smooth	ADJ
iajs-2675	316	17	muscle	muscle	NOUN
iajs-2675	316	18	cells	cell	NOUN
iajs-2675	316	19	.	.	PUNCT
iajs-2675	317	1	ann	ann	PROPN
iajs-2675	317	2	n	n	PROPN
iajs-2675	317	3	y	y	PROPN
iajs-2675	317	4	acad	acad	PROPN
iajs-2675	317	5	sci	sci	PROPN
iajs-2675	317	6	.	.	PROPN
iajs-2675	317	7	2000	2000	NUM
iajs-2675	317	8	,	,	PUNCT
iajs-2675	317	9	902,323	902,323	NUM
iajs-2675	317	10	-	-	SYM
iajs-2675	317	11	327	327	NUM
iajs-2675	317	12	,	,	PUNCT
iajs-2675	317	13	doi	doi	NOUN
iajs-2675	317	14	:	:	PUNCT
iajs-2675	317	15	10.1111	10.1111	NUM
iajs-2675	317	16	/	/	SYM
iajs-2675	317	17	j.17496632.2000.tb06332.x	j.17496632.2000.tb06332.x	PROPN
iajs-2675	317	18	.	.	PROPN
iajs-2675	317	19	43	43	NUM
iajs-2675	317	20	.	.	PUNCT
iajs-2675	318	1	minami	minami	PROPN
iajs-2675	318	2	,	,	PUNCT
iajs-2675	318	3	m.	m.	NOUN
iajs-2675	318	4	;	;	PUNCT
iajs-2675	318	5	kume	kume	PROPN
iajs-2675	318	6	,	,	PUNCT
iajs-2675	318	7	n.	n.	PROPN
iajs-2675	318	8	;	;	PUNCT
iajs-2675	318	9	kataoka	kataoka	PROPN
iajs-2675	318	10	,	,	PUNCT
iajs-2675	318	11	h.	h.	PROPN
iajs-2675	318	12	;	;	PUNCT
iajs-2675	318	13	morimoto	morimoto	NOUN
iajs-2675	318	14	,	,	PUNCT
iajs-2675	318	15	m.	m.	NOUN
iajs-2675	318	16	;	;	PUNCT
iajs-2675	318	17	hayashida	hayashida	PROPN
iajs-2675	318	18	,	,	PUNCT
iajs-2675	318	19	k.	k.	PROPN
iajs-2675	318	20	;	;	PUNCT
iajs-2675	318	21	sawamura	sawamura	NOUN
iajs-2675	318	22	,	,	PUNCT
iajs-2675	318	23	t.	t.	PROPN
iajs-2675	318	24	;	;	PUNCT
iajs-2675	318	25	masaki	masaki	PROPN
iajs-2675	318	26	,	,	PUNCT
iajs-2675	318	27	t.	t.	PROPN
iajs-2675	318	28	;	;	PUNCT
iajs-2675	318	29	kita	kita	PROPN
iajs-2675	318	30	,	,	PUNCT
iajs-2675	318	31	t.	t.	NOUN
iajs-2675	318	32	transforming	transform	VERB
iajs-2675	318	33	growth	growth	NOUN
iajs-2675	318	34	factor	factor	NOUN
iajs-2675	318	35	-	-	PUNCT
iajs-2675	318	36	beta(1	beta(1	NOUN
iajs-2675	318	37	)	)	PUNCT
iajs-2675	318	38	increases	increase	VERB
iajs-2675	318	39	the	the	DET
iajs-2675	318	40	expression	expression	NOUN
iajs-2675	318	41	of	of	ADP
iajs-2675	318	42	lectinlike	lectinlike	PROPN
iajs-2675	318	43	oxidized	oxidize	VERB
iajs-2675	318	44	low	low	ADJ
iajs-2675	318	45	-	-	PUNCT
iajs-2675	318	46	density	density	NOUN
iajs-2675	318	47	lipoprotein	lipoprotein	ADJ
iajs-2675	318	48	receptor-1	receptor-1	NOUN
iajs-2675	318	49	.	.	PUNCT
iajs-2675	319	1	biochem	biochem	PROPN
iajs-2675	319	2	biophys	biophy	VERB
iajs-2675	319	3	res	re	NOUN
iajs-2675	319	4	commun	commun	PROPN
iajs-2675	319	5	.	.	PUNCT
iajs-2675	320	1	2000	2000	NUM
iajs-2675	320	2	,	,	PUNCT
iajs-2675	320	3	272,357	272,357	NUM
iajs-2675	320	4	-	-	SYM
iajs-2675	320	5	61	61	NUM
iajs-2675	320	6	,	,	PUNCT
iajs-2675	320	7	doi	doi	NOUN
iajs-2675	320	8	:	:	PUNCT
iajs-2675	320	9	10.1006	10.1006	NUM
iajs-2675	320	10	/	/	SYM
iajs-2675	320	11	bbrc.2000.2778	bbrc.2000.2778	NOUN
iajs-2675	320	12	.	.	PUNCT
iajs-2675	321	1	44	44	NUM
iajs-2675	321	2	.	.	PUNCT
iajs-2675	322	1	kataoka	kataoka	PROPN
iajs-2675	322	2	,	,	PUNCT
iajs-2675	322	3	h.	h.	PROPN
iajs-2675	322	4	;	;	PUNCT
iajs-2675	322	5	kume	kume	PROPN
iajs-2675	322	6	,	,	PUNCT
iajs-2675	322	7	n.	n.	PROPN
iajs-2675	322	8	;	;	PUNCT
iajs-2675	322	9	miyamoto	miyamoto	NOUN
iajs-2675	322	10	,	,	PUNCT
iajs-2675	322	11	s.	s.	PROPN
iajs-2675	322	12	;	;	PUNCT
iajs-2675	322	13	minami	minami	PROPN
iajs-2675	322	14	,	,	PUNCT
iajs-2675	322	15	m.	m.	NOUN
iajs-2675	322	16	;	;	PUNCT
iajs-2675	322	17	moriwaki	moriwaki	PROPN
iajs-2675	322	18	,	,	PUNCT
iajs-2675	322	19	h.	h.	PROPN
iajs-2675	322	20	;	;	PUNCT
iajs-2675	322	21	murase	murase	NOUN
iajs-2675	322	22	,	,	PUNCT
iajs-2675	322	23	t.	t.	PROPN
iajs-2675	322	24	;	;	PUNCT
iajs-2675	322	25	sawamura	sawamura	NOUN
iajs-2675	322	26	,	,	PUNCT
iajs-2675	322	27	t.	t.	PROPN
iajs-2675	322	28	;	;	PUNCT
iajs-2675	322	29	masaki	masaki	PROPN
iajs-2675	322	30	,	,	PUNCT
iajs-2675	322	31	t.	t.	PROPN
iajs-2675	322	32	;	;	PUNCT
iajs-2675	322	33	hashimoto	hashimoto	NOUN
iajs-2675	322	34	,	,	PUNCT
iajs-2675	322	35	n.	n.	PROPN
iajs-2675	322	36	;	;	PUNCT
iajs-2675	322	37	kita	kita	PROPN
iajs-2675	322	38	,	,	PUNCT
iajs-2675	322	39	t.	t.	NOUN
iajs-2675	322	40	expression	expression	NOUN
iajs-2675	322	41	of	of	ADP
iajs-2675	322	42	lectinlike	lectinlike	PROPN
iajs-2675	322	43	oxidized	oxidize	VERB
iajs-2675	322	44	lowdensity	lowdensity	NOUN
iajs-2675	322	45	lipoprotein	lipoprotein	ADJ
iajs-2675	322	46	receptor-1	receptor-1	NUM
iajs-2675	322	47	in	in	ADP
iajs-2675	322	48	human	human	ADJ
iajs-2675	322	49	atherosclerotic	atherosclerotic	ADJ
iajs-2675	322	50	lesions	lesion	NOUN
iajs-2675	322	51	.	.	PUNCT
iajs-2675	323	1	circulation	circulation	NOUN
iajs-2675	323	2	.	.	PUNCT
iajs-2675	324	1	1999,99,3110	1999,99,3110	NUM
iajs-2675	324	2	-	-	SYM
iajs-2675	324	3	7	7	NUM
iajs-2675	324	4	,	,	PUNCT
iajs-2675	324	5	doi	doi	NOUN
iajs-2675	324	6	:	:	PUNCT
iajs-2675	324	7	10.1161/01.cir.99.24.3110	10.1161/01.cir.99.24.3110	NUM
iajs-2675	324	8	.	.	PUNCT
iajs-2675	325	1	45	45	NUM
iajs-2675	325	2	.	.	PUNCT
iajs-2675	326	1	kataoka	kataoka	PROPN
iajs-2675	326	2	,	,	PUNCT
iajs-2675	326	3	h.	h.	PROPN
iajs-2675	326	4	;	;	PUNCT
iajs-2675	326	5	kume	kume	PROPN
iajs-2675	326	6	,	,	PUNCT
iajs-2675	326	7	n.	n.	PROPN
iajs-2675	326	8	;	;	PUNCT
iajs-2675	326	9	miyamoto	miyamoto	NOUN
iajs-2675	326	10	,	,	PUNCT
iajs-2675	326	11	s.	s.	PROPN
iajs-2675	326	12	;	;	PUNCT
iajs-2675	326	13	minami	minami	PROPN
iajs-2675	326	14	,	,	PUNCT
iajs-2675	326	15	m.	m.	NOUN
iajs-2675	326	16	;	;	PUNCT
iajs-2675	326	17	morimoto	morimoto	NOUN
iajs-2675	326	18	,	,	PUNCT
iajs-2675	326	19	m.	m.	NOUN
iajs-2675	326	20	;	;	PUNCT
iajs-2675	326	21	hayashida	hayashida	PROPN
iajs-2675	326	22	,	,	PUNCT
iajs-2675	326	23	k.	k.	PROPN
iajs-2675	326	24	;	;	PUNCT
iajs-2675	326	25	hashimoto	hashimoto	NOUN
iajs-2675	326	26	,	,	PUNCT
iajs-2675	326	27	n.	n.	PROPN
iajs-2675	326	28	;	;	PUNCT
iajs-2675	326	29	kita	kita	PROPN
iajs-2675	326	30	,	,	PUNCT
iajs-2675	326	31	t.	t.	PROPN
iajs-2675	326	32	oxidized	oxidize	VERB
iajs-2675	326	33	ldl	ldl	NOUN
iajs-2675	326	34	modulates	modulate	NOUN
iajs-2675	326	35	bax	bax	NOUN
iajs-2675	326	36	/	/	SYM
iajs-2675	326	37	bcl-2	bcl-2	NOUN
iajs-2675	326	38	through	through	ADP
iajs-2675	326	39	the	the	DET
iajs-2675	326	40	lectinlike	lectinlike	ADJ
iajs-2675	326	41	ox	ox	NOUN
iajs-2675	326	42	-	-	NOUN
iajs-2675	326	43	ldl	ldl	NOUN
iajs-2675	326	44	receptor-1	receptor-1	NUM
iajs-2675	326	45	in	in	ADP
iajs-2675	326	46	vascular	vascular	ADJ
iajs-2675	326	47	smooth	smooth	ADJ
iajs-2675	326	48	muscle	muscle	NOUN
iajs-2675	326	49	cells	cell	NOUN
iajs-2675	326	50	.	.	PUNCT
iajs-2675	327	1	arterioscler	arterioscler	PROPN
iajs-2675	327	2	thromb	thromb	PROPN
iajs-2675	327	3	vasc	vasc	PROPN
iajs-2675	327	4	biol	biol	PROPN
iajs-2675	327	5	.	.	PUNCT
iajs-2675	328	1	2001	2001	NUM
iajs-2675	328	2	,	,	PUNCT
iajs-2675	328	3	21	21	NUM
iajs-2675	328	4	,	,	PUNCT
iajs-2675	328	5	95560	95560	NUM
iajs-2675	328	6	,	,	PUNCT
iajs-2675	328	7	doi	doi	NOUN
iajs-2675	328	8	:	:	PUNCT
iajs-2675	328	9	10.1161	10.1161	NUM
iajs-2675	328	10	/	/	SYM
iajs-2675	328	11	01.atv.21.6.955	01.atv.21.6.955	NOUN
iajs-2675	328	12	.	.	PUNCT
iajs-2675	329	1	46	46	NUM
iajs-2675	329	2	.	.	PUNCT
iajs-2675	329	3	kume	kume	PROPN
iajs-2675	329	4	,	,	PUNCT
iajs-2675	329	5	n.	n.	PROPN
iajs-2675	329	6	;	;	PUNCT
iajs-2675	329	7	kita	kita	PROPN
iajs-2675	329	8	,	,	PUNCT
iajs-2675	329	9	t.	t.	NOUN
iajs-2675	329	10	apoptosis	apoptosis	NOUN
iajs-2675	329	11	of	of	ADP
iajs-2675	329	12	vascular	vascular	ADJ
iajs-2675	329	13	cells	cell	NOUN
iajs-2675	329	14	by	by	ADP
iajs-2675	329	15	oxidized	oxidized	ADJ
iajs-2675	329	16	ldl	ldl	NOUN
iajs-2675	329	17	:	:	PUNCT
iajs-2675	329	18	involvement	involvement	NOUN
iajs-2675	329	19	of	of	ADP
iajs-2675	329	20	caspases	caspase	NOUN
iajs-2675	329	21	and	and	CCONJ
iajs-2675	329	22	lox-1	lox-1	NOUN
iajs-2675	329	23	,	,	PUNCT
iajs-2675	329	24	and	and	CCONJ
iajs-2675	329	25	its	its	PRON
iajs-2675	329	26	implication	implication	NOUN
iajs-2675	329	27	in	in	ADP
iajs-2675	329	28	atherosclerotic	atherosclerotic	ADJ
iajs-2675	329	29	plaque	plaque	NOUN
iajs-2675	329	30	rupture	rupture	NOUN
iajs-2675	329	31	.	.	PUNCT
iajs-2675	330	1	circ	circ	PROPN
iajs-2675	330	2	res	re	NOUN
iajs-2675	330	3	.	.	PUNCT
iajs-2675	331	1	2004,94,269	2004,94,269	PROPN
iajs-2675	331	2	-	-	PUNCT
iajs-2675	331	3	70	70	NUM
iajs-2675	331	4	,	,	PUNCT
iajs-2675	331	5	doi	doi	NOUN
iajs-2675	331	6	:	:	PUNCT
iajs-2675	331	7	10.1161/01.res.0000119804.92239.97	10.1161/01.res.0000119804.92239.97	NOUN
iajs-2675	331	8	.	.	PROPN
iajs-2675	332	1	47	47	NUM
iajs-2675	332	2	.	.	PUNCT
iajs-2675	333	1	li	li	PROPN
iajs-2675	333	2	,	,	PUNCT
iajs-2675	333	3	d.	d.	PROPN
iajs-2675	333	4	;	;	PUNCT
iajs-2675	333	5	mehta	mehta	PROPN
iajs-2675	333	6	,	,	PUNCT
iajs-2675	333	7	j.l	j.l	PROPN
iajs-2675	333	8	.	.	PROPN
iajs-2675	333	9	intracellular	intracellular	NOUN
iajs-2675	333	10	signaling	signal	VERB
iajs-2675	333	11	of	of	ADP
iajs-2675	333	12	lox-1	lox-1	PUNCT
iajs-2675	333	13	in	in	ADP
iajs-2675	333	14	endothelial	endothelial	ADJ
iajs-2675	333	15	cell	cell	NOUN
iajs-2675	333	16	apoptosis	apoptosis	NOUN
iajs-2675	333	17	.	.	PUNCT
iajs-2675	334	1	circ	circ	PROPN
iajs-2675	334	2	res	re	NOUN
iajs-2675	334	3	2009	2009	NUM
iajs-2675	334	4	,	,	PUNCT
iajs-2675	334	5	104,566	104,566	NUM
iajs-2675	334	6	-	-	SYM
iajs-2675	334	7	568	568	NUM
iajs-2675	334	8	,	,	PUNCT
iajs-2675	334	9	doi	doi	NOUN
iajs-2675	334	10	:	:	PUNCT
iajs-2675	334	11	10.1161	10.1161	NUM
iajs-2675	334	12	/	/	SYM
iajs-2675	334	13	circresaha.109.194209	circresaha.109.194209	NOUN
iajs-2675	334	14	.	.	PUNCT
iajs-2675	335	1	ibn	ibn	PROPN
iajs-2675	335	2	al	al	PROPN
iajs-2675	335	3	-	-	PUNCT
iajs-2675	335	4	haitham	haitham	PROPN
iajs-2675	335	5	jour	jour	X
iajs-2675	335	6	.	.	PROPN
iajs-2675	335	7	for	for	ADP
iajs-2675	335	8	pure	pure	ADJ
iajs-2675	335	9	&	&	CCONJ
iajs-2675	335	10	appl	appl	PROPN
iajs-2675	335	11	.	.	PUNCT
iajs-2675	336	1	sci	sci	PROPN
iajs-2675	336	2	.	.	PROPN
iajs-2675	337	1	34(3)2021	34(3)2021	NUM
iajs-2675	337	2	36	36	NUM
iajs-2675	337	3	48	48	NUM
iajs-2675	337	4	.	.	PUNCT
iajs-2675	338	1	ishino	ishino	PROPN
iajs-2675	338	2	,	,	PUNCT
iajs-2675	338	3	s.	s.	PROPN
iajs-2675	338	4	;	;	PUNCT
iajs-2675	338	5	mukai	mukai	PROPN
iajs-2675	338	6	,	,	PUNCT
iajs-2675	338	7	t.	t.	PROPN
iajs-2675	338	8	;	;	PUNCT
iajs-2675	338	9	kume	kume	PROPN
iajs-2675	338	10	,	,	PUNCT
iajs-2675	338	11	n.	n.	PROPN
iajs-2675	338	12	;	;	PUNCT
iajs-2675	338	13	asano	asano	PROPN
iajs-2675	338	14	,	,	PUNCT
iajs-2675	338	15	d.	d.	PROPN
iajs-2675	338	16	;	;	PUNCT
iajs-2675	338	17	ogawa	ogawa	PROPN
iajs-2675	338	18	,	,	PUNCT
iajs-2675	338	19	m.	m.	NOUN
iajs-2675	338	20	;	;	PUNCT
iajs-2675	338	21	kuge	kuge	NOUN
iajs-2675	338	22	,	,	PUNCT
iajs-2675	338	23	y.	y.	PROPN
iajs-2675	338	24	;	;	PUNCT
iajs-2675	338	25	minami	minami	PROPN
iajs-2675	338	26	,	,	PUNCT
iajs-2675	338	27	m.	m.	NOUN
iajs-2675	338	28	;	;	PUNCT
iajs-2675	338	29	kita	kita	PROPN
iajs-2675	338	30	,	,	PUNCT
iajs-2675	338	31	t.	t.	PROPN
iajs-2675	338	32	;	;	PUNCT
iajs-2675	338	33	shiomi	shiomi	PROPN
iajs-2675	338	34	,	,	PUNCT
iajs-2675	338	35	m.	m.	NOUN
iajs-2675	338	36	;	;	PUNCT
iajs-2675	338	37	saji	saji	PROPN
iajs-2675	338	38	,	,	PUNCT
iajs-2675	338	39	h.	h.	PROPN
iajs-2675	338	40	lectin	lectin	PROPN
iajs-2675	338	41	-	-	PUNCT
iajs-2675	338	42	like	like	ADJ
iajs-2675	338	43	oxidized	oxidize	VERB
iajs-2675	338	44	ldl	ldl	NOUN
iajs-2675	338	45	receptor1	receptor1	PROPN
iajs-2675	338	46	(	(	PUNCT
iajs-2675	338	47	lox-1	lox-1	NOUN
iajs-2675	338	48	)	)	PUNCT
iajs-2675	338	49	expression	expression	NOUN
iajs-2675	338	50	is	be	AUX
iajs-2675	338	51	associated	associate	VERB
iajs-2675	338	52	with	with	ADP
iajs-2675	338	53	atherosclerotic	atherosclerotic	ADJ
iajs-2675	338	54	plaque	plaque	NOUN
iajs-2675	338	55	instability	instability	NOUN
iajs-2675	338	56	-	-	PUNCT
iajs-2675	338	57	analysis	analysis	NOUN
iajs-2675	338	58	in	in	ADP
iajs-2675	338	59	hypercholesterolemic	hypercholesterolemic	ADJ
iajs-2675	338	60	rabbits	rabbit	NOUN
iajs-2675	338	61	.	.	PUNCT
iajs-2675	339	1	atherosclerosis	atherosclerosis	NOUN
iajs-2675	339	2	2007	2007	NUM
iajs-2675	339	3	,	,	PUNCT
iajs-2675	339	4	195	195	NUM
iajs-2675	339	5	,	,	PUNCT
iajs-2675	339	6	48	48	NUM
iajs-2675	339	7	-	-	SYM
iajs-2675	339	8	56	56	NUM
iajs-2675	339	9	,	,	PUNCT
iajs-2675	339	10	doi	doi	NOUN
iajs-2675	339	11	:	:	PUNCT
iajs-2675	339	12	10.1016	10.1016	NUM
iajs-2675	339	13	/	/	SYM
iajs-2675	339	14	j.atherosclerosis.2006.11.031	j.atherosclerosis.2006.11.031	PROPN
iajs-2675	339	15	.	.	PROPN
iajs-2675	339	16	49	49	NUM
iajs-2675	339	17	.	.	PUNCT
iajs-2675	339	18	kuge	kuge	NOUN
iajs-2675	339	19	,	,	PUNCT
iajs-2675	339	20	y.	y.	PROPN
iajs-2675	339	21	;	;	PUNCT
iajs-2675	339	22	kume	kume	PROPN
iajs-2675	339	23	,	,	PUNCT
iajs-2675	339	24	n.	n.	PROPN
iajs-2675	339	25	;	;	PUNCT
iajs-2675	339	26	ishino	ishino	PROPN
iajs-2675	339	27	,	,	PUNCT
iajs-2675	339	28	s.	s.	PROPN
iajs-2675	339	29	;	;	PUNCT
iajs-2675	339	30	takai	takai	PROPN
iajs-2675	339	31	,	,	PUNCT
iajs-2675	339	32	n.	n.	PROPN
iajs-2675	339	33	;	;	PUNCT
iajs-2675	339	34	ogawa	ogawa	PROPN
iajs-2675	339	35	,	,	PUNCT
iajs-2675	339	36	y.	y.	PROPN
iajs-2675	339	37	;	;	PUNCT
iajs-2675	339	38	mukai	mukai	PROPN
iajs-2675	339	39	,	,	PUNCT
iajs-2675	339	40	t.	t.	PROPN
iajs-2675	339	41	;	;	PUNCT
iajs-2675	339	42	minami	minami	PROPN
iajs-2675	339	43	,	,	PUNCT
iajs-2675	339	44	m.	m.	NOUN
iajs-2675	339	45	;	;	PUNCT
iajs-2675	339	46	shiomi	shiomi	PROPN
iajs-2675	339	47	.	.	PUNCT
iajs-2675	339	48	m.	m.	NOUN
iajs-2675	339	49	;	;	PUNCT
iajs-2675	339	50	saji	saji	PROPN
iajs-2675	339	51	,	,	PUNCT
iajs-2675	339	52	h.	h.	PROPN
iajs-2675	339	53	prominent	prominent	ADJ
iajs-2675	339	54	lectin	lectin	NOUN
iajs-2675	339	55	-	-	PUNCT
iajs-2675	339	56	like	like	ADJ
iajs-2675	339	57	oxidized	oxidize	VERB
iajs-2675	339	58	ldl	ldl	NOUN
iajs-2675	339	59	receptor-1	receptor-1	NUM
iajs-2675	339	60	(	(	PUNCT
iajs-2675	339	61	lox-1	lox-1	NOUN
iajs-2675	339	62	)	)	PUNCT
iajs-2675	339	63	expression	expression	NOUN
iajs-2675	339	64	in	in	ADP
iajs-2675	339	65	atherosclerotic	atherosclerotic	ADJ
iajs-2675	339	66	lesions	lesion	NOUN
iajs-2675	339	67	is	be	AUX
iajs-2675	339	68	associated	associate	VERB
iajs-2675	339	69	with	with	ADP
iajs-2675	339	70	tissue	tissue	NOUN
iajs-2675	339	71	factor	factor	NOUN
iajs-2675	339	72	expression	expression	NOUN
iajs-2675	339	73	and	and	CCONJ
iajs-2675	339	74	apoptosis	apoptosis	NOUN
iajs-2675	339	75	in	in	ADP
iajs-2675	339	76	hypercholesterolemic	hypercholesterolemic	ADJ
iajs-2675	339	77	rabbits	rabbit	NOUN
iajs-2675	339	78	.	.	PUNCT
iajs-2675	340	1	biol	biol	PROPN
iajs-2675	340	2	pharm	pharm	PROPN
iajs-2675	340	3	bull	bull	PROPN
iajs-2675	340	4	.	.	PUNCT
iajs-2675	341	1	2008	2008	NUM
iajs-2675	341	2	,	,	PUNCT
iajs-2675	341	3	31,1475	31,1475	NUM
iajs-2675	341	4	-	-	SYM
iajs-2675	341	5	82	82	NUM
iajs-2675	341	6	,	,	PUNCT
iajs-2675	341	7	doi	doi	NOUN
iajs-2675	341	8	:	:	PUNCT
iajs-2675	341	9	10.1248	10.1248	NUM
iajs-2675	341	10	/	/	SYM
iajs-2675	341	11	bpb.31.1475	bpb.31.1475	PROPN
iajs-2675	341	12	.	.	PUNCT
iajs-2675	342	1	50	50	NUM
iajs-2675	342	2	.	.	X
iajs-2675	342	3	ishino	ishino	PROPN
iajs-2675	342	4	,	,	PUNCT
iajs-2675	342	5	s.	s.	PROPN
iajs-2675	342	6	;	;	PUNCT
iajs-2675	342	7	mukai	mukai	PROPN
iajs-2675	342	8	,	,	PUNCT
iajs-2675	342	9	t.	t.	PROPN
iajs-2675	342	10	;	;	PUNCT
iajs-2675	342	11	kuge	kuge	NOUN
iajs-2675	342	12	,	,	PUNCT
iajs-2675	342	13	y.	y.	PROPN
iajs-2675	342	14	;	;	PUNCT
iajs-2675	342	15	kume	kume	PROPN
iajs-2675	342	16	,	,	PUNCT
iajs-2675	342	17	n.	n.	PROPN
iajs-2675	342	18	;	;	PUNCT
iajs-2675	342	19	ogawa	ogawa	PROPN
iajs-2675	342	20	,	,	PUNCT
iajs-2675	342	21	m.	m.	NOUN
iajs-2675	342	22	;	;	PUNCT
iajs-2675	342	23	takai	takai	PROPN
iajs-2675	342	24	,	,	PUNCT
iajs-2675	342	25	n.	n.	NOUN
iajs-2675	342	26	;	;	PUNCT
iajs-2675	342	27	kamihashi	kamihashi	PROPN
iajs-2675	342	28	,	,	PUNCT
iajs-2675	342	29	j.	j.	PROPN
iajs-2675	342	30	;	;	PUNCT
iajs-2675	342	31	shiomi	shiomi	PROPN
iajs-2675	342	32	,	,	PUNCT
iajs-2675	342	33	m.	m.	NOUN
iajs-2675	342	34	;	;	PUNCT
iajs-2675	342	35	minami	minami	PROPN
iajs-2675	342	36	,	,	PUNCT
iajs-2675	342	37	m.	m.	NOUN
iajs-2675	342	38	;	;	PUNCT
iajs-2675	342	39	kita	kita	PROPN
iajs-2675	342	40	,	,	PUNCT
iajs-2675	342	41	t.	t.	PROPN
iajs-2675	342	42	;	;	PUNCT
iajs-2675	342	43	saji	saji	PROPN
iajs-2675	342	44	,	,	PUNCT
iajs-2675	342	45	h.	h.	PROPN
iajs-2675	342	46	targeting	targeting	NOUN
iajs-2675	342	47	of	of	ADP
iajs-2675	342	48	lectinlike	lectinlike	NOUN
iajs-2675	342	49	oxidized	oxidize	VERB
iajs-2675	342	50	low	low	ADJ
iajs-2675	342	51	-	-	PUNCT
iajs-2675	342	52	density	density	NOUN
iajs-2675	342	53	lipoprotein	lipoprotein	ADJ
iajs-2675	342	54	receptor	receptor	NOUN
iajs-2675	342	55	1	1	NUM
iajs-2675	342	56	(	(	PUNCT
iajs-2675	342	57	lox-1	lox-1	NOUN
iajs-2675	342	58	)	)	PUNCT
iajs-2675	342	59	with	with	ADP
iajs-2675	342	60	99mtclabeled	99mtclabeled	ADJ
iajs-2675	342	61	anti	anti	ADJ
iajs-2675	342	62	-	-	ADJ
iajs-2675	342	63	lox-1	lox-1	ADJ
iajs-2675	342	64	antibody	antibody	NOUN
iajs-2675	342	65	:	:	PUNCT
iajs-2675	342	66	potential	potential	ADJ
iajs-2675	342	67	target	target	NOUN
iajs-2675	342	68	for	for	ADP
iajs-2675	342	69	imaging	imaging	NOUN
iajs-2675	342	70	of	of	ADP
iajs-2675	342	71	vulnerable	vulnerable	ADJ
iajs-2675	342	72	plaque	plaque	NOUN
iajs-2675	342	73	.	.	PUNCT
iajs-2675	343	1	j	j	PROPN
iajs-2675	343	2	nucl	nucl	PROPN
iajs-2675	343	3	med	med	PROPN
iajs-2675	343	4	.	.	PROPN
iajs-2675	343	5	2008	2008	NUM
iajs-2675	343	6	,	,	PUNCT
iajs-2675	343	7	49	49	NUM
iajs-2675	343	8	,	,	PUNCT
iajs-2675	343	9	1677	1677	NUM
iajs-2675	343	10	-	-	SYM
iajs-2675	343	11	85	85	NUM
iajs-2675	343	12	,	,	PUNCT
iajs-2675	343	13	doi	doi	NOUN
iajs-2675	343	14	:	:	PUNCT
iajs-2675	343	15	10.2967	10.2967	NUM
iajs-2675	343	16	/	/	SYM
iajs-2675	343	17	jnumed.107.049536	jnumed.107.049536	NOUN
iajs-2675	343	18	.	.	PUNCT
iajs-2675	344	1	epub	epub	PROPN
iajs-2675	344	2	2008	2008	NUM
iajs-2675	344	3	sep	sep	PROPN
iajs-2675	344	4	15	15	NUM
iajs-2675	344	5	.	.	PUNCT
iajs-2675	345	1	51	51	NUM
iajs-2675	345	2	.	.	PUNCT
iajs-2675	346	1	demarco	demarco	PROPN
iajs-2675	346	2	,	,	PUNCT
iajs-2675	346	3	v.g	v.g	PROPN
iajs-2675	346	4	.	.	PROPN
iajs-2675	346	5	;	;	PUNCT
iajs-2675	346	6	aroor	aroor	ADJ
iajs-2675	346	7	,	,	PUNCT
iajs-2675	346	8	a.r	a.r	PROPN
iajs-2675	346	9	.	.	PROPN
iajs-2675	346	10	;	;	PUNCT
iajs-2675	346	11	sowers	sower	NOUN
iajs-2675	346	12	,	,	PUNCT
iajs-2675	346	13	j.r	j.r	PROPN
iajs-2675	346	14	.	.	PROPN
iajs-2675	347	1	the	the	DET
iajs-2675	347	2	pathophysiology	pathophysiology	NOUN
iajs-2675	347	3	of	of	ADP
iajs-2675	347	4	hypertension	hypertension	NOUN
iajs-2675	347	5	in	in	ADP
iajs-2675	347	6	patients	patient	NOUN
iajs-2675	347	7	with	with	ADP
iajs-2675	347	8	obesity	obesity	NOUN
iajs-2675	347	9	.	.	PUNCT
iajs-2675	348	1	nat	nat	PROPN
iajs-2675	348	2	rev	rev	PROPN
iajs-2675	348	3	endocrinol	endocrinol	NOUN
iajs-2675	348	4	.	.	PUNCT
iajs-2675	349	1	2014,10	2014,10	NOUN
iajs-2675	349	2	,	,	PUNCT
iajs-2675	349	3	364–376	364–376	NUM
iajs-2675	349	4	,	,	PUNCT
iajs-2675	349	5	doi	doi	NOUN
iajs-2675	349	6	:	:	PUNCT
iajs-2675	349	7	10.1038	10.1038	NUM
iajs-2675	349	8	/	/	SYM
iajs-2675	349	9	nrendo.2014.44	nrendo.2014.44	NOUN
iajs-2675	349	10	.	.	PUNCT
iajs-2675	350	1	52	52	NUM
iajs-2675	350	2	.	.	PUNCT
iajs-2675	351	1	padilla	padilla	PROPN
iajs-2675	351	2	,	,	PUNCT
iajs-2675	351	3	j.	j.	PROPN
iajs-2675	351	4	;	;	PUNCT
iajs-2675	351	5	vierira	vierira	NOUN
iajs-2675	351	6	-	-	PUNCT
iajs-2675	351	7	potter	potter	NOUN
iajs-2675	351	8	,	,	PUNCT
iajs-2675	351	9	v.j	v.j	PROPN
iajs-2675	351	10	.	.	PROPN
iajs-2675	351	11	;	;	PUNCT
iajs-2675	351	12	jia	jia	PROPN
iajs-2675	351	13	,	,	PUNCT
iajs-2675	351	14	g.	g.	PROPN
iajs-2675	351	15	;	;	PUNCT
iajs-2675	351	16	sowers	sower	NOUN
iajs-2675	351	17	,	,	PUNCT
iajs-2675	351	18	j.r	j.r	PROPN
iajs-2675	351	19	.	.	PROPN
iajs-2675	351	20	role	role	NOUN
iajs-2675	351	21	of	of	ADP
iajs-2675	351	22	perivascular	perivascular	ADJ
iajs-2675	351	23	adipose	adipose	PRON
iajs-2675	351	24	tissue	tissue	NOUN
iajs-2675	351	25	on	on	ADP
iajs-2675	351	26	vascular	vascular	ADJ
iajs-2675	351	27	reactive	reactive	ADJ
iajs-2675	351	28	oxygen	oxygen	NOUN
iajs-2675	351	29	species	specie	NOUN
iajs-2675	351	30	in	in	ADP
iajs-2675	351	31	type	type	NOUN
iajs-2675	351	32	2	2	NUM
iajs-2675	351	33	diabetes	diabete	NOUN
iajs-2675	351	34	:	:	PUNCT
iajs-2675	351	35	a	a	DET
iajs-2675	351	36	give	give	NOUN
iajs-2675	351	37	and	and	CCONJ
iajs-2675	351	38	take	take	VERB
iajs-2675	351	39	relationship	relationship	NOUN
iajs-2675	351	40	.	.	PUNCT
iajs-2675	352	1	diabetes	diabetes	NOUN
iajs-2675	352	2	.	.	PUNCT
iajs-2675	353	1	2015	2015	NUM
iajs-2675	353	2	,	,	PUNCT
iajs-2675	353	3	64,1904–06	64,1904–06	PROPN
iajs-2675	353	4	,	,	PUNCT
iajs-2675	353	5	doi	doi	NOUN
iajs-2675	353	6	:	:	PUNCT
iajs-2675	353	7	10.2337	10.2337	NUM
iajs-2675	353	8	/	/	SYM
iajs-2675	353	9	db15	db15	PROPN
iajs-2675	353	10	-	-	PUNCT
iajs-2675	353	11	0096	0096	NUM
iajs-2675	353	12	.	.	PUNCT
iajs-2675	354	1	53	53	NUM
iajs-2675	354	2	.	.	PUNCT
iajs-2675	354	3	massiera	massiera	PROPN
iajs-2675	354	4	,	,	PUNCT
iajs-2675	354	5	f.	f.	PROPN
iajs-2675	354	6	;	;	PUNCT
iajs-2675	354	7	seydoux	seydoux	NUM
iajs-2675	354	8	,	,	PUNCT
iajs-2675	354	9	j.	j.	PROPN
iajs-2675	354	10	;	;	PUNCT
iajs-2675	354	11	geloen	geloen	NOUN
iajs-2675	354	12	,	,	PUNCT
iajs-2675	354	13	a.	a.	NOUN
iajs-2675	354	14	;	;	PUNCT
iajs-2675	354	15	quignard	quignard	ADJ
iajs-2675	354	16	-	-	PUNCT
iajs-2675	354	17	boulange	boulange	NOUN
iajs-2675	354	18	,	,	PUNCT
iajs-2675	354	19	i.	i.	NOUN
iajs-2675	354	20	;	;	PUNCT
iajs-2675	354	21	turban	turban	PROPN
iajs-2675	354	22	,	,	PUNCT
iajs-2675	354	23	s.	s.	PROPN
iajs-2675	354	24	;	;	PUNCT
iajs-2675	354	25	saint	saint	PROPN
iajs-2675	354	26	-	-	PUNCT
iajs-2675	354	27	marc	marc	PROPN
iajs-2675	354	28	,	,	PUNCT
iajs-2675	354	29	p.	p.	NOUN
iajs-2675	354	30	;	;	PUNCT
iajs-2675	354	31	fukamizu	fukamizu	ADJ
iajs-2675	354	32	,	,	PUNCT
iajs-2675	354	33	a.;negrel	a.;negrel	NOUN
iajs-2675	354	34	,	,	PUNCT
iajs-2675	354	35	r.	r.	PROPN
iajs-2675	354	36	;	;	PUNCT
iajs-2675	354	37	ailhaud	ailhaud	ADJ
iajs-2675	354	38	,	,	PUNCT
iajs-2675	354	39	g.	g.	PROPN
iajs-2675	354	40	;	;	PUNCT
iajs-2675	354	41	teboul	teboul	PROPN
iajs-2675	354	42	,	,	PUNCT
iajs-2675	354	43	m.	m.	NOUN
iajs-2675	354	44	angiotensinogen	angiotensinogen	NOUN
iajs-2675	354	45	-	-	PUNCT
iajs-2675	354	46	deficient	deficient	ADJ
iajs-2675	354	47	mice	mouse	NOUN
iajs-2675	354	48	exhibit	exhibit	VERB
iajs-2675	354	49	impairment	impairment	NOUN
iajs-2675	354	50	of	of	ADP
iajs-2675	354	51	diet	diet	NOUN
iajs-2675	354	52	-	-	PUNCT
iajs-2675	354	53	induced	induce	VERB
iajs-2675	354	54	weight	weight	NOUN
iajs-2675	354	55	gain	gain	NOUN
iajs-2675	354	56	with	with	ADP
iajs-2675	354	57	alteration	alteration	NOUN
iajs-2675	354	58	in	in	ADP
iajs-2675	354	59	adipose	adipose	ADJ
iajs-2675	354	60	tissue	tissue	NOUN
iajs-2675	354	61	development	development	NOUN
iajs-2675	354	62	and	and	CCONJ
iajs-2675	354	63	increased	increase	VERB
iajs-2675	354	64	locomotor	locomotor	NOUN
iajs-2675	354	65	activity	activity	NOUN
iajs-2675	354	66	.	.	PUNCT
iajs-2675	355	1	endocrinology	endocrinology	NOUN
iajs-2675	355	2	.	.	PUNCT
iajs-2675	356	1	2001,142,5220–5225	2001,142,5220–5225	NUM
iajs-2675	356	2	,	,	PUNCT
iajs-2675	356	3	doi	doi	NOUN
iajs-2675	356	4	:	:	PUNCT
iajs-2675	356	5	10.1210	10.1210	NUM
iajs-2675	356	6	/	/	SYM
iajs-2675	356	7	endo.142.12.8556	endo.142.12.8556	NOUN
iajs-2675	356	8	.	.	PUNCT
iajs-2675	357	1	54	54	NUM
iajs-2675	357	2	.	.	PUNCT
iajs-2675	358	1	yvan	yvan	PROPN
iajs-2675	358	2	-	-	PUNCT
iajs-2675	358	3	charvet	charvet	PROPN
iajs-2675	358	4	,	,	PUNCT
iajs-2675	358	5	l.	l.	PROPN
iajs-2675	358	6	;	;	PUNCT
iajs-2675	358	7	even	even	ADV
iajs-2675	358	8	,	,	PUNCT
iajs-2675	358	9	p.	p.	NOUN
iajs-2675	358	10	;	;	PUNCT
iajs-2675	358	11	bloch	bloch	PROPN
iajs-2675	358	12	-	-	PUNCT
iajs-2675	358	13	faure	faure	PROPN
iajs-2675	358	14	,	,	PUNCT
iajs-2675	358	15	m.	m.	NOUN
iajs-2675	358	16	;	;	PUNCT
iajs-2675	358	17	guerre	guerre	PROPN
iajs-2675	358	18	-	-	PUNCT
iajs-2675	358	19	millo	millo	PROPN
iajs-2675	358	20	,	,	PUNCT
iajs-2675	358	21	m.;moustaid	m.;moustaid	NOUN
iajs-2675	358	22	-	-	PUNCT
iajs-2675	358	23	moussa.n	moussa.n	PROPN
iajs-2675	358	24	.	.	PUNCT
iajs-2675	358	25	;	;	PUNCT
iajs-2675	358	26	ferre	ferre	PROPN
iajs-2675	358	27	,	,	PUNCT
iajs-2675	358	28	p.	p.	NOUN
iajs-2675	358	29	;	;	PUNCT
iajs-2675	358	30	quignard	quignard	ADJ
iajs-2675	358	31	-	-	PUNCT
iajs-2675	358	32	boulange	boulange	NOUN
iajs-2675	358	33	,	,	PUNCT
iajs-2675	358	34	a.	a.	NOUN
iajs-2675	358	35	deletion	deletion	NOUN
iajs-2675	358	36	of	of	ADP
iajs-2675	358	37	the	the	DET
iajs-2675	358	38	angiotensin	angiotensin	NOUN
iajs-2675	358	39	type	type	NOUN
iajs-2675	358	40	2	2	NUM
iajs-2675	358	41	receptor	receptor	NOUN
iajs-2675	358	42	reduces	reduce	VERB
iajs-2675	358	43	adipose	adipose	PRON
iajs-2675	358	44	cell	cell	NOUN
iajs-2675	358	45	size	size	NOUN
iajs-2675	358	46	and	and	CCONJ
iajs-2675	358	47	protects	protect	VERB
iajs-2675	358	48	from	from	ADP
iajs-2675	358	49	diet	diet	NOUN
iajs-2675	358	50	-	-	PUNCT
iajs-2675	358	51	induced	induce	VERB
iajs-2675	358	52	obesity	obesity	NOUN
iajs-2675	358	53	and	and	CCONJ
iajs-2675	358	54	insulin	insulin	NOUN
iajs-2675	358	55	resistance	resistance	NOUN
iajs-2675	358	56	.	.	PUNCT
iajs-2675	359	1	diabetes	diabetes	NOUN
iajs-2675	359	2	.	.	PUNCT
iajs-2675	360	1	2005,54	2005,54	NUM
iajs-2675	360	2	,	,	PUNCT
iajs-2675	360	3	991–999	991–999	NUM
iajs-2675	360	4	,	,	PUNCT
iajs-2675	360	5	doi	doi	NOUN
iajs-2675	360	6	:	:	PUNCT
iajs-2675	360	7	10.2337	10.2337	NUM
iajs-2675	360	8	/	/	SYM
iajs-2675	360	9	diabetes.54.4.991	diabetes.54.4.991	NOUN
iajs-2675	360	10	.	.	PUNCT
iajs-2675	361	1	55	55	NUM
iajs-2675	361	2	.	.	X
iajs-2675	361	3	yiannikouris	yiannikouris	PROPN
iajs-2675	361	4	,	,	PUNCT
iajs-2675	361	5	f.	f.	PROPN
iajs-2675	361	6	;	;	PUNCT
iajs-2675	361	7	gupte	gupte	PROPN
iajs-2675	361	8	,	,	PUNCT
iajs-2675	361	9	;	;	PUNCT
iajs-2675	361	10	putnam	putnam	PROPN
iajs-2675	361	11	.	.	PUNCT
iajs-2675	361	12	k.	k.	PROPN
iajs-2675	361	13	;	;	PUNCT
iajs-2675	361	14	thatcher	thatcher	PROPN
iajs-2675	361	15	,	,	PUNCT
iajs-2675	361	16	s.	s.	PROPN
iajs-2675	361	17	;	;	PUNCT
iajs-2675	361	18	charnigo	charnigo	PROPN
iajs-2675	361	19	,	,	PUNCT
iajs-2675	361	20	r.	r.	PROPN
iajs-2675	361	21	;	;	PUNCT
iajs-2675	361	22	rateri	rateri	PROPN
iajs-2675	361	23	,	,	PUNCT
iajs-2675	361	24	dl	dl	PROPN
iajs-2675	361	25	.	.	PROPN
iajs-2675	361	26	;	;	PUNCT
iajs-2675	361	27	daugherty	daugherty	PROPN
iajs-2675	361	28	.	.	PUNCT
iajs-2675	361	29	a.	a.	PROPN
iajs-2675	361	30	;	;	PUNCT
iajs-2675	362	1	lisa	lisa	PROPN
iajs-2675	362	2	.	.	PUNCT
iajs-2675	362	3	a.	a.	NOUN
iajs-2675	362	4	cassis	cassis	NOUN
iajs-2675	362	5	adipocyte	adipocyte	NOUN
iajs-2675	362	6	deficiency	deficiency	NOUN
iajs-2675	362	7	of	of	ADP
iajs-2675	362	8	angiotensinogen	angiotensinogen	NOUN
iajs-2675	362	9	prevents	prevent	VERB
iajs-2675	362	10	obesityinduced	obesityinduced	ADJ
iajs-2675	362	11	hypertension	hypertension	NOUN
iajs-2675	362	12	in	in	ADP
iajs-2675	362	13	male	male	ADJ
iajs-2675	362	14	mice	mouse	NOUN
iajs-2675	362	15	.	.	PUNCT
iajs-2675	363	1	hypertension	hypertension	NOUN
iajs-2675	363	2	.	.	PUNCT
iajs-2675	364	1	2012,60	2012,60	NUM
iajs-2675	364	2	,	,	PUNCT
iajs-2675	364	3	1524–30	1524–30	NUM
iajs-2675	364	4	,	,	PUNCT
iajs-2675	364	5	doi.org/10.1161/hypertensionaha.112.192690	doi.org/10.1161/hypertensionaha.112.192690	VERB
iajs-2675	364	6	56	56	NUM
iajs-2675	364	7	.	.	PUNCT
iajs-2675	365	1	mehta	mehta	PROPN
iajs-2675	365	2	,	,	PUNCT
iajs-2675	365	3	p.k	p.k	PROPN
iajs-2675	365	4	.	.	PROPN
iajs-2675	365	5	;	;	PUNCT
iajs-2675	365	6	griendling	griendle	VERB
iajs-2675	365	7	,	,	PUNCT
iajs-2675	365	8	k.k	k.k	PROPN
iajs-2675	365	9	.	.	PROPN
iajs-2675	365	10	angiotensin	angiotensin	PROPN
iajs-2675	365	11	ii	ii	PROPN
iajs-2675	365	12	cell	cell	NOUN
iajs-2675	365	13	signaling	signal	VERB
iajs-2675	365	14	:	:	PUNCT
iajs-2675	365	15	physiological	physiological	ADJ
iajs-2675	365	16	and	and	CCONJ
iajs-2675	365	17	pathological	pathological	ADJ
iajs-2675	365	18	effects	effect	NOUN
iajs-2675	365	19	in	in	ADP
iajs-2675	365	20	the	the	DET
iajs-2675	365	21	cardiovascular	cardiovascular	ADJ
iajs-2675	365	22	system	system	NOUN
iajs-2675	365	23	.	.	PUNCT
iajs-2675	366	1	am	be	AUX
iajs-2675	366	2	j	j	PROPN
iajs-2675	366	3	physiol	physiol	PROPN
iajs-2675	366	4	,	,	PUNCT
iajs-2675	366	5	cell	cell	NOUN
iajs-2675	366	6	physiol	physiol	NOUN
iajs-2675	366	7	.	.	PUNCT
iajs-2675	367	1	2007,292,82	2007,292,82	NUM
iajs-2675	367	2	–	–	PUNCT
iajs-2675	367	3	97	97	NUM
iajs-2675	367	4	,	,	PUNCT
iajs-2675	367	5	doi	doi	NOUN
iajs-2675	367	6	:	:	PUNCT
iajs-2675	367	7	10.1152	10.1152	NUM
iajs-2675	367	8	/	/	SYM
iajs-2675	367	9	ajpcell.00287.2006	ajpcell.00287.2006	NOUN
iajs-2675	367	10	.	.	PUNCT
iajs-2675	368	1	57	57	NUM
iajs-2675	368	2	.	.	PUNCT
iajs-2675	368	3	briones	briones	PROPN
iajs-2675	368	4	,	,	PUNCT
iajs-2675	368	5	a.m.	a.m.	ADV
iajs-2675	368	6	;	;	PUNCT
iajs-2675	368	7	dinh	dinh	NOUN
iajs-2675	368	8	cat	cat	NOUN
iajs-2675	368	9	.	.	PUNCT
iajs-2675	369	1	a.n	a.n	PROPN
iajs-2675	369	2	.	.	PROPN
iajs-2675	369	3	;	;	PUNCT
iajs-2675	369	4	callera	callera	NOUN
iajs-2675	369	5	,	,	PUNCT
iajs-2675	369	6	g.e.;yogi	g.e.;yogi	PROPN
iajs-2675	369	7	,	,	PUNCT
iajs-2675	369	8	a.	a.	NOUN
iajs-2675	369	9	;	;	PUNCT
iajs-2675	369	10	burger	burger	NOUN
iajs-2675	369	11	,	,	PUNCT
iajs-2675	369	12	d.	d.	PROPN
iajs-2675	369	13	;	;	PUNCT
iajs-2675	370	1	he	he	PRON
iajs-2675	370	2	,	,	PUNCT
iajs-2675	370	3	y.	y.	PROPN
iajs-2675	370	4	;	;	PUNCT
iajs-2675	370	5	corrêa.j.w	corrêa.j.w	PROPN
iajs-2675	370	6	.	.	PUNCT
iajs-2675	370	7	;	;	PUNCT
iajs-2675	370	8	gagnon	gagnon	PROPN
iajs-2675	370	9	,	,	PUNCT
iajs-2675	370	10	a.m.	a.m.	ADV
iajs-2675	370	11	;	;	PUNCT
iajs-2675	370	12	gomez	gomez	PROPN
iajs-2675	370	13	-	-	PUNCT
iajs-2675	370	14	sanchez	sanchez	PROPN
iajs-2675	370	15	,	,	PUNCT
iajs-2675	370	16	c.e	c.e	PROPN
iajs-2675	370	17	.	.	PROPN
iajs-2675	370	18	;	;	PUNCT
iajs-2675	370	19	gomez	gomez	PROPN
iajs-2675	370	20	-	-	PUNCT
iajs-2675	370	21	sanchez	sanchez	PROPN
iajs-2675	370	22	,	,	PUNCT
iajs-2675	370	23	e.p.;sorisky	e.p.;sorisky	PROPN
iajs-2675	370	24	,	,	PUNCT
iajs-2675	370	25	a.	a.	NOUN
iajs-2675	370	26	;	;	PUNCT
iajs-2675	370	27	ooi.t.c	ooi.t.c	PROPN
iajs-2675	370	28	.	.	PUNCT
iajs-2675	370	29	;	;	PUNCT
iajs-2675	370	30	ruzicka.m	ruzicka.m	NUM
iajs-2675	370	31	.	.	PUNCT
iajs-2675	370	32	;	;	PUNCT
iajs-2675	370	33	burns.k.d	burns.k.d	PROPN
iajs-2675	370	34	.	.	PUNCT
iajs-2675	370	35	;	;	PUNCT
iajs-2675	371	1	touyz.r.m	touyz.r.m	PROPN
iajs-2675	371	2	.	.	PUNCT
iajs-2675	372	1	adipocytes	adipocyte	NOUN
iajs-2675	372	2	produce	produce	VERB
iajs-2675	372	3	aldosterone	aldosterone	NOUN
iajs-2675	372	4	through	through	ADP
iajs-2675	372	5	calcineurindependent	calcineurindependent	ADJ
iajs-2675	372	6	signaling	signal	VERB
iajs-2675	372	7	pathways	pathway	NOUN
iajs-2675	372	8	:	:	PUNCT
iajs-2675	372	9	implications	implication	NOUN
iajs-2675	372	10	in	in	ADP
iajs-2675	372	11	diabetes	diabetes	NOUN
iajs-2675	372	12	mellitus	mellitus	NOUN
iajs-2675	372	13	-	-	PUNCT
iajs-2675	372	14	associated	associate	VERB
iajs-2675	372	15	obesity	obesity	NOUN
iajs-2675	372	16	and	and	CCONJ
iajs-2675	372	17	ibn	ibn	PROPN
iajs-2675	372	18	al	al	PROPN
iajs-2675	372	19	-	-	PUNCT
iajs-2675	372	20	haitham	haitham	PROPN
iajs-2675	372	21	jour	jour	X
iajs-2675	372	22	.	.	PROPN
iajs-2675	373	1	for	for	ADP
iajs-2675	373	2	pure	pure	ADJ
iajs-2675	373	3	&	&	CCONJ
iajs-2675	373	4	appl	appl	PROPN
iajs-2675	373	5	.	.	PUNCT
iajs-2675	374	1	sci	sci	PROPN
iajs-2675	374	2	.	.	PROPN
iajs-2675	375	1	34(3)2021	34(3)2021	NUM
iajs-2675	375	2	37	37	NUM
iajs-2675	375	3	vascular	vascular	ADJ
iajs-2675	375	4	dysfunction	dysfunction	NOUN
iajs-2675	375	5	.	.	PUNCT
iajs-2675	376	1	hypertension	hypertension	NOUN
iajs-2675	376	2	.	.	PUNCT
iajs-2675	377	1	2012,59,1069–1078	2012,59,1069–1078	NUM
iajs-2675	377	2	,	,	PUNCT
iajs-2675	377	3	doi:10.1161	doi:10.1161	NOUN
iajs-2675	377	4	/	/	SYM
iajs-2675	377	5	hypertensionaha.111.190223	hypertensionaha.111.190223	NOUN
iajs-2675	377	6	.	.	PUNCT
iajs-2675	378	1	58	58	NUM
iajs-2675	378	2	.	.	PUNCT
iajs-2675	379	1	bender	bender	PROPN
iajs-2675	379	2	,	,	PUNCT
iajs-2675	379	3	s.b	s.b	PROPN
iajs-2675	379	4	.	.	PROPN
iajs-2675	379	5	;	;	PUNCT
iajs-2675	379	6	mcgraw	mcgraw	PROPN
iajs-2675	379	7	,	,	PUNCT
iajs-2675	379	8	a.p	a.p	PROPN
iajs-2675	379	9	.	.	PROPN
iajs-2675	379	10	;	;	PUNCT
iajs-2675	379	11	jaffe	jaffe	PROPN
iajs-2675	379	12	,	,	PUNCT
iajs-2675	379	13	i.z	i.z	PROPN
iajs-2675	379	14	.	.	PROPN
iajs-2675	379	15	;	;	PUNCT
iajs-2675	379	16	sowers	sower	NOUN
iajs-2675	379	17	,	,	PUNCT
iajs-2675	379	18	j.r	j.r	PROPN
iajs-2675	379	19	.	.	PROPN
iajs-2675	379	20	mineralocorticoid	mineralocorticoid	PROPN
iajs-2675	379	21	receptormediated	receptormediate	VERB
iajs-2675	379	22	vascular	vascular	ADJ
iajs-2675	379	23	insulin	insulin	NOUN
iajs-2675	379	24	resistance	resistance	NOUN
iajs-2675	379	25	:	:	PUNCT
iajs-2675	379	26	an	an	DET
iajs-2675	379	27	early	early	ADJ
iajs-2675	379	28	contributor	contributor	NOUN
iajs-2675	379	29	to	to	ADP
iajs-2675	379	30	diabetes	diabetes	NOUN
iajs-2675	379	31	-	-	PUNCT
iajs-2675	379	32	related	relate	VERB
iajs-2675	379	33	vascular	vascular	ADJ
iajs-2675	379	34	disease	disease	NOUN
iajs-2675	379	35	?	?	PUNCT
iajs-2675	379	36	.	.	PUNCT
iajs-2675	380	1	diabetes	diabetes	NOUN
iajs-2675	380	2	.	.	PUNCT
iajs-2675	381	1	2013	2013	NUM
iajs-2675	381	2	,	,	PUNCT
iajs-2675	381	3	62(2),313–9	62(2),313–9	ADV
iajs-2675	381	4	,	,	PUNCT
iajs-2675	381	5	doi	doi	NOUN
iajs-2675	381	6	:	:	PUNCT
iajs-2675	381	7	10.2337	10.2337	NUM
iajs-2675	381	8	/	/	SYM
iajs-2675	381	9	db12	db12	PROPN
iajs-2675	381	10	-	-	PUNCT
iajs-2675	381	11	0905	0905	NUM
iajs-2675	381	12	.	.	PUNCT
iajs-2675	382	1	59	59	NUM
iajs-2675	382	2	.	.	PUNCT
iajs-2675	382	3	jia	jia	PROPN
iajs-2675	382	4	,	,	PUNCT
iajs-2675	382	5	g.	g.	PROPN
iajs-2675	382	6	;	;	PUNCT
iajs-2675	382	7	habibi	habibi	PROPN
iajs-2675	382	8	,	,	PUNCT
iajs-2675	382	9	j.	j.	PROPN
iajs-2675	382	10	;	;	PUNCT
iajs-2675	382	11	aroor	aroor	ADJ
iajs-2675	382	12	,	,	PUNCT
iajs-2675	382	13	a.r	a.r	PROPN
iajs-2675	382	14	.	.	PROPN
iajs-2675	382	15	;	;	PUNCT
iajs-2675	382	16	martinez	martinez	PROPN
iajs-2675	382	17	-	-	PUNCT
iajs-2675	382	18	lemus	lemus	PROPN
iajs-2675	382	19	,	,	PUNCT
iajs-2675	382	20	l.a	l.a	PROPN
iajs-2675	382	21	.	.	PROPN
iajs-2675	382	22	;	;	PUNCT
iajs-2675	382	23	demarco	demarco	PROPN
iajs-2675	382	24	,	,	PUNCT
iajs-2675	382	25	v.g	v.g	PROPN
iajs-2675	382	26	.	.	PROPN
iajs-2675	382	27	;	;	PUNCT
iajs-2675	382	28	ramirez	ramirez	PROPN
iajs-2675	382	29	-	-	PUNCT
iajs-2675	382	30	perez	perez	PROPN
iajs-2675	382	31	,	,	PUNCT
iajs-2675	382	32	f.i	f.i	PROPN
iajs-2675	382	33	.	.	PROPN
iajs-2675	382	34	;	;	PUNCT
iajs-2675	382	35	sun	sun	PROPN
iajs-2675	382	36	,	,	PUNCT
iajs-2675	382	37	z.	z.	PROPN
iajs-2675	382	38	;	;	PUNCT
iajs-2675	382	39	hayden	hayden	PROPN
iajs-2675	382	40	,	,	PUNCT
iajs-2675	382	41	m.r	m.r	PROPN
iajs-2675	382	42	.	.	PROPN
iajs-2675	382	43	;	;	PUNCT
iajs-2675	382	44	meininger	meininger	NOUN
iajs-2675	382	45	,	,	PUNCT
iajs-2675	382	46	g.a	g.a	PROPN
iajs-2675	382	47	.	.	PROPN
iajs-2675	382	48	;	;	PUNCT
iajs-2675	382	49	mueller	mueller	PROPN
iajs-2675	382	50	,	,	PUNCT
iajs-2675	382	51	k.b	k.b	PROPN
iajs-2675	382	52	.	.	PROPN
iajs-2675	382	53	;	;	PUNCT
iajs-2675	382	54	jaffe	jaffe	PROPN
iajs-2675	382	55	,	,	PUNCT
iajs-2675	382	56	i.z	i.z	PROPN
iajs-2675	382	57	.	.	PROPN
iajs-2675	382	58	;	;	PUNCT
iajs-2675	382	59	sower	sower	NOUN
iajs-2675	382	60	,	,	PUNCT
iajs-2675	382	61	j.r	j.r	PROPN
iajs-2675	382	62	.	.	PROPN
iajs-2675	382	63	endothelial	endothelial	ADJ
iajs-2675	382	64	mineralocorticoid	mineralocorticoid	NOUN
iajs-2675	382	65	receptor	receptor	NOUN
iajs-2675	382	66	mediates	mediate	VERB
iajs-2675	382	67	diet	diet	NOUN
iajs-2675	382	68	-	-	PUNCT
iajs-2675	382	69	induced	induce	VERB
iajs-2675	382	70	aortic	aortic	ADJ
iajs-2675	382	71	stiffness	stiffness	NOUN
iajs-2675	382	72	in	in	ADP
iajs-2675	382	73	females	female	NOUN
iajs-2675	382	74	.	.	PUNCT
iajs-2675	383	1	circ	circ	PROPN
iajs-2675	383	2	res	re	NOUN
iajs-2675	383	3	.	.	PROPN
iajs-2675	383	4	2016	2016	NUM
iajs-2675	383	5	,	,	PUNCT
iajs-2675	383	6	118,935–943	118,935–943	NUM
iajs-2675	383	7	,	,	PUNCT
iajs-2675	383	8	doi	doi	NOUN
iajs-2675	383	9	:	:	PUNCT
iajs-2675	384	1	10.1161	10.1161	NUM
iajs-2675	384	2	/	/	SYM
iajs-2675	384	3	circresaha.115.308269	circresaha.115.308269	NOUN
iajs-2675	384	4	.	.	PUNCT
iajs-2675	385	1	60ando	60ando	NUM
iajs-2675	385	2	,	,	PUNCT
iajs-2675	385	3	k.	k.	PROPN
iajs-2675	385	4	;	;	PUNCT
iajs-2675	385	5	fujita	fujita	PROPN
iajs-2675	385	6	,	,	PUNCT
iajs-2675	385	7	t.	t.	PROPN
iajs-2675	385	8	metabolic	metabolic	PROPN
iajs-2675	385	9	syndrome	syndrome	NOUN
iajs-2675	385	10	and	and	CCONJ
iajs-2675	385	11	oxidative	oxidative	ADJ
iajs-2675	385	12	stress	stress	NOUN
iajs-2675	385	13	.	.	PUNCT
iajs-2675	386	1	free	free	ADJ
iajs-2675	386	2	radic	radic	ADJ
iajs-2675	386	3	biol	biol	PROPN
iajs-2675	386	4	med	me	VERB
iajs-2675	386	5	.	.	PUNCT
iajs-2675	387	1	2009	2009	NUM
iajs-2675	387	2	,	,	PUNCT
iajs-2675	387	3	47(3),213	47(3),213	NUM
iajs-2675	387	4	-	-	SYM
iajs-2675	387	5	8	8	NUM
iajs-2675	387	6	,	,	PUNCT
iajs-2675	387	7	doi	doi	NOUN
iajs-2675	387	8	:	:	PUNCT
iajs-2675	387	9	10.1016	10.1016	NUM
iajs-2675	387	10	/	/	SYM
iajs-2675	387	11	j.freeradbiomed.2009.04.030	j.freeradbiomed.2009.04.030	PROPN
iajs-2675	387	12	.	.	PROPN
iajs-2675	387	13	61	61	NUM
iajs-2675	387	14	.	.	PUNCT
iajs-2675	388	1	allen	allen	PROPN
iajs-2675	388	2	,	,	PUNCT
iajs-2675	388	3	c.l	c.l	PROPN
iajs-2675	388	4	.	.	PROPN
iajs-2675	388	5	;	;	PUNCT
iajs-2675	388	6	bayraktutan	bayraktutan	NOUN
iajs-2675	388	7	,	,	PUNCT
iajs-2675	388	8	u.	u.	NOUN
iajs-2675	388	9	oxidative	oxidative	ADJ
iajs-2675	388	10	stress	stress	NOUN
iajs-2675	388	11	and	and	CCONJ
iajs-2675	388	12	its	its	PRON
iajs-2675	388	13	role	role	NOUN
iajs-2675	388	14	in	in	ADP
iajs-2675	388	15	the	the	DET
iajs-2675	388	16	pathogenesis	pathogenesis	NOUN
iajs-2675	388	17	of	of	ADP
iajs-2675	388	18	ischemic	ischemic	ADJ
iajs-2675	388	19	stroke	stroke	NOUN
iajs-2675	388	20	.	.	PUNCT
iajs-2675	389	1	international	international	ADJ
iajs-2675	389	2	journal	journal	PROPN
iajs-2675	389	3	of	of	ADP
iajs-2675	389	4	stroke	stroke	PROPN
iajs-2675	389	5	.	.	PUNCT
iajs-2675	390	1	2009,4,461–470	2009,4,461–470	NUM
iajs-2675	390	2	,	,	PUNCT
iajs-2675	390	3	doi.org/10.1111/j.17474949.2009.00387.x	doi.org/10.1111/j.17474949.2009.00387.x	X
iajs-2675	390	4	62	62	NUM
iajs-2675	390	5	.	.	PUNCT
iajs-2675	391	1	kaneto	kaneto	PROPN
iajs-2675	391	2	,	,	PUNCT
iajs-2675	391	3	h.	h.	PROPN
iajs-2675	391	4	;	;	PUNCT
iajs-2675	391	5	katakami	katakami	NOUN
iajs-2675	391	6	,	,	PUNCT
iajs-2675	391	7	n.	n.	NOUN
iajs-2675	391	8	;	;	PUNCT
iajs-2675	391	9	matsuhisa	matsuhisa	NOUN
iajs-2675	391	10	,	,	PUNCT
iajs-2675	391	11	m.	m.	NOUN
iajs-2675	391	12	;	;	PUNCT
iajs-2675	391	13	matsuoka	matsuoka	NOUN
iajs-2675	391	14	,	,	PUNCT
iajs-2675	391	15	t.	t.	ADJ
iajs-2675	391	16	role	role	NOUN
iajs-2675	391	17	of	of	ADP
iajs-2675	391	18	reactive	reactive	ADJ
iajs-2675	391	19	oxygen	oxygen	NOUN
iajs-2675	391	20	species	specie	NOUN
iajs-2675	391	21	in	in	ADP
iajs-2675	391	22	the	the	DET
iajs-2675	391	23	progression	progression	NOUN
iajs-2675	391	24	of	of	ADP
iajs-2675	391	25	type	type	NOUN
iajs-2675	391	26	2	2	NUM
iajs-2675	391	27	diabetes	diabetes	NOUN
iajs-2675	391	28	and	and	CCONJ
iajs-2675	391	29	atherosclerosis	atherosclerosis	NOUN
iajs-2675	391	30	.	.	PUNCT
iajs-2675	392	1	mediators	mediator	NOUN
iajs-2675	392	2	of	of	ADP
iajs-2675	392	3	inflammation	inflammation	NOUN
iajs-2675	392	4	.	.	PUNCT
iajs-2675	393	1	2010	2010	NUM
iajs-2675	393	2	,	,	PUNCT
iajs-2675	393	3	2010	2010	NUM
iajs-2675	393	4	,	,	PUNCT
iajs-2675	393	5	article	article	NOUN
iajs-2675	393	6	i	i	PROPN
iajs-2675	393	7	d	d	PROPN
iajs-2675	393	8	453892	453892	NUM
iajs-2675	393	9	,	,	PUNCT
iajs-2675	393	10	11	11	NUM
iajs-2675	393	11	pages	page	NOUN
iajs-2675	393	12	doi	doi	NOUN
iajs-2675	393	13	:	:	PUNCT
iajs-2675	393	14	10.1155/2010/453892	10.1155/2010/453892	NUM
iajs-2675	393	15	.	.	PUNCT
iajs-2675	393	16	63	63	NUM
iajs-2675	393	17	.	.	PUNCT
iajs-2675	394	1	nikolay	nikolay	NOUN
iajs-2675	394	2	,	,	PUNCT
iajs-2675	394	3	v.g	v.g	PROPN
iajs-2675	394	4	.	.	PROPN
iajs-2675	394	5	;	;	PUNCT
iajs-2675	395	1	pavel	pavel	PROPN
iajs-2675	395	2	,	,	PUNCT
iajs-2675	395	3	v.a	v.a	PROPN
iajs-2675	395	4	.	.	PROPN
iajs-2675	395	5	;	;	PUNCT
iajs-2675	395	6	alexander	alexander	PROPN
iajs-2675	395	7	,	,	PUNCT
iajs-2675	395	8	d.n	d.n	PROPN
iajs-2675	395	9	.	.	PROPN
iajs-2675	395	10	;	;	PUNCT
iajs-2675	395	11	irina	irina	PROPN
iajs-2675	395	12	,	,	PUNCT
iajs-2675	395	13	l.z	l.z	PROPN
iajs-2675	395	14	.	.	PROPN
iajs-2675	395	15	;	;	PUNCT
iajs-2675	395	16	richard	richard	PROPN
iajs-2675	395	17	,	,	PUNCT
iajs-2675	395	18	o.j	o.j	PROPN
iajs-2675	395	19	.	.	PROPN
iajs-2675	395	20	reactive	reactive	ADJ
iajs-2675	395	21	oxygen	oxygen	NOUN
iajs-2675	395	22	species	specie	NOUN
iajs-2675	395	23	in	in	ADP
iajs-2675	395	24	pathogenesis	pathogenesis	NOUN
iajs-2675	395	25	of	of	ADP
iajs-2675	395	26	atherosclerosis	atherosclerosis	NOUN
iajs-2675	395	27	.	.	PUNCT
iajs-2675	396	1	current	current	ADJ
iajs-2675	396	2	pharmaceutical	pharmaceutical	ADJ
iajs-2675	396	3	design	design	NOUN
iajs-2675	396	4	.	.	PUNCT
iajs-2675	397	1	2015	2015	NUM
iajs-2675	397	2	,	,	PUNCT
iajs-2675	397	3	21,1134	21,1134	NUM
iajs-2675	397	4	–	–	PUNCT
iajs-2675	397	5	1146	1146	NUM
iajs-2675	397	6	,	,	PUNCT
iajs-2675	397	7	doi	doi	NOUN
iajs-2675	397	8	:	:	PUNCT
iajs-2675	397	9	10.2174/1381612820666141014142557	10.2174/1381612820666141014142557	NUM
iajs-2675	397	10	64	64	NUM
iajs-2675	397	11	.	.	PUNCT
iajs-2675	398	1	gregor	gregor	PROPN
iajs-2675	398	2	,	,	PUNCT
iajs-2675	398	3	m.f	m.f	PROPN
iajs-2675	398	4	.	.	PROPN
iajs-2675	398	5	;	;	PUNCT
iajs-2675	398	6	hotamisligil	hotamisligil	PROPN
iajs-2675	398	7	,	,	PUNCT
iajs-2675	398	8	g.s	g.s	PROPN
iajs-2675	398	9	.	.	PROPN
iajs-2675	398	10	inflammatory	inflammatory	ADJ
iajs-2675	398	11	mechanisms	mechanism	NOUN
iajs-2675	398	12	in	in	ADP
iajs-2675	398	13	obesity	obesity	NOUN
iajs-2675	398	14	,	,	PUNCT
iajs-2675	398	15	annual	annual	ADJ
iajs-2675	398	16	review	review	NOUN
iajs-2675	398	17	of	of	ADP
iajs-2675	398	18	immunology	immunology	NOUN
iajs-2675	398	19	.	.	PUNCT
iajs-2675	399	1	2011	2011	NUM
iajs-2675	399	2	,	,	PUNCT
iajs-2675	399	3	29	29	NUM
iajs-2675	399	4	,	,	PUNCT
iajs-2675	399	5	415–445	415–445	NUM
iajs-2675	399	6	,	,	PUNCT
iajs-2675	399	7	doi	doi	NOUN
iajs-2675	399	8	:	:	PUNCT
iajs-2675	399	9	10.1146	10.1146	NUM
iajs-2675	399	10	/	/	SYM
iajs-2675	399	11	annurev	annurev	NOUN
iajs-2675	399	12	-	-	PUNCT
iajs-2675	399	13	immunol-031210	immunol-031210	NOUN
iajs-2675	399	14	-	-	PUNCT
iajs-2675	399	15	101322	101322	NUM
iajs-2675	399	16	.	.	PUNCT
iajs-2675	400	1	65	65	NUM
iajs-2675	400	2	.	.	PUNCT
iajs-2675	401	1	hotamisligil	hotamisligil	PROPN
iajs-2675	401	2	,	,	PUNCT
iajs-2675	401	3	g.s	g.s	PROPN
iajs-2675	401	4	.	.	PROPN
iajs-2675	401	5	;	;	PUNCT
iajs-2675	401	6	shargill	shargill	PROPN
iajs-2675	401	7	,	,	PUNCT
iajs-2675	401	8	n.s	n.s	PROPN
iajs-2675	401	9	.	.	PROPN
iajs-2675	401	10	;	;	PUNCT
iajs-2675	401	11	spiegelman	spiegelman	NOUN
iajs-2675	401	12	,	,	PUNCT
iajs-2675	401	13	b.m	b.m	PROPN
iajs-2675	401	14	.	.	PROPN
iajs-2675	401	15	adipose	adipose	NOUN
iajs-2675	401	16	expression	expression	NOUN
iajs-2675	401	17	of	of	ADP
iajs-2675	401	18	tumor	tumor	NOUN
iajs-2675	401	19	necrosis	necrosis	NOUN
iajs-2675	401	20	factor	factor	NOUN
iajs-2675	401	21	-	-	PUNCT
iajs-2675	401	22	α	α	NOUN
iajs-2675	401	23	:	:	PUNCT
iajs-2675	401	24	direct	direct	ADJ
iajs-2675	401	25	role	role	NOUN
iajs-2675	401	26	in	in	ADP
iajs-2675	401	27	obesity	obesity	NOUN
iajs-2675	401	28	-	-	PUNCT
iajs-2675	401	29	linked	link	VERB
iajs-2675	401	30	insulin	insulin	NOUN
iajs-2675	401	31	resistance	resistance	NOUN
iajs-2675	401	32	,	,	PUNCT
iajs-2675	401	33	science	science	NOUN
iajs-2675	401	34	.	.	PUNCT
iajs-2675	401	35	1993	1993	NUM
iajs-2675	401	36	,	,	PUNCT
iajs-2675	401	37	259(5091	259(5091	NUM
iajs-2675	401	38	)	)	PUNCT
iajs-2675	401	39	,	,	PUNCT
iajs-2675	401	40	87	87	NUM
iajs-2675	401	41	-	-	SYM
iajs-2675	401	42	91	91	NUM
iajs-2675	401	43	,	,	PUNCT
iajs-2675	401	44	doi	doi	NOUN
iajs-2675	401	45	:	:	PUNCT
iajs-2675	401	46	10.1126	10.1126	NUM
iajs-2675	401	47	/	/	SYM
iajs-2675	401	48	science.7678183	science.7678183	PROPN
iajs-2675	401	49	.	.	PROPN
iajs-2675	401	50	66	66	NUM
iajs-2675	401	51	.	.	PUNCT
iajs-2675	402	1	hotamisligil	hotamisligil	PROPN
iajs-2675	402	2	,	,	PUNCT
iajs-2675	402	3	g.s	g.s	PROPN
iajs-2675	402	4	.	.	PROPN
iajs-2675	402	5	;	;	PUNCT
iajs-2675	402	6	arner	arner	NOUN
iajs-2675	402	7	,	,	PUNCT
iajs-2675	402	8	p.	p.	NOUN
iajs-2675	402	9	;	;	PUNCT
iajs-2675	402	10	caro	caro	PROPN
iajs-2675	402	11	,	,	PUNCT
iajs-2675	402	12	j.f	j.f	PROPN
iajs-2675	402	13	.	.	PROPN
iajs-2675	402	14	;	;	PUNCT
iajs-2675	402	15	atkinson	atkinson	PROPN
iajs-2675	402	16	,	,	PUNCT
iajs-2675	402	17	r.l	r.l	PROPN
iajs-2675	402	18	.	.	PROPN
iajs-2675	402	19	;	;	PUNCT
iajs-2675	402	20	spiegelman	spiegelman	NOUN
iajs-2675	402	21	,	,	PUNCT
iajs-2675	402	22	b.m	b.m	PROPN
iajs-2675	402	23	.	.	PROPN
iajs-2675	402	24	increased	increase	VERB
iajs-2675	402	25	adipose	adipose	ADP
iajs-2675	402	26	tissue	tissue	NOUN
iajs-2675	402	27	expression	expression	NOUN
iajs-2675	402	28	of	of	ADP
iajs-2675	402	29	tumor	tumor	NOUN
iajs-2675	402	30	necrosis	necrosis	NOUN
iajs-2675	402	31	factor	factor	NOUN
iajs-2675	402	32	-	-	PUNCT
iajs-2675	402	33	α	α	NOUN
iajs-2675	402	34	in	in	ADP
iajs-2675	402	35	human	human	ADJ
iajs-2675	402	36	obesity	obesity	NOUN
iajs-2675	402	37	and	and	CCONJ
iajs-2675	402	38	insulin	insulin	NOUN
iajs-2675	402	39	resistance.the	resistance.the	PROPN
iajs-2675	402	40	journal	journal	NOUN
iajs-2675	402	41	of	of	ADP
iajs-2675	402	42	clinical	clinical	ADJ
iajs-2675	402	43	investigation	investigation	NOUN
iajs-2675	402	44	.	.	PUNCT
iajs-2675	403	1	1995	1995	NUM
iajs-2675	403	2	,	,	PUNCT
iajs-2675	403	3	95(5	95(5	NUM
iajs-2675	403	4	)	)	PUNCT
iajs-2675	403	5	,	,	PUNCT
iajs-2675	403	6	2409–2415	2409–2415	NUM
iajs-2675	403	7	,	,	PUNCT
iajs-2675	403	8	doi	doi	NOUN
iajs-2675	403	9	:	:	PUNCT
iajs-2675	403	10	10.1172	10.1172	NUM
iajs-2675	403	11	/	/	SYM
iajs-2675	403	12	jci117936	jci117936	PROPN
iajs-2675	403	13	.	.	PUNCT
iajs-2675	404	1	67	67	NUM
iajs-2675	404	2	.	.	PUNCT
iajs-2675	405	1	hotamisligil	hotamisligil	PROPN
iajs-2675	405	2	,	,	PUNCT
iajs-2675	405	3	g.s	g.s	PROPN
iajs-2675	405	4	.	.	PROPN
iajs-2675	405	5	;	;	PUNCT
iajs-2675	405	6	spiegelman	spiegelman	NOUN
iajs-2675	405	7	,	,	PUNCT
iajs-2675	405	8	b.m	b.m	PROPN
iajs-2675	405	9	.	.	PROPN
iajs-2675	405	10	tumor	tumor	PROPN
iajs-2675	405	11	necrosis	necrosis	NOUN
iajs-2675	405	12	factor	factor	NOUN
iajs-2675	405	13	α	α	NOUN
iajs-2675	405	14	:	:	PUNCT
iajs-2675	405	15	a	a	DET
iajs-2675	405	16	key	key	ADJ
iajs-2675	405	17	component	component	NOUN
iajs-2675	405	18	of	of	ADP
iajs-2675	405	19	the	the	DET
iajs-2675	405	20	obesity	obesity	NOUN
iajs-2675	405	21	-	-	PUNCT
iajs-2675	405	22	diabetes	diabetes	NOUN
iajs-2675	405	23	link.diabetes.1994	link.diabetes.1994	PROPN
iajs-2675	405	24	,	,	PUNCT
iajs-2675	405	25	43(11	43(11	NUM
iajs-2675	405	26	)	)	PUNCT
iajs-2675	405	27	,	,	PUNCT
iajs-2675	405	28	1271–1278	1271–1278	NUM
iajs-2675	405	29	,	,	PUNCT
iajs-2675	405	30	doi	doi	NOUN
iajs-2675	405	31	:	:	PUNCT
iajs-2675	405	32	10.2337	10.2337	NUM
iajs-2675	405	33	/	/	SYM
iajs-2675	405	34	diab.43.11.1271	diab.43.11.1271	PROPN
iajs-2675	405	35	.	.	PUNCT
iajs-2675	406	1	68.chiarelli	68.chiarelli	X
iajs-2675	406	2	,	,	PUNCT
iajs-2675	406	3	f.	f.	PROPN
iajs-2675	406	4	;	;	PUNCT
iajs-2675	406	5	mohn	mohn	PROPN
iajs-2675	406	6	,	,	PUNCT
iajs-2675	406	7	a.	a.	NOUN
iajs-2675	406	8	early	early	ADJ
iajs-2675	406	9	diagnosis	diagnosis	NOUN
iajs-2675	406	10	of	of	ADP
iajs-2675	406	11	metabolic	metabolic	NOUN
iajs-2675	406	12	syndrome	syndrome	NOUN
iajs-2675	406	13	in	in	ADP
iajs-2675	406	14	children	child	NOUN
iajs-2675	406	15	.	.	PUNCT
iajs-2675	407	1	lancet	lancet	PROPN
iajs-2675	407	2	child	child	PROPN
iajs-2675	407	3	adolesc	adolesc	PROPN
iajs-2675	407	4	health	health	NOUN
iajs-2675	407	5	.	.	PUNCT
iajs-2675	408	1	2017,1(2),86	2017,1(2),86	X
iajs-2675	408	2	-	-	SYM
iajs-2675	408	3	88	88	NUM
iajs-2675	408	4	,	,	PUNCT
iajs-2675	408	5	doi	doi	NOUN
iajs-2675	408	6	:	:	PUNCT
iajs-2675	408	7	10.1016	10.1016	NUM
iajs-2675	408	8	/	/	SYM
iajs-2675	408	9	s2352	s2352	PROPN
iajs-2675	408	10	-	-	PUNCT
iajs-2675	408	11	4642(17)30043	4642(17)30043	NOUN
iajs-2675	408	12	-	-	PUNCT
iajs-2675	408	13	3	3	NUM
iajs-2675	408	14	.	.	PUNCT
iajs-2675	409	1	69.chambers	69.chambers	NUM
iajs-2675	409	2	,	,	PUNCT
iajs-2675	409	3	j.h	j.h	PROPN
iajs-2675	409	4	.	.	PROPN
iajs-2675	409	5	;	;	PUNCT
iajs-2675	409	6	zerofsky	zerofsky	ADV
iajs-2675	409	7	,	,	PUNCT
iajs-2675	409	8	m.	m.	NOUN
iajs-2675	409	9	;	;	PUNCT
iajs-2675	409	10	lustig	lustig	PROPN
iajs-2675	409	11	,	,	PUNCT
iajs-2675	409	12	r.h	r.h	PROPN
iajs-2675	409	13	.	.	PROPN
iajs-2675	409	14	;	;	PUNCT
iajs-2675	409	15	rosenthal	rosenthal	PROPN
iajs-2675	409	16	,	,	PUNCT
iajs-2675	409	17	p.	p.	NOUN
iajs-2675	409	18	;	;	PUNCT
iajs-2675	409	19	perito	perito	PROPN
iajs-2675	409	20	,	,	PUNCT
iajs-2675	409	21	e.	e.	PROPN
iajs-2675	409	22	r.	r.	PROPN
iajs-2675	409	23	diet	diet	PROPN
iajs-2675	409	24	and	and	CCONJ
iajs-2675	409	25	exercise	exercise	VERB
iajs-2675	409	26	in	in	ADP
iajs-2675	409	27	pediatric	pediatric	ADJ
iajs-2675	409	28	liver	liver	NOUN
iajs-2675	409	29	transplant	transplant	NOUN
iajs-2675	409	30	recipients	recipient	NOUN
iajs-2675	409	31	:	:	PUNCT
iajs-2675	409	32	behaviors	behavior	NOUN
iajs-2675	409	33	and	and	CCONJ
iajs-2675	409	34	association	association	NOUN
iajs-2675	409	35	with	with	ADP
iajs-2675	409	36	metabolic	metabolic	NOUN
iajs-2675	409	37	syndrome	syndrome	NOUN
iajs-2675	409	38	.	.	PUNCT
iajs-2675	410	1	j	j	PROPN
iajs-2675	410	2	pediatr	pediatr	PROPN
iajs-2675	410	3	gastroenterol	gastroenterol	PROPN
iajs-2675	410	4	nutr	nutr	PROPN
iajs-2675	410	5	.	.	PUNCT
iajs-2675	410	6	2019,68(1),81	2019,68(1),81	PROPN
iajs-2675	410	7	-	-	PUNCT
iajs-2675	410	8	88	88	NUM
iajs-2675	410	9	,	,	PUNCT
iajs-2675	410	10	doi	doi	NOUN
iajs-2675	410	11	:	:	PUNCT
iajs-2675	410	12	10.1097	10.1097	NUM
iajs-2675	410	13	/	/	SYM
iajs-2675	410	14	mpg.0000000000002150	mpg.0000000000002150	NOUN
iajs-2675	410	15	.	.	PUNCT
iajs-2675	411	1	ibn	ibn	PROPN
iajs-2675	411	2	al	al	PROPN
iajs-2675	411	3	-	-	PUNCT
iajs-2675	411	4	haitham	haitham	PROPN
iajs-2675	411	5	jour	jour	X
iajs-2675	411	6	.	.	PROPN
iajs-2675	411	7	for	for	ADP
iajs-2675	411	8	pure	pure	ADJ
iajs-2675	411	9	&	&	CCONJ
iajs-2675	411	10	appl	appl	PROPN
iajs-2675	411	11	.	.	PUNCT
iajs-2675	412	1	sci	sci	PROPN
iajs-2675	412	2	.	.	PROPN
iajs-2675	413	1	34(3)2021	34(3)2021	NUM
iajs-2675	413	2	38	38	NUM
iajs-2675	413	3	70.kelley	70.kelley	NUM
iajs-2675	413	4	,	,	PUNCT
iajs-2675	413	5	e.	e.	PROPN
iajs-2675	413	6	;	;	PUNCT
iajs-2675	413	7	imboden	imboden	ADJ
iajs-2675	413	8	,	,	PUNCT
iajs-2675	413	9	m.t	m.t	PROPN
iajs-2675	413	10	.	.	PROPN
iajs-2675	413	11	;	;	PUNCT
iajs-2675	414	1	harber	harber	PROPN
iajs-2675	414	2	,	,	PUNCT
iajs-2675	414	3	m.p	m.p	PROPN
iajs-2675	414	4	.	.	PROPN
iajs-2675	414	5	;	;	PUNCT
iajs-2675	414	6	finch	finch	PROPN
iajs-2675	414	7	,	,	PUNCT
iajs-2675	414	8	h.	h.	PROPN
iajs-2675	414	9	;	;	PUNCT
iajs-2675	414	10	kaminsky	kaminsky	PROPN
iajs-2675	414	11	,	,	PUNCT
iajs-2675	414	12	l.a	l.a	PROPN
iajs-2675	414	13	.	.	PROPN
iajs-2675	414	14	;	;	PUNCT
iajs-2675	414	15	whaley	whaley	PROPN
iajs-2675	414	16	,	,	PUNCT
iajs-2675	414	17	m.h	m.h	PROPN
iajs-2675	414	18	.	.	PROPN
iajs-2675	414	19	cardiorespiratory	cardiorespiratory	PROPN
iajs-2675	414	20	fitness	fitness	PROPN
iajs-2675	414	21	is	be	AUX
iajs-2675	414	22	inversely	inversely	ADV
iajs-2675	414	23	associated	associate	VERB
iajs-2675	414	24	with	with	ADP
iajs-2675	414	25	clustering	clustering	NOUN
iajs-2675	414	26	of	of	ADP
iajs-2675	414	27	metabolic	metabolic	NOUN
iajs-2675	414	28	syndrome	syndrome	NOUN
iajs-2675	414	29	risk	risk	NOUN
iajs-2675	414	30	factors	factor	NOUN
iajs-2675	414	31	:	:	PUNCT
iajs-2675	414	32	the	the	DET
iajs-2675	414	33	ball	ball	NOUN
iajs-2675	414	34	state	state	NOUN
iajs-2675	414	35	adult	adult	PROPN
iajs-2675	414	36	fitness	fitness	NOUN
iajs-2675	414	37	program	program	NOUN
iajs-2675	414	38	longitudinal	longitudinal	ADJ
iajs-2675	414	39	lifestyle	lifestyle	PROPN
iajs-2675	414	40	study	study	NOUN
iajs-2675	414	41	.	.	PUNCT
iajs-2675	415	1	mayo	mayo	PROPN
iajs-2675	415	2	clin	clin	PROPN
iajs-2675	415	3	proc	proc	PROPN
iajs-2675	415	4	innov	innov	PROPN
iajs-2675	415	5	qual	qual	PROPN
iajs-2675	415	6	outcomes	outcome	NOUN
iajs-2675	415	7	.	.	PUNCT
iajs-2675	416	1	2018,2(2	2018,2(2	NUM
iajs-2675	416	2	)	)	PUNCT
iajs-2675	416	3	,	,	PUNCT
iajs-2675	416	4	155	155	NUM
iajs-2675	416	5	-	-	SYM
iajs-2675	416	6	164	164	NUM
iajs-2675	416	7	,	,	PUNCT
iajs-2675	416	8	doi	doi	NOUN
iajs-2675	416	9	:	:	PUNCT
iajs-2675	416	10	10.1016	10.1016	NUM
iajs-2675	416	11	/	/	SYM
iajs-2675	416	12	j.mayocpiqo.2018.03.001	j.mayocpiqo.2018.03.001	PROPN
iajs-2675	416	13	.	.	PUNCT
iajs-2675	417	1	71.hohenester	71.hohenester	NUM
iajs-2675	417	2	,	,	PUNCT
iajs-2675	417	3	s.	s.	PROPN
iajs-2675	417	4	;	;	PUNCT
iajs-2675	417	5	christiansen	christiansen	PROPN
iajs-2675	417	6	,	,	PUNCT
iajs-2675	417	7	s.	s.	PROPN
iajs-2675	417	8	;	;	PUNCT
iajs-2675	417	9	nagel	nagel	PROPN
iajs-2675	417	10	,	,	PUNCT
iajs-2675	417	11	j.	j.	PROPN
iajs-2675	417	12	;	;	PUNCT
iajs-2675	417	13	wimmer	wimmer	PROPN
iajs-2675	417	14	,	,	PUNCT
iajs-2675	417	15	r.	r.	PROPN
iajs-2675	417	16	;	;	PUNCT
iajs-2675	417	17	artmann	artmann	PROPN
iajs-2675	417	18	,	,	PUNCT
iajs-2675	417	19	r.	r.	PROPN
iajs-2675	417	20	;	;	PUNCT
iajs-2675	417	21	denk	denk	PROPN
iajs-2675	417	22	.	.	PUNCT
iajs-2675	418	1	g.	g.	PROPN
iajs-2675	418	2	;	;	PUNCT
iajs-2675	418	3	bischoff	bischoff	PROPN
iajs-2675	418	4	,	,	PUNCT
iajs-2675	418	5	m.	m.	NOUN
iajs-2675	418	6	;	;	PUNCT
iajs-2675	418	7	bischoff	bischoff	PROPN
iajs-2675	418	8	,	,	PUNCT
iajs-2675	418	9	g.	g.	PROPN
iajs-2675	418	10	;	;	PUNCT
iajs-2675	418	11	rust	rust	NOUN
iajs-2675	418	12	.	.	PUNCT
iajs-2675	419	1	c.	c.	PROPN
iajs-2675	419	2	lifestyle	lifestyle	PROPN
iajs-2675	419	3	intervention	intervention	NOUN
iajs-2675	419	4	for	for	ADP
iajs-2675	419	5	morbid	morbid	ADJ
iajs-2675	419	6	obesity	obesity	NOUN
iajs-2675	419	7	:	:	PUNCT
iajs-2675	419	8	effects	effect	NOUN
iajs-2675	419	9	on	on	ADP
iajs-2675	419	10	liver	liver	NOUN
iajs-2675	419	11	steatosis	steatosis	NOUN
iajs-2675	419	12	,	,	PUNCT
iajs-2675	419	13	inflammation	inflammation	NOUN
iajs-2675	419	14	,	,	PUNCT
iajs-2675	419	15	and	and	CCONJ
iajs-2675	419	16	fibrosis	fibrosis	NOUN
iajs-2675	419	17	.	.	PUNCT
iajs-2675	420	1	am	be	AUX
iajs-2675	420	2	j	j	PROPN
iajs-2675	420	3	physiol	physiol	PROPN
iajs-2675	420	4	gastrointest	gastrointest	PROPN
iajs-2675	420	5	liver	liver	PROPN
iajs-2675	420	6	physiol	physiol	NOUN
iajs-2675	420	7	.	.	PUNCT
iajs-2675	421	1	2018	2018	NUM
iajs-2675	421	2	,	,	PUNCT
iajs-2675	421	3	01,315(3),329	01,315(3),329	PROPN
iajs-2675	421	4	-	-	PUNCT
iajs-2675	421	5	338	338	NUM
iajs-2675	421	6	,	,	PUNCT
iajs-2675	421	7	doi	doi	NOUN
iajs-2675	421	8	:	:	PUNCT
iajs-2675	421	9	10.1152	10.1152	NUM
iajs-2675	421	10	/	/	SYM
iajs-2675	421	11	ajpgi.00044.2018	ajpgi.00044.2018	PROPN
iajs-2675	421	12	.	.	PUNCT
iajs-2675	422	1	72.cordero	72.cordero	NUM
iajs-2675	422	2	,	,	PUNCT
iajs-2675	422	3	p.	p.	NOUN
iajs-2675	422	4	;	;	PUNCT
iajs-2675	422	5	li	li	PROPN
iajs-2675	422	6	,	,	PUNCT
iajs-2675	422	7	j.	j.	PROPN
iajs-2675	422	8	;	;	PUNCT
iajs-2675	422	9	oben	oben	PROPN
iajs-2675	422	10	,	,	PUNCT
iajs-2675	422	11	j.a	j.a	PROPN
iajs-2675	422	12	.	.	PROPN
iajs-2675	422	13	bariatric	bariatric	ADJ
iajs-2675	422	14	surgery	surgery	NOUN
iajs-2675	422	15	as	as	ADP
iajs-2675	422	16	a	a	DET
iajs-2675	422	17	treatment	treatment	NOUN
iajs-2675	422	18	for	for	ADP
iajs-2675	422	19	metabolic	metabolic	NOUN
iajs-2675	422	20	syndrome	syndrome	NOUN
iajs-2675	422	21	.	.	PUNCT
iajs-2675	423	1	j	j	PROPN
iajs-2675	423	2	r	r	PROPN
iajs-2675	423	3	coll	coll	PROPN
iajs-2675	423	4	physicians	physician	NOUN
iajs-2675	423	5	edinb	edinb	NOUN
iajs-2675	423	6	.	.	PUNCT
iajs-2675	424	1	2017,47(4),364	2017,47(4),364	NUM
iajs-2675	424	2	-	-	SYM
iajs-2675	424	3	368	368	NUM
iajs-2675	424	4	,	,	PUNCT
iajs-2675	424	5	doi	doi	NOUN
iajs-2675	424	6	:	:	PUNCT
iajs-2675	424	7	10.4997	10.4997	NUM
iajs-2675	424	8	/	/	SYM
iajs-2675	424	9	jrcpe.2017.414	jrcpe.2017.414	PROPN
iajs-2675	424	10	.	.	PUNCT